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Gregory S. Davis 
 
 
Nontypeable Haemophilus influenzae (NTHi), a Gram-negative bacterium that 
commonly resides within the human pharynx as a commensal, is also capable of causing 
localized infections of the respiratory tract and invasive disease. Among children, NTHi is a 
leading cause of acute otitis media (AOM) which is a significant cause of childhood morbidity 
and the most common reason for prescribing antibiotics in the US. In adults, NTHi is often 
associated with acute exacerbations of chronic obstructive disease (COPD), the fourth leading 
cause of death worldwide. Because NTHi is human restricted its long term survival is dependent 
upon its ability to successfully colonize new hosts. Adherence to host epithelium, mediated by 
bacterial adhesins, is proposed to be one of the first steps in bacterial colonization and since 
disease-causing NTHi strains originate from strains that colonize the pharynges, adherence also 
marks one of the first steps in NTHi pathogenesis. NTHi encode several adhesins, including the 
high molecular weight (HMW) adhesins that mediate attachment to the respiratory epithelium 
where they interact with the host immune system, eliciting a strong humoral response. hmwA, 
which encodes the HMW adhesin, displays marked amino acid diversity and also demonstrated 
phase variation mediated by 7-base pair tandem repeats located within the hmwA promoter 
region. Thus, to gain further insight into the role of HMW adhesins during colonization and 




 true nontypeable H. influenzae, (2) sequenced the hmwA core binding domains from a collection 
of 170 geographically distributed commensal and AOM isolates, demonstrating that they form 
four distinct phylogenetic clusters, (3) found evidence of positive selection operating on the 
hmwA region that encodes the core binding domain, and (4) demonstrated, using a mathematical 
model, that the occurrence of large, yet rare, phase variable deletion events allows for the stable 
maintenance of a small population of adherent NTHi cells during colonization in spite of HMW-
specific antibody mediated immunity. This work has direct implications for ongoing efforts 
aimed at developing an effective NTHi vaccine and, at a more basic level, advances our 







Public health significance of acute otitis media and chronic obstructive pulmonary 
diseases. Acute otitis media (AOM), which is an infection of the middle ear, is the most common 
childhood bacterial disease for which antibiotics are prescribed (30). During 2005 there were an 
estimated 709 million cases of AOM globally, reflecting an annual incidence rate of 
approximately 11%, with the majority of those cases occurring in children under five years of 
age (61). In the United States, approximately 83% of children have had at least one episode of 
AOM by the age of three years and 45% have suffered at least three AOM episodes (96). 
Recurrent episodes of AOM are associated with long term sequelae including hearing loss, which 
in turn can lead to impaired speech development and impaired cognitive ability (3, 66). In 
addition, otitis media with effusion resulting from AOM is the leading reason for performing 
tympanostomy-tube insertions, the most common childhood operation (1, 59). AOM imposes a 
significant burden on the health care system. In 2009, the total annual cost of AOM in the US 
was estimated to be $4.2 billion (69). Thus, reducing the incidence of AOM, ideally through 
preventive measures, will reduce a significant burden on our healthcare system. 
Both viral and bacterial pathogens are associated with AOM and often an episode of 
bacterial AOM is preceded by a viral upper respiratory tract infection (73). Three predominant 
bacterial species isolated from the middle ear spaces of children with AOM are Haemophilus 
influenzae (Hi), Streptococcus pneumoniae, and Moraxella catarrhalis. The most recent 
estimates suggest that the percentage of AOM cases attributable to S. pneumoniae ranges from 
42 – 48%, nontypeable H. influenzae 36 – 45%, and M. catarrhalis 13 – 16% (17). 
Interestingly, these same three bacterial pathogens are associated with another human 
disease, namely chronic obstructive pulmonary disease (COPD) (46, 82). COPD is a chronic, 
progressive lung disease resulting from interactions between environmental factors (e.g., 




colonize the respiratory tract. COPD prevalence increases with age, reaching approximately 12% 
among US adults aged 65 – 74 (77). In the US alone, the total economic cost of COPD/asthma 
for 2008 was estimated to be $68 billion (43) and chronic lower respiratory tract infections, 
which include COPD, were the third leading cause of death (77). On a global scale, the WHO 
estimates that during 2008 COPD was responsible for 3.28 million deaths worldwide, making it 
the fourth leading cause of death (70, accessed September 19, 2012). Bacteria  commonly 
isolated from the sputum of COPD patients include Streptococcus pneumoniae, Moraxella 
catarrhalis, and Haemophilus influenzae, the same three bacterial species most often associated 
the AOM in children (46, 82). Importantly, nontypeable H. influenzae are commonly associated 
with acute exacerbations of COPD and these events are often treated with antibiotics (46, 56).   
Given the significant contribution of nontypeable H. influenzae (NTHi) to both AOM and 
COPD, decreasing the incidence of NTHi-associated diseases can reduce a significant burden on 
our healthcare system and has the potential to decrease antibiotic usage and the associated 
concerns regarding emerging antibiotic resistance. To these ends, current efforts to lower NTHi 
disease incidence, especially AOM, are primarily focused on developing preventive measures 
such as vaccines. 
Haemophilus influenzae. Haemophilus influenzae are small, nonmotile, Gram-negative 
coccobacilli that reside exclusively within humans, typically within the nasopharynges. H. 
influenzae strains can be designated as either typeable or nontypeable based upon their reactivity 
with typing antisera developed against each of six immunologically distinct polysaccharide 
capsules. Because of the capsule, typeable and nontypeable H. influenzae are fundamentally 
different, but differentiating between typeable and nontypeable strains is challenging. Serum 
agglutination, using type specific serum directed against each of the six immunologically distinct 
H. influenzae capsules, has classically been used to test for the presence of a capsule and to 
determine capsular type. By these criteria, strains that fail to react with typing sera are 
considered “nontypeable”, but strains can fail to react with typing sera for several different 
reasons. These reasons include false negative typing reactions, failure to produce functional 
capsule due to mutations in the bexA gene that encodes a protein required for capsule export, and 
the complete lack of the capsule genetic locus due to long past evolutionary events. Only in the 




evolutionary past, would the strain be considered a true nontypeable H. influenzae. Thus, 
“nontypeable” strains defined only by lack of reactivity with typing sera are a heterogeneous 
collection of strains and this can confound epidemiologic studies.  
More recently, partially based on evidence for poor reliability of serum based methods, 
typing schemes have been transitioning from phenotypic based typing to the use of genetic 
typing. Genetic typing methods rely on polymerase chain reaction (PCR) based detection of cap-
locus genes that encode the proteins necessary for capsule synthesis and expression. The cap-
locus consists of three distinct regions (I to III). Region I and III genes flank the cap locus, are 
highly conserved across all capsular types, and encode proteins responsible for transporting the 
capsule across the outer membrane (49-51, 79, 93). Region II genes encode proteins specific to 
each capsular type, a to f, and, thus vary by capsular type. The most commonly employed H. 
influenzae genetic typing scheme involves PCR detection of the conserved region I gene bexA 
and one of the six capsule-specific region II genes (28, 58). This approach is cumbersome, 
requiring seven PCR reactions to identify a true NTHi strain (i.e., a strain that lacks the entire 
capsule locus). Thus, re-examination of the current H. influenzae typing scheme is warranted. 
Typeable H. influenzae tend to be relatively clonal, with lineages demarcated by capsular 
type, whereas extensive genetic diversity is a hallmark of nontypeable H. influenzae (NTHi) (14, 
29, 53, 64, 98). Encapsulated strains are commonly associated with invasive human infections 
such as meningitis and septicemia among non-immune children. In contrast, NTHi are generally 
associated with localized infections of the respiratory tract such as pneumonia, sinusitis, and 
acute otitis media (AOM). 
NTHi is a common inhabitant of the human pharynx with colonization prevalence among 
healthy children between 25 – 84% (15, 27, 42). NTHi colonization occurs early during 
childhood and is a dynamic process marked by simultaneous colonization with multiple strains 
and presumably high rates of strain turnover (27, 39, 62, 91, 97, 101). Recent studies suggest that 
two-year old children are at a significantly greater risk of being colonized with H. influenzae if 
their mother is also colonized, but interestingly, the strains that colonize mother-child pairs are 
genetically distinct (54). This suggests that host genetic factors may play a role in susceptibility 
to H. influenzae colonization even though NTHi does not appear to be vertically transmitted; 




AOM-associated pathogenic NTHi arise from the community of colonizing strains that 
reside within the pharynx (Figure 1.1). While not fully elaborated, the pathogenic pathway for an 
AOM strain involves person to person transmission, colonization of the pharynx, ascension of 
the Eustachian tube, establishment in the middle ear space, and finally, induction of an 
inflammatory response. One of the first steps in NTHi AOM pathogenesis, therefore, is 
adherence of bacterial cells to cells of the host respiratory tract. 
 
NTHi adhesins. NTHi adherence to the respiratory epithelium is mediated by a number 
of surface exposed pilin and non-pilin adhesins (85-88, 95). The pilin adhesins include 
hemagglutinating pili (33, 86, 92, 99), H. influenzae surface fibril, Hsf (85, 86), P5-fimbriae (6, 
63, 78, 83), and  type IV pili (4).  There are also numerous non-pilin adhesins including the 
Haemophilus adherence and penetration protein, Hap, and lipooligosaccharide (LOS) both of 
which mediate attachment to and invasion of epithelial cells (87, 95). The cell envelope opacity-
associated protein A, OpaA, is also involved in epithelial cell adherence (76). Finally, nearly all 
NTHi cells encode either a homolog of the Hib Hsf adhesin, Hia, or a pair of high molecular 
weight adhesins, HMW1 and HMW2 (11, 13, 24, 90). 
The HMW adhesins. The HMW adhesins were originally identified by 
radioimmunoprecipitation assay and are the predominant NTHi non-pilin adhesins (8, 10, 13, 
88). Across a wide diversity of NTHi strain types, including commensal, invasive, AOM-, and 
COPD-associated strains, the prevalence of either hmwA genes or functional HMW ranges from 
approximately 36 to 75% (11, 24-26, 90, 100). HMW is more prevalent among disease isolates 
than colonizing strains (11, 24, 90), suggesting that they may contribute to AOM pathogenesis.  
HMW adhesins are encoded by the hmw loci, each of which contains three genes, hmwA, 
hmwB, and hmwC (Fig. 1.2) (12). Each hmw-positive strain possesses two complete copies of the 
hmw locus, designated hmw1 and hmw2, located in conserved but unlinked locations within the 
NTHi chromosome that are likely the results of a gene duplication event that occurred early 
during the evolution of NTHi (11, 16). The functional HMWs are encoded by hmw1A and 
hmw2A, which in strain 12 are 71% identical (80% similarity) at the amino acid level (11). 
HMWB, encoded by hmwB, is an outer membrane protein responsible for transporting HMW to 




required for HMW maturation (36, 37, 40). In contrast to HMWA, which displays marked amino 
acid diversity, NTHi strain 12 HMW1B/2B and HMW1C/2C are highly conserved at the amino 
acid level, displaying ≈ 99% and 97% identity, respectively (11).  
NTHi strain 12 hmw1A and hmw2A have been extensively characterized. HMW proteins 
are translated as preproteins that can be divided into three distinct functional regions: (1) the 
signal sequence region, (2) the core-binding domain, and (3) a conserved carboxy-terminus (20). 
The first 441 amino acids of HMW encode a highly conserved signal sequence that is required 
for Sec-dependent transport across the cytoplasmic membrane and trafficking through the 
periplasm (11, 20). In its functional form, the glycosylated HMW adhesin is displayed on the 
bacterial cell surface and remains tethered to the bacterial cell via non-covalent interactions 
between HMWB and the carboxy terminus of HMWA (5, 38, 89).  
HMW adhesin diversity. The HMW binding domain, located in the amino terminus of 
the mature protein, is responsible for binding to the host epithelium (20). Amino acid diversity 
within the binding domain is quite high both within and between strains; for example, strain 12 
HMW1 and HMW2 binding domains share only ≈50% amino acid identity (11, 16, 20, 23, 34). 
Furthermore, the majority of the glycosylated asparagine residues within strain 12 HMW1 are 
also localized to the binding domain region (40). HMW adhesin amino acid diversity, and 
possibly glycosylation, affects both NTHi tissue tropism and antigenic diversity. 
 HMW1 and HMW2 adhesins bestow differing in vitro adherence properties to NTHi. 
Strain 12 HMW1 mediates high level adherence to Chang cells, Hep-2, HaCaT, and NCI-H292 
cells, interacting specifically with α-2,3 N-linked sialic acids, whereas strain 12 HMW2 
primarily mediates adherence to HaCaT and NCI-H292 cells and the exact nature of its 
interaction with these cells remains elusive (88, 89). Despite the relatively high amino acid 
diversity among HMW adhesin core binding domains most strains demonstrate an adherence 
profile similar to that of strain 12 with one HMWA conferring HMW1-like adherence and the 
other HMW2-like adherence (16). Phylogenetic relationships among the core binding domains 
reveal two major sequence clusters that correspond with in vitro adherence characteristics, that 
is, sequences that encode the HMW1-like adhesins form one cluster and those encoding the 




diversity observed among the HMW-family of adhesins defines their tissue tropism, there is also 
selective pressure to conserve functionality. 
Pharyngeal NTHi colonization stimulates the host’s adaptive immune response resulting 
in serum IgG, IgM, and IgA (9, 10, 35, 47, 74). Many of these antibodies target outer membrane 
proteins, including HMW (10, 35, 41, 67); in fact, HMW proteins are the immunodominant 
NTHi outer membrane proteins (10). Numerous studies have demonstrated a role for immune 
driven positive selection, which can generate antigenic diversity in surface exposed proteins (31, 
60, 68, 84). Thus, while yet to be formally tested, it is likely that antibody mediated immunity 
applies positive selective pressure upon the HMW adhesins favoring antigenic diversity via the 
process of diversifying selection. Empirical evidence for HMW antigenic diversity is 
demonstrated by the varying levels of cross reactivity of anti-HMW antibodies against the HMW 
adhesins from heterologous strains (100). Antigenic variation resulting from amino acid 
substitutions or recombination events is a relatively slow process that begets species level 
diversity and operates between hosts. With regard to the HMW adhesins, species level diversity 
can be maintained because allele-specific host immunity imposes a fitness cost on those strains 
expressing the most prevalent HMW alleles whereas rare HMW variants experience a fitness 
advantage. 
HMW phase variation. Phase variation involves heritable, reversible, and stochastic 
phenotypic changes mediated through various different mechanisms such as invertible elements, 
gene conversion, or changes in the numbers of simple sequence repeats. Simple sequence repeats 
(SSR) consist of multiple tandem copies of short, for example, one to nine nucleotides (75), 
repetitive DNA sequences. One hallmark of phase variation is that it generates phenotypic 
changes at rates much greater than that of the average background mutation rate. For example, 
applying Drake’s Rule (22, 94), the overall H. influenzae mutation rate, assuming a genome size 
of 1.8 Mb, is approximately 1.14 x 10
-9
 mutations per nucleotide site per generation compared to 
mutation rates of 2.03 x 10
-4
 mutations per SSR per generation for H. influenzae tetranucleotide 
SSRs (21). Thus, background mutation rates generate less than a single mutation, on average, per 
NTHi generation (assuming a genome size of 1.8 x 10
-6
). Through the gain or loss of repeat units 
by slipped stranded mispairing during DNA synthesis (e.g., during DNA replication), phase 




tract. SSR mediated phase variation is a common theme among bacterial pathogens, such as 
Campylobacter jejuni (72), Neisseria meningitidis (80), and Helicobacter pylori (2) all of which 
contain numerous phase variable loci. The net result of phase variation is the generation of 
population level phenotypic diversity that accumulates in the absence of any external stimuli. 
This diversity increases the probability that at least some members of a population are able to 
survive rapid environmental changes, such as those incurred during transmission between hosts. 
In contrast to the relatively slow pace of antigenic variation as outlined above, phase variation 
occrus at relatively high rates and affects the bacterial population within an individual host.  
H. influenzae possesses numerous SSRs. Tetranucleotide repeats are the most numerous, 
and best characterized, type of Hi SSRs (32, 44). A 2009 study of the H. influenzae pangenome, 
based on only 16 Hi strains, identified over 750 SSRs of which 199 were tetranucleotide SSRs, 
but, only a fraction of the SSRs were potentially phase variable (75). Analysis of four complete 
H. influenzae genomes determined that 14/18 tetranucleotide SSRs mediated on-off  phase 
variable protein expression of Hi virulence associated genes (44, 75). In contrast, 3/5 
heptanucleotide SSRs were phase variable and only one of the SSRs was located within an open 
reading frame (75). 
The HMW adhesin genes are phase variable. Both hmwA alleles possess 7-base pair (bp) 
SSRs located within their promoter regions (Figure 1.2) (19). Repeats are gained and lost 
stochastically during DNA synthesis by Rec-independent slipped stranded mispairing (19). 
Because the SSRs are located within the promoter region, changes in repeat number affect hmwA 
transcription while the amino acid composition of the HMW adhesin remains unaltered. As the 
number of repeats increases, hmwA transcription and translation decrease in a graded fashion 
(19). Furthermore, studies of tetranucleotide SSRs observed that there was a linear relationship 
between the rate at which repeats are gained or lost and the overall length of the SSR tract (21). 
The mutation rate of the hmwA SSR has not been determined. Assuming that hmwA phase 
variation rates increase with SSR number, this means that the hmwA SSRs regulate both the level 
of protein expressed and the rate at which expression levels change. The net result of this process 
is that any given NTHi population contains cells displaying varying amounts of surface exposed 




and, given that HMW is highly immunogenic, it impacts a cell’s ability to avoid clearance due to 
antibody mediated immunity.  
Phase variable HMW adhesin expression has important implications for NTHi 
pathogenesis, during both AOM and COPD, and for vaccine development. Healthy children and 
adults are often simultaneously colonized with multiple different strains of NTHi, but during 
AOM the NTHi population is homogeneous and there is typically only a single strain present in 
both the middle ear and the nasopharynx (14, 48, 57, 65). Strains isolated from these different 
sites are often isogenic based on study-specific typing criteria, but examination of the SSR 
repeats within the hmwA promoter often reveal differences in repeat numbers. More specifically, 
middle ear isolates generally have a greater number of SSR repeats, and express less HMW 
adhesin, than do their isogenic counterparts isolated from the nasopharynx (19). hmwA-
associated SSRs have also been studied longitudinally among individuals suffering from COPD 
by comparing isogenic NTHi strains collected from sputum samples during repeated physician 
visits. In general, the number of SSRs within the hmwA promoter increased over time and this 
increase was associated with decreased in vitro adherence to respiratory epithelial cells (18). 
Finally, phase variable expression of HMW adhesins has the potential to mediate escape from 
antibody mediated immunity as was highlighted in a vaccine study exploring the impact of 
immunization with HMW using a chinchilla model of experimental otitis media (7, 19). In this 
study, 5/10 immunized animals were protected when challenged with an isogenic NTHi isolate 
(7) and further examination of the NTHi isolates collected from the unprotected animals revealed 
an association between vaccine failure and increased numbers of hmwA SSRs (19). Each of these 
studies suggest that pathogenic NTHi strains benefit from down-regulation of HMW adhesins 
and highlight the complexity of the association, which varies in both space and time, between 
HMW adhesin phase variation and disease.  
Mathematical analyses of SSR phase variation. Estimating mutation rates in vivo is, at 
best, a laborious process owing, in part, to the relative rarity of most mutational events. These 
challenges can be compounded by the absence of an easily detectable phenotype associated with 
the mutational event of interest. For example, changes in the hmwA-associated SSRs result in 
incremental changes in HMW-protein production which are difficult to monitor at the level of 




manipulation, for example, using recombinant DNA technology to insert reporters such as lacZ, 
this is not always possible. Mathematical modeling provides a way to generate predictions, 
hypotheses, and to extend our intuition on experimentally intractable systems. As a case in point, 
mathematical modeling has be used to elucidate the conditions under which phase variable gene 
regulation would evolve and to estimate optimal phase variation rates under varying 
environmental conditions (45, 52, 55, 71). 
To date, mathematical models of SSR phase variation have primarily focused on two-
state ON and OFF systems; that is, the phase variable character is either expressed or it is not. 
These models typically consist of two loci, a mutator locus and a two-state phenotypic locus, 
within the context of a fluctuating environment. The fitness of each phenotype in a given 
environment is defined with a selection coefficient, s, and the length of time spent in each 
environment is defined as T. Natural selection acts directly on the phenotypic locus but selection 
on the mutator locus is indirect and is a consequence of genetic linkage between the two loci. 
Within the context of on-off phase variation, the mutator locus would represent a SSR region and 
the phenotypic locus a gene responsible for encoding an adhesin; changes in SSR number shift 
the adhesin gene in or out of frame resulting in on-off phase variable adhesin expression.  
When only two different environmental conditions exist and the rate of mutation is the 
same in both directions, that is, the on-off rate is equal to the off-on rate, then the reciprocal of 
the average duration to time spent in each environment (1/T), approximates the optimal mutation 
rate (45, 55).  Extending the two-locus model to incorporate multiple phenotypes and multiple 
environments, Kussell and Leibler (52) demonstrated that the optimal mutation rates were solely 
determined by the duration of time spent in each environment and the probability of an 
environmental change. Their analysis assumed, however, sufficient time was spent in each 
environment for the population to reach equilibrium. Under these conditions, optimal mutation 
rates from phenotype a to b were inversely proportional to the time spent in the environment 
most suitable for phenotype a and proportional to the probability the environment changes from 
one favorable to phenotype a to one favorable to phenotype b. 
Saunders et al, investigated the impact of phase variation on population structure using a 
dynamical model in which bacteria display one of two phenotypes, A or B, and each phenotype 




switching from A to B does not have to be the same as from B to A, as could the fitness 
associated with each phenotype (81). In the absence of fitness differences, mutation rates were 
the sole determinant of the population structure at equilibrium and, if switching rates were equal, 
the time to equilibrium was approximately equal to the reciprocal of the mutation rate. When the 
phenotypes differed in fitness, the population structure and the time it took for the population to 
reach equilibrium was determined by the fitness difference. Within the context of a colonizing 
bacterial population, this means that even when the mutation rates are low–so low that, in the 
absence of selection, equilibrium would not be achievable in a biologically plausible time frame–
a rare phenotype with a fitness advantage of 10% could nearly replace the initial phenotype in a 
matter of days. Specific immune responses can presumably result in fitness differences much 
greater than 10% (81) thus, even when the mutation rate is low, a rare phenotype capable of 
evading specific host immune responses (e.g., antibody mediated immunity), could nearly 
replace the less-fit phenotype within a matter of days. To frame this within the context of hmwA 
phase variation, in the presence of a threshold effect such that cells expressing very low levels of 
HMW adhesins were capable of evading antibody-mediated immunity, these cells would realize 
an increased fitness relative to cells with high levels of HMW adhesins and, thus, would 
predominate. 
More recently, Palmer et al. (71), simulated changes in a population of individuals under 
varying selective pressure (s) and duration of time in each environment (T), where each 
individual encodes a single SSR locus with mutation rates that vary depending on the length of 
the SSR tract; as the tract length increases mutation rate increases. This still represents a two-
locus model of phase variation with one locus consisting of a SSR and the other an on-off 
selectable phenotype, but it is a significant extension of previous models for the following 
reasons: (1) phase variation rates vary among individuals as a function of SSR tract length and 
(2) it parameterizes the mutation rates based on the in vitro behavior of H. influenzae 
tetranucleotide SSRs , with respect to mutation rates and types of mutational events as 
determined by De Bolle et al.(21). They found that a wide range of conditions favor the 
evolution of SSRs with adjustable mutation rate; that is, the mutation rate is a function of SSR 
tract length. In general, when the product of the selection coefficient (s) and the duration of time 
spent in each environment (T) is large enough for the favored phenotype to reach fixation before 




favored. Nonminimal phase variation rates were also favored when s*T was low but 
symmetrical, i.e., the product of the selection coefficient and the duration of time is equivalent in 
both environments. In contrast, when s*T was small and differed between environments (i.e., s*T  
was asymmetrical), only minimal phase variation rates evolved, meaning that the SSR tracts 
were relatively short and repeats were gained or lost at a slow rate. 
HMW adhesin phase variation can be placed within a two-locus framework, but, there are 
some critical distinctions between the classic two-locus model and HMW adhesin phase 
variation. The HMW adhesins do not display on-off phase variation but, instead, changes in the 
number of SSRs within the hmwA promoter (the mutator locus) affect HMW adhesin production 
(the phenotypic locus) in a graded fashion. A second distinction involves the way in which 
environmental changes have been modeled, as classic two-locus models generally consider 
alternating transitions between two different environments. Alternating environments can occur 
both within and between hosts, e.g., during a transmission events where each host would 
represent a distinct environment. One of the more significant challenges facing a NTHi 
population during colonization is likely to be antibody mediated immunity; this is especially true 
with regard to the HMW adhesins as they represent an immunodominant surface protein. In the 
scenario of a naïve host, antibody mediated immunity would apply a gradually increasing 
selective pressure, not an alternating selective pressure as most classic two-locus models assume. 
To date I am not aware  of models that capture the behavior of systems analogous to HMW 
adhesin SSR mediated phase variation, but this system is amenable to mathematical modeling 
that could provide valuable insight into the role of HMW adhesin phase variation during 
colonization.  
Research objectives. The research presented in this dissertation aims to: (1) describe a 
molecular typing method to differentiate typeable from true nontypeable H. influenzae, (2) 
characterize a geographically distributed collection of NTHi isolates with respect to hmwA 
prevalence and sequence diversity, (3) test for evidence of selective pressures operating on 
hmwA, and (4) develop a mathematical model that will provide a theoretical framework for 
exploring how hmwA phase variation and host mediated immunity interact to shape NTHi 
within-host population structure. I tackle these aims from an interdisciplinary perspective, 




Since the HMW adhesins are still being pursued as potential candidates for inclusion in a multi-
valent NTHi vaccine, this work has both practical and theoretical implications for ongoing 
efforts aimed at developing an effective NTHi vaccine. At a more basic level, this work will 
advance our understanding of host-pathogen interactions, and importantly, host-commensal 
interactions with implications that reach well beyond H. influenzae, as phase and antigenic 
variation are common themes among human-restricted bacteria, for example, Helicobacter pylori 







Figure 1.1. Conceptual model of H. influenzae transmission, colonization, and disease. H. influenzae are 
small cococobacilli that reside exclusively within humans, typically within the nasopharynges. 
H. influenzae are transmitted person to person via infected respiratory droplets. Encapsulated 
strains are divided into six capsular serotypes (a–f), with serotype b (Hib) being commonly 
associated with invasive human diseases such as meningitis and septicemia among non-immune 
children. In contrast, nonencapsulated strains, which are commonly referred to as nontypeable H. 
influenzae (NTHi), are generally associated with localized infections of the respiratory tract such 
as pneumonia, sinusitis, and acute otitis media (AOM). NTHi colonization occurs early during 
childhood and is a dynamic process marked by simultaneous colonization with multiple strains 
(indicated with different colors in the figure) and presumably high rates of strain turnover (27, 
38, 61, 90, 96, 100). NTHi colonization stimulates an adaptive immune response resulting in 
serum IgG, IgM, and IgA, many of which target outer membrane proteins (9, 10, 34, 46, 73). 
Pathogenic NTHi, e.g., those causing AOM, arise from the community of colonizing NTHi 
strains. While the community of H. influenzae colonizing the pharynx can contain multiple 
different strains, disease-causing isolates collected from normally sterile sites are typically clonal 
(as indicated with the homogeneous strains in each disease site). While the exact mechanisms 
leading to invasion of normally sterile sites by disease causing strains is not fully understood, the 
bacterial factors associated with pathogenicity, such as, virulence factors, may differ by site of 






Figure 1.2. Chromosomal arrangement of the hmw loci (upper) and arrangement of the 7-bp 
repeat region upstream of hmwA (lower). HMW adhesins are encoded by the hmw locus which 
contains three genes, hmwA, hmwB, and hmwC (12). Each hmw-positive strain possesses two 
complete copies of the hmw locus, designated hmw1 and hmw2, which are located in conserved 
but unlinked locations within the NTHi chromosome (16). The functional HMW adhesins are 
encoded by hmw1A and hmw2A, which in strain 12 share 71% amino acid identity (80% 
similarity) (11). The HMW binding domain is responsible for binding the host epithelium (20) 
(lower) Expression of both hmwA copies is phase variable and is mediated by 7-base pair (bp) 
tandem nucleotide repeats located within the hmwA promoter region (19). Repeats are gained and 
lost stochastically during DNA synthesis by slipped stranded mispairing and changes in the 
number of tandem repeats affects hmwA transcription and translation; as the repeat tract length 
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Haemophilus influenzae are classified as typeable or nontypeable (NTHi) based upon the 
presence or absence of capsule. In addition to serotyping, which is subject to false positive 
results, typeable strains can be identified through the detection of the capsular export gene bexA 
and one of six capsule-specific genes, which is resource intensive, especially when 
characterizing large numbers of strains. To address these challenges, we developed a bexB-based 
method to differentiate true NTHi from typeable strains. We validated a PCR-based method to 
detect bexB in ten strains whose capsule status was well-defined. Among 40 strains that were 
previously serotype positive in clinical microbiology laboratories, five lacked bexA, bexB and 
capsule type-specific genes by PCR analysis and, thus likely represent false positive serotyping 
results. Among 94 additional otitis media, commensal, and serotype b negative invasive strains, 
85 were bexA and bexB negative and nine contained either a complete or partial capsule locus, 
i.e. eight were bexA and bexB-positive and one was bexA-negative but bexB-positive. Finally, we 
adapted the method for use in a high-throughput DNA hybridization-based microarray method, 
which showed 98.75 and 97.5% concordance to the PCR method for bexA and bexB, 
respectively. In addition, bexB showed 84% or greater nucleotide identity among strains 
containing the capsule locus. In this study, we demonstrate that bexB is a reliable proxy for the 
capsule locus and its detection provides a simple and reliable method for differentiating strains 
that lack the entire capsule locus from those containing a partial or complete capsule locus.
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Haemophilus influenzae, gram-negative bacteria that commonly reside as commensals 
within the human pharynx and may cause respiratory or invasive infections, are variable in 
presence of a polysaccharide capsule. Historically, H. influenzae lacking a capsule were detected 
by their failure to react with antibodies directed against the six immunologically distinct capsular 
polysaccharides and were designated as nontypeable, i.e. serotype negative, H. influenzae 
(NTHi) (33). Nontypeable strains predominate among commensal organisms (9, 29) and those 
causing respiratory infections such as with acute otitis media (AOM), sinusitis, or bronchitis, 
while serotypeable strains are more often isolated from clinical samples of patients with invasive 
infections such as bacteremia, meningitis, facial cellulitis and septic arthritis. In addition, 
multilocus sequence typing has shown that NTHi are genetically widely variable while 
serotypeable strains are more clonal (25).  
The polysaccharide capsule of typeable H. influenzae strains is encoded by the cap-locus 
composed of three distinct regions, designated I – III (Figure 2.1b). The genes contained within 
regions I and III, designated bexDCBA and hcsAB, respectively, are highly conserved across all 
capsular types and are required for transport of capsule constituents across the outer membrane 
(20, 21, 23, 37, 40). Region II genes encode capsule types a through f-specific proteins and, thus, 
vary by serotype. The organization and genetics of the cap-locus are complex; duplications, 
partial loss, and complete loss of the cap-locus have been documented (3, 4, 12, 14-17, 19, 21, 
22, 32, 37, 38, 44).  
Differentiating typeable from nontypeable H. influenzae can be challenging. Type 
specific serum agglutination has classically been used to confirm the presence and specificity of 
the H. influenzae capsule. A strain may, however, fail to react with typing sera, and thus be 
classified as “non-typeable,” for several reasons. First, inaccuracies in performing and 
interpreting slide agglutination tests have been well-documented (30, 45). Second, strains with 
one copy of the cap region in which bexA is partially deleted (3, 4, 12, 14, 15, 17, 19) are 
referred to as capsule-deficient variants as they contain a majority of the cap-locus; genetically 
these isolates are cap-locus positive, but show altered ability to produce functional capsule and 
fail to agglutinate with typing serum, i.e., they are nonserotypeable. Third, a previously 




strain Rd, a nontypeable variant of a type d strain that has been extensively passed in the 
laboratory (37). Finally, a strain may lack the entire cap-locus as a consequence of long past 
evolutionary events, i.e., be a true NTHi. 
Detection of bexA and capsule specific genes by polymerase chain reaction (PCR) is the 
most commonly used method of capsule genotyping. PCR methods based on detection of bexA 
alone, however, fail to identify capsule deficient variants because the 5’ primer of the standard 
primer pair hybridizes in the deleted region of bexA. This problem was overcome by the addition 
of PCR analyses to detect individual types a-f capsule specific regions, along with bexA, for each 
strain (8, 26). This approach, however, requires up to seven separate PCR reactions, making it 
both labor and resource intensive when studying a large number of isolates, especially when 
clinical or epidemiological data suggest that a significant portion of the strains may be NTHi. 
This study was motivated by the need for a simple and accurate method to differentiate true 
NTHi, from genetically cap locus positive H. influenzae strains. 
We hypothesized that bexB, which is located within region I of the cap locus (Fig 2.1), 
could serve as a more reliable marker for the capsule locus than bexA, based on the observations 
that region I genes are present across all capsular types (20, 23) and there are no reports of bexB 
partial deletions analogous to those observed in bexA. We first validated the PCR method to 
detect bexB using H. influenzae strains whose capsule status had been well defined. We then 
tested 40 H. influenzae strains that had been serotype positive when tested in clinical 
microbiology laboratories. To better understand the prevalence of genetically cap region-positive 
strains that fail to produce a bexA amplicon, we then tested the bexB PCR method on invasive 
strains that were serotype negative in the clinical microbiology laboratories and on strains likely 
to be nontypeable based upon their site of isolation (i.e, commensal and otitis media isolates). 
Finally, we adapted the molecular capsular typing method for use in a high-throughput 
hybridization format and tested it with a microarray containing the genomic DNA of 546 H. 
influenzae strains. We demonstrate here that screening for bexB provides a simple and reliable 
method for distinguishing H. influenzae strains containing a complete or partial capsule locus 






Materials and Methods 
Bacterial strains. All strains used in this study were defined as H. influenzae using current 
clinical laboratory criteria. H. influenzae isolates, maintained with minimal passage, were stored 
in skim milk at -80 
o
C and, for testing, were cultured on Chocolate II Agar (BD Diagnostics) at 
37
 o
C in the presence of 5% CO2. 
H. influenzae types a, c, and d strains were obtained from ATCC; the fully sequenced H. 
influenzae strain Rd is a lab-adapted strain that lacks the entire capsule locus; the well-studied 
strain Eagan (1) was the source of chemically purified type b capsule; two type b capsule 
deficient variant strains were previously described (15, 27); and two fully sequenced nontypeable 
otitis media strains, 86-028NP (a kind gift from Dr. Lauren Bakaletz, Ohio State University) and 
R2846 (a kind gift from Dr. Arnold Smith, University of Washington) lack capsule genes. The 
capsule status of these strains was considered to be well defined (see Table 2.2A). A H. 
haemolyticus strain served as a non-H. influenzae control.  
H. influenzae strains used for the PCR and microarray based analyses were chosen from 
our large collection of H. influenzae clinical and commensal isolates collected over 30 years 
from Michigan, California, Kentucky, Pittsburgh, Minnesota, and Georgia (a kind gift of Dr. 
Monica Farley of the Atlanta VA Hospital) and included 40 H. influenzae strains previously 
found to be serotype positive by clinical microbiology laboratories (see Table 2.2B). Also 
included were throat isolates from healthy children attending day care (9, 39), middle ear isolates 
of children with acute otitis media from Finland (a kind gift of Dr. Tehri Kilpi) and Israel (a kind 
gift of Dr. Ron Dagan), all considered likely to be NTHi based on site of isolation, as well as 
invasive blood or cerebrospinal fluid isolates that failed to react with the type b serotyping serum 
in the clinical microbiology laboratory (see Table 2.2C).  
PCR based studies. The design of PCR primers targeting a 567 or 760 base-pair (bp) 
region of H. influenzae bexB (Table 2.1) was based on sequence data available in GenBank. 
Primers targeting bexA, pepN (which served as a DNA positive control), and serotype-specific 
capsule genes have been previously described (Table 2.1) (6, 8, 28). Whole cell lysate, i.e., crude 
lysate, served as the DNA template source for PCR reactions and was prepared by suspending 




(TE, pH 7.5), heating for 10 min at 100 
o
C in a thermocycler, centrifuging for 10 min, and 
removing the supernatant, which was stored at – 20 
o
C until used for PCR. For routine screening, 
PCR was performed with Taq polymerase (New England Biolabs, Ipswich, MA, cat. no. 
M0267). Each 20 µl PCR reaction consisted of 1X ThermoPol Reaction buffer, 0.2 mM each 
dNTP, 0.2 µM each primer, 2.0 U Taq, and 1 µl crude lysate (template). Reactions were 
subjected to an initial denaturation step of 2 minutes at 95 
o
C followed by 30 amplification 
cycles of 95 
o
C for 30 seconds, 54 
o
C for 30 seconds and 72 
o
C for 45 seconds. All bexB positive 
isolates were subjected to further analysis with region II serotype-specific primers (Table 2.1). 
Amplicons were separated on 1.5% agarose gels in 1X Tris-Acetate-EDTA (TAE) buffer and 
visualized with ethidium bromide staining.  
Microarray studies. H. influenzae library-on-a-slide (LOS) microarrays, consisting of H. 
influenzae genomic DNA arrayed on a glass slide, were prepared, tested, and analyzed as 
previously described (36, 46). In brief, total genomic DNA from each H. influenzae strain was 
isolated and spotted in duplicate onto membrane coated slides. First, a digoxygenin labeled 
genomic DNA quantity control probe consisting of equal amounts of each of the seven H. 
influenzae multilocus sequence typing (MLST) genes (http://Haemophilus.mlst.net) and pepN 
was hybridized to the microarray (36). The intensity of control probe hybridization to each spot 
was determined using Spotfinder v.3.1.1 (http://www.tm4.org/spotfinder.html) and duplicate 
spots were averaged using MIDAS v.2.19 (http://www.tm4.org/midas.html) (34). The slides 
were stripped and then rehybridized with either a bexA or bexB fluorescein labeled probe (18). 
The bexA and bexB probes were “mixed probes” in that they contained equal concentrations of 
either bexA or bexB amplified from strains representing each of the six capsular serotypes (type 
a, strain ATCC9006; type b, strain AA194; type c, strain ATCC 9007; type d, strain ATCC 9008; 
type e, strains AA52 and M4; type f, strain F2243.7). The mixed probes were PCR amplified 
from genomic DNA with primers HI-1 and HI-2 (bexA probe) or bexB.1 primers (bexB probe) 
(Table 2.1). Signal intensities were calculated as described above and the ratio of the log 
transformed bexA or bexB signal to the MLST-pepN concentration control signal was calculated 
for each spot and the distribution of intensities was modeled using programs written in the 
statistical software “R” (http://www.r-project.org); spots were classified as positive, negative, or 




Concordance of the bexA and bexB results between the PCR based method and the 
microarray method was estimated by testing 80 strains for these two genes by both PCR and by 
hybridization of bexA and bexB probes on microarray. 
DNA sequence analysis. To test for the magnitude of DNA sequence identity among a 
relatively large number of capsule-gene containing H. influenzae strains, DNA sequence analysis 
was conducted on 45 bexB positive isolates by first amplifying a 760 bp internal region of bexB 
with the Expand High Fidelity System (Roche, Indianapolis, IN, cat. no. 11732641) using 1X 
Expand High Fidelity Buffer with 1.5 mM MgCl2, 0.2 mM of each dNTP, 0.2 µM each primer 
(bexB.FLF and bexB.FLR); 1.3 U Expand High Fidelity Enzyme mix, and 1 µl crude lysate 
(template) per 25 µl reaction. The resultant amplicon was purified with the Qiagen QIAquick 
PCR purification kit (QIAGEN, Valencia, CA, cat. no. 28104) following the manufacturer’s 
protocol. Sequencing was performed directly from the purified PCR product, in both directions, 
at the University of Michigan DNA Sequencing Core. Sequences were analyzed with 
DNASTAR Lasergene (v8). After removal of primers and poor quality sequences, 666 
nucleotides from each strain were aligned using Clustal W (43) and then adjusted manually 
where necessary. Phylogenetic analyses, using all codon positions, were conducted in MEGA4 
(41). Whenever two or more sequences from strains of the same capsule type were 100% 






bexB PCR test results. Both pairs of bexB primers, bexB.1F/bexB.1R and 
bexB.FLF/bexB.FLR produced amplicons of the expected size, 567 bp and 760 bp, respectively, 
and the bexA and pepN primers produced amplicons of the expected sizes 343 bp and 918 bp, 
respectively. Figure 2.1d shows the PCR products of 5 representative strains: the type b strain 
Eagan, from which type b capsule has been chemically isolated and characterized (1); the true 
nontypeable strain 86-028NP (13) which lacks the capsule locus by DNA sequence analysis and 
thus is bexA and bexB negative; Strain Rd, initially characterized as a type d strain, which lacks 
the entire capsule locus due to a deletion (11) by DNA sequence analysis and thus is bexA-, 
bexB-, and cap d-negative; and two previously described strains that are cap region-positive by 
gene analysis, but serotype negative (i.e., capsule deficient variants) (15, 27), and, as expected, 
are bexA-negative, bexB-positive, and contained their respective cap specific genes.  
 bexB PCR validation results. Table 2.2a shows the results of the study to validate the 
bexB PCR method using well defined H. influenzae strains that were known to be capsule 
positive or negative by gene analysis or capsule isolation, or were obtained as serotypeable 
strains from ATCC. As expected, all four serotypeable strains (the ATCC types a, c, and d strains 
and type b Eagan) were bexA- and bexB-positive. The two strains previously known to be 
capsule deficient variants (15, 27) were, as expected, bexA-negative and bexB-positive, while the 
four strains known by genomic sequence analysis to lack the cap region were bexA- and bexB-
negative. The H. haemolyticus strain was bexA- and bexB-negative.  
Correlation between bexB PCR and serotyping. Among the 40 strains previously 
serotyped in clinical microbiology laboratories (Table 2.2b), 35 were bexA- and bexB-positive, 
consistent with the serotyping results performed at the time of isolation. Five were bexA- and 
bexB-negative and lacked region II capsule specific genes, strongly suggesting that these strains 
are in fact true NTHi lacking the entire capsule locus. This finding is consistent with other 
reports of false positive serotyping of H. influenzae (2, 24, 31, 32), even when tested in reference 
laboratories.  
bexB gene among strains likely to be NTHi. To identify the prevalence of capsule 




influenzae strains likely to be non-typeable (Table 2.2c) were tested by PCR with bexA, bexB, 
and region II capsule-specific PCR primers. Among 23 commensal H. influenzae from the 
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, a type f capsule deficient 
variant because it was PCR positive for the type f-specific region II but is unable to export 
capsule because of the bexA deletion. All 16 invasive blood or cerebrospinal isolates found to be 




, confirming that they 
were true NTHi (Table 2.2c).  
bexA and bexB microarray results. To assess the ability of bexB probe to hybridize 
with H. influenzae genomic DNA and to expand the capsule characterization of a large number 
of strains using a high through-put assay, a total of 546 H. influenzae strains were screened by 
whole genome DNA microarray for hybridization with bexA and bexB (Table 2.3). Only ten of 
the 546 (1.8%) strains tested by microarray hybridization showed indeterminate results due to 
technical difficulties, such as, damage to the array surface, too little genomic DNA, etc. Among 




 strains were identified. Of 135 strains originally serotyped as type a 




 commensal strain that lacked serotype-




 invasive strain that possessed a serotype b-specific gene, that is, 
a genetically type b capsule-deficient variant, and thus would have been misclassified as NTHi 
by bexA PCR or hybridization alone or by serotyping. 
bexA and bexB PCR-microarray concordance. The concordance between bexA and 
bexB detection by microarray hybridization using gene specific probes and by PCR using gene 
specific primers was assessed using 80 strains that were analyzed by both methods. One strain 
was discordant for bexA (98.7% concordance) and two strains were discordant for bexB (97.5% 
concordance), one of which was the bexA discordant strain, suggesting a possible strain mix-up 
(Table 2.4).  
bexB sequencing results and phylogenetic analyses. To gain insight into bexB 
nucleotide diversity across all capsule types, a 760 base-pair (bp) region of bexB was sequenced, 




of 666 bexB bps from each strain, with no gaps, were available for analysis (GenBank accession 
HQ699679-HQ699723). All 23 type b bexB sequences were 100% identical at the nucleotide 
level. There were three unique type f sequences (type f.1, f.2, and f.3), with three variable sites 
among 666 bps (0.45%) and three unique type e sequences (type e.1, e.2, e.3) with five variable 
sites among 666 bps (0.75%). Nucleotide sequence similarities and genetic distances were 
estimated from a 666 bp region of bexB from 45 bexB-positive strains (Table 2.5). Pairwise 
nucleotide similarity ranged from 84.2 – 100% and averaged 91.7% across all sequences. 
Evolutionary distances, estimated using the maximum composite likelihood method (41, 42), and 
percent nucleotide similarity were estimated for all unique sequences. Maximum composite 
likelihood distances ranged from 0 to 0.199 base substitutions per site with an overall average 
distance across sequences of 0.101.  
To address the potential for nucleotide diversity within the bexB.1F/bexB.1R primer 
annealing regions, the nucleotide sequences within the primer annealing regions were analyzed. 
Four and two substitutions were identified in the bexB.1F and bexB.1R primers, respectively. 
With the exception of the forward primer (bexB.1F) and type a bexB, none of the substitutions 
were localized to the 3’ end of the primer (Figure 2.2). 
Maximum parsimony phylogenetic analysis produced 45 equally most parsimonious 
unrooted trees (length = 148) that varied only slightly in topology. Based upon the 100% 
consensus tree (Figure 2.3), type e and f sequences were closely related and remained 
unresolved; bootstrap branch support for the type e and type f cluster was 99% (based upon 
5,000 replicates). Type a bexB was sister to the group composed of type e and f bexB sequences 
and the branch support for the type a, e, and f grouping was 99%. Type c and d bexB sequences 






 Current molecular capsule typing methods rely, in part, on bexA, which encodes a protein 
important in capsule exportation, as a marker for the cap locus; these methods are reliable for the 
many strains that possess two copies of the cap locus—one complete copy and a second copy 
with a deletion in bexA. Some H. influenzae strains, however, contain a single cap locus with a 
partially deleted bexA (Figure 1c) that is not detected with currently used bexA primers. Accurate 
capsule locus status of these strains requires seven PCR reactions for each strain, one for bexA 
and when negative, then testing for each cap-specific region II genes. We have demonstrated that 
bexB, which is located adjacent to bexA in region I of the capsule locus and encodes another 
protein important in capsule exportation, is a more reliable marker of the capsule locus because it 
can be detected in H. influenzae strains that possess a single cap locus and a bexA mutation in 
that locus. Importantly, none of the 76 cap region positive strains in this study were bexA
+
bexB-, 
demonstrating a high concordance between bexB positivity and presence of type-specific cap 
region genes. The ability to identify true NTHi strains using a single bexB PCR reaction, as 
demonstrated in this study, is especially useful for laboratories specifically interested in capsule 
characterization of large H. influenzae strain collections.  
The utility of bexB as a capsule type-independent marker for the capsule locus was 
confirmed in this study using 40 H. influenzae strains previously serotyped in clinical 
microbiology laboratories. We identified strains possessing cap region genes, regardless of 
capsule type or bexA status, based upon the presence of a single bexB amplicon. The capsule type 
of each bexB+ strain was then determined by cap specific PCR. Two previously described type b 
capsule deficient variants, Aar117 and Aar64 (15, 27), were correctly identified as bexA-
negative/bexB-positive in this study (Figure 2.1d; Table 2.2a). Previous studies (2, 24, 31, 32), 
have clearly documented the poor sensitivity of serotyping to distinguish cap region positive 
from cap region negative H. influenzae, even in reference laboratories. The most common 





 strains that were previously serotype positive in the clinical 
microbiology laboratory. While a portion of the cap locus of these strains could conceivably 
have been deleted subsequent to serotype analysis in the clinical microbiology laboratory, we 




also lacked region II capsule-specific genes as assessed by PCR and, thus, would be unable to 
express capsule. Thus, we concluded that these five strains (Table 2.2b) reflect false positive 
serotyping results. 
The bexB PCR-based test identified an otitis media type f-capsule deficient variant that 
lacked bexA and would not have been identified using only bexA primers for the PCR reaction 
(Table 2.2b). In addition, the bexB microarray study (Table 2.2c) identified an invasive type b-
capsule deficient variant that lacked bexA. Similarly, Cerquetti et al. (5) described four of 41 
non-type b invasive strains that failed to generate an amplicon using bexA primers but contained 
type b specific regions. Similarly, Nelson and Smith (31), using a multiplex PCR to amplify 
bexA and the cap specific gene regions from H. influenzae invasive isolates, identified three 
strains with absence of bexA but presence of cap b specific regions. While such capsule deficient 
variants were rare, their identification is important to fully characterize disease-causing or 
commensal H. influenzae strains. 
PCR based screening methods dependent upon “universal” primers may not yield an 
amplicon if nucleotide polymorphisms, particularly those localized to the 3’ primer annealing 
regions, preclude adequate annealing of the primers to the target gene region. Indeed, sequence 
diversity of bexA has been shown to compromise its detection by PCR (35, 47). To assess this 
potential in bexB, a 666 base-pair internal region of bexB, which encompassed the entire 
bexB.1F and bexB.1R primer annealing sites, of 45 bexB
+
 strains were PCR amplified and their 
sequences analyzed. Nucleotide substitutions were observed within the primer annealing regions 
across serotypes, but, with the exception of the type a bexB, none of the substitutions are 
localized to the 3’ end of the primer (Figure 2.2). Thus we concluded that given our current 
knowledge of bexB sequence diversity, the bexB.1F-R primer pair used in this study will amplify 
bexB across all six capsule types.  
For testing large numbers of H. influenzae strains, high-throughput hybridization based 
methods present an attractive and efficient alternative to PCR screening. Furthermore, probe-
based hybridization methods, such as dot blots and microarrays, have the potential to improve 
sensitivity of the test because they rely on a much larger region of probe-target complementarity 
than do PCR based approaches (567 versus 44 base-pairs in the case of bexB) and are thus are 




sequences that vary by as much as 15% (L. Zhang, personal communication). To increase the 
probability of detecting bexB-positive strains across all serotypes, we employed a mixed probe 
composed of bexB sequences representing each of the six capsule types (a to f). Using the mixed 
bexB probe, we demonstrated the utility and accuracy (97.5% bexB concordance with detection 
by PCR) of this method by screening a large collection of H. influenzae isolates, simultaneously, 
using a genomic DNA microarray hybridization technique.  
DNA sequence analyses revealed two distinct bexB sequence groups based upon 
nucleotide identity, one containing type c, d, and b strains and the other type e and f; this 
grouping is similar to that of bexA (35, 47). Our finding of 100% nucleotide identity in bexB of 
type b strains is consistent with the 100% identity of bexA among type b strains reported by Zhou 
and Sam (35, 47). In contrast to the 100% nucleotide identity of bexA sequences among both 
type e and type f strains reported previously (35, 47), we identified a small amount of nucleotide 
diversity among bexB sequences of both type e and type f strains, 5/666 (0.75%) and 3/666 
(0.45%), respectively.  
While bexB appears to be a reliable marker for the capsule locus, this method is not 
without limitations. The sequence diversity within the bexB primer annealing sites across all six 
serotypes could compromise its use in PCR assays. We noted, however, that all of the 28 strains 
that hybridized the mixed bexB probe on the microarray assay also amplified using the bexB.1 
bexB PCR primers (Table 2.4), suggesting that the bexB primers we used were sufficient to 
amplify most, if not all, H. influenzae bexB sequences. A second limitation is that targeting bexB 
alone cannot differentiate true NTHi strains from strains, such as Rd (21), from which the entire 
capsule locus has been deleted. The magnitude of this limitation is difficult to assess, as the 
frequency of naturally occurring, complete cap-locus deletions is simply not known. This 
limitation is, however, not unique to the approach presented here, as none of the available 
molecular typing methods can detect complete capsule deletions. 
In conclusion, we have described a bexB-targeted molecular strategy that rapidly and 
reliably distinguishes true non-typeable H. influenzae (i.e., those lacking the capsule locus) from 
those containing a complete or partial cap-locus (Figure 2.4). Ongoing surveillance for H. 
influenzae is necessary for assessing the organisms associated with H. influenzae type b (Hib) 




strains, while challenging, is essential for any successful H. influenzae surveillance program, and 
incorporating bexB-based methods into molecular typing schemes can simplify strain 
characterization while simultaneously improving the ability to detect genetically typeable H. 
influenzae (i.e., improved sensitivity). Thus bexB, used as a stand-alone marker for the cap-
locus, provides a valuable addition to the armamentarium of H. influenzae molecular 
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Table 2.1. Polymerase chain reaction primers used in this study. 
 





    





    





    





    











Table 2.2. Results of bexA and bexB detection by PCR among H. influenzae strains. (a) bexA and 
bexB detection among strains with known capsule status. (b) bexA and bexB detection among H. 
influenzae strains previously serotyped in clinical microbiology laboratories. (c) bexA and bexB 
detection among H. influenzae isolates likely to be NTHi based on site of isolation or on negative 
type b serotyping by clinical microbiology laboratories. 
 
a. Validation study 




ATCC 9006 a + + 
Eagan† b + + 
ATCC 9007 c + + 
ATCC 9008 d + + 
Rd (KW20)
# 
cap-minus 0 0 
AAr117
∫
 b-minus 0 + 
AAr64
∫
 b-minus 0 + 
86-028NP
# 
NTHi 0 0 
R2846
# 
NTHi 0 0 
R2866
# 
NTHi 0 0 






b. Strains previously serotyped in clinical microbiology laboratories  
















type a  (7) 5 0 0 2 
type b  (20) 20 0 0 0 
type c  (1) 1 0 0 0 
type d  (3) 1 0 0 2 
type e  (4) 4 0 0 0 
type f  (5) 4 0 0 1 
 
c. Strains likely to be NTHi based on site of isolation or negative type b serotyping 



















Commensal (23) 4 0 0 19 type e (3), type f (1) 
Otitis media (55) 4 1 0 50 type f (5) 
Invasive
$ 
(16) 0 0 0 16  
 
*
 + = present, 0 = absent 
† type b capsule isolated and chemically characterized 
#
 complete genomic sequences available 
∫
 lacks cap region by gene analysis, as previously reported (15, 27) 
$
 serotype non-b 
&






















Commensal,   
n = 322 
 
 












Otitis media,  











3  (3 NTHi)
** 
 
Invasive strains,  












* Indeterminate results on microarray with bexA and bexB probes 











PCR positive 28 1 29 
PCR negative  0 51 51 
Total 28 52 80 
bexB     
PCR positive 28 2 30 
PCR negative  0 50 50 




Table 2.5. Pairwise percent nucleotide identities and maximum composite likelihood 
evolutionary distances among a 666 bp region of H. influenzae bexB. Percent nucleotide 
identities are listed above the diagonal and maximum composite likelihood distances (41, 42) are 
listed below the diagonal. Of the 45 bexB sequences analyzed, ten were unique.  
 












type a   88.1 86.2 87.5 90.7 90.2 90.5 90.4 90.2 90.7 
type b 0.141   96.7 98.8 86.2 85.7 86.0 85.9 85.7 86.2 
type c 0.170 0.035   97.6 84.7 84.2 84.5 84.4 84.2 84.7 
type d 0.150 0.012 0.025   85.6 85.1 85.4 85.3 85.1 85.6 
type e.1 0.107 0.170 0.192 0.178   99.4 99.8 99.7 99.5 100 
type e.2 0.113 0.177 0.199 0.186 0.006   99.3 99.7 99.6 99.4 
type e.3 0.109 0.172 0.194 0.180 0.002 0.008   99.5 99.4 99.8 
type f.1 0.111 0.175 0.197 0.183 0.003 0.003 0.005   99.8 99.7 
type f.2 0.113 0.177 0.199 0.185 0.005 0.005 0.006 0.002   99.5 











Figure 2.1. Schematic representations of the capsule locus. (A) The capsule locus can be 
categorized based upon its location in the H. influenzae genome relative to either an IS1016 
element or sodC. In one arrangement the cap-locus is flanked by IS1016 insertion element 
sequences. In the second arrangement, sodC is upstream of the cap-locus. (B) The cap-locus is 
divided into three regions, region I, II, and III; both bexA and bexB are located within region I. 
Previously described bexA specific primers produce a 343 bp amplicon (8) and the bexB primers 
used in this study amplify a 567 bp product. (C) Representative cap-locus arrangements. (i) A 
duplicated IS1016-cap locus harboring a bexA partial deletion in one copy. (ii) A single copy 
IS1016-cap arrangement. (*partial bexA deletion, precludes annealing with the standard bexA 5’ 
primer). (D) Representative PCR results. Eagan is a type b strain, containing intact bexA, bexB, 
and the serotype b specific cap gene; 86-028NP is a NTHi strain lacking bexA and bexB; Strain 
Rd is a type d strain in which the entire cap region has been deleted; Aar64 is a bexA- type b 
capsule deficient variant; and, F22477 is a bexA- type f capsule deficient variant strain. 







Figure 2.2. Substitutions within bexB primer annealing regions. The top row of each sequence set 
represents the actual PCR primer used (Table 2.1); dots represent agreement with the primer 
sequence. Primers were designed using publicly available type b nucleotide sequences. The 
bexB.1R and bexB.1F primer set amplified bexB from all six capsular types. There is a 
nucleotide substitution localized to the 3’-end of the forward primer (bexB_1R) relative to type a 






Figure 2.3. bexB evolutionary history inferred using the Maximum Parsimony method (7). The 
100% consensus tree from the 45 most parsimonious trees (tree length = 148) is shown. The 
consistency index is 0.965217, the retention index is 0.981651, and the composite index is 
0.947507 for all sites and the 98 parsimony-informative sites. The percentage of replicate trees in 
which the associated taxa clustered together in the bootstrap test (5000 replicates) are shown next 
to the branches (10). A total of 666 nucleotides were included in the final dataset and 98 
nucleotides were parsimony informative. Phylogenetic analyses were conducted in MEGA4 (41) 






Figure 2.4. Suggested workflow for characterizing H. influenzae strain collections with regard to 
the capsule locus. Gene names listed within an oval represent detection of that gene via a PCR or 
probe based technique. Identification of “true” NTHi strains can be achieved by screening for the 
presence of bexB; strains lacking bexB represent true NTHi or typeable strains in which the 
entire capsule locus has been deleted. In the second step, presence of bexA differentiates 
potentially serotypeable strains (bexA-positive) from capsule deficient but genetically typeable 
strains (nonserotypeable, bexA-minus, cap locus-positive). Among bexB-positive strains, 
capsular type can be assigned by screening for capsule specific genes residing within region 2 of 
the capsule locus (8). Finally, if necessary, production of a functional capsule can be verified 
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Prevalence, distribution, and sequence diversity of hmwA among a diverse collection 






 Nontypeable Haemophilus influenzae (NTHi) are Gram-negative bacteria that colonize 
the human pharynx, their only known natural reservoir. Adherence to the host epithelium marks 
one of the first step in NTHi colonization and pathogenesis. Approximately 75% of NTHi strains 
encode a pair of high molecular weight (HMW) adhesins that mediate attachment to the host 
epithelium. HMW adhesins are highly immunogenic, antigenically diverse, and display a wide 
range of amino acid diversity both within and between strains. In this study, prevalence of 
hmwA, which encodes the HMW adhesin, was determined a collection of 170 NTHi strains 
collected from the ears (OM strains) or throats (commensal strains) of children from Finland, 
Israel, and the US. Overall, hmwA was detected in 72% of NTHi isolates and was significantly 
more prevalent (P = 0.038) among OM isolates than commensal isolates; the prevalence ratio 
comparing hmwA prevalence among ear strains with that of commensal strains was 1.23 (95% CI 
(1.01, 1.50). Among 91 hmwA-positive NTHi strains, 93% possessed two hmw loci in conserved 
locations on the chromosome. To extend our understanding of hmwA binding domain sequence 
diversity, we selected 33 strains for sequencing. The average amino acid identity across all 
hmwA sequences was 62%. Phylogenetic analyses of the hmwA binding domains revealed four 
distinct hmwA sequence clusters, and the majority of sequences (83%) belonged to one of two 
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sequence clusters. hmwA sequences did not cluster by chromosomal location, geographic region, 
or disease status. These results contribute to our understanding of HMW adhesin diversity among 






Nontypeable Haemophilus influenzae (NTHi) are Gram-negative bacteria that colonize 
the human pharynx, their only known natural reservoir. Although generally considered a 
commensal, NTHi is capable of causing localized infections of the upper and lower respiratory 
tract, for example, acute otitis media, as well as more severe invasive infections. NTHi 
colonization is initiated by adherence of bacterial cells to the host epithelium, and since disease 
causing strains arise from the strains colonizing the pharynx, adherence also marks the first step 
in NTHi pathogenesis. NTHi produce a wide array of surface exposed adhesins that mediate 
attachment to epithelial cells (50-53, 56). High molecular weight (HMW) adhesins, which are 
expressed by approximately 75% of NTHi strains (5), are one of the predominant non-pilin 
NTHi adhesins. HMW adhesins are widely distributed across NTHi phylogenetic groups  as 
defined by MLST (25) or by multi-locus enzyme electrophoresis (55).  
The HMW adhesins are a family of paralogous proteins encoded by the hmw locus, 
which is present in two copies on the NTHi chromosome (9). Both the gene content and the 
chromosomal locations of the hmw loci, designated hmw1 and hmw2, are conserved across 
strains (6, 9). Each hmw locus encodes three proteins, hmwA, hmwB, and hmwC (6). The 
functional HMW adhesins are encoded by hmwA; hmwB and hmwC encode proteins required for 
HMW adhesin maturation, glycosylation, and secretion (5, 6, 31, 32, 54). The hmw1 and hmw2 
loci are located  downstream of HI1679 and HI1598, respectively, as specified with respect to H. 
influenzae strain Rd (5).  
HMW adhesins display a wide range of amino acid diversity both within and between 
strains (5, 9, 18, 29). The amino acid diversity is not evenly distributed throughout the mature 
HMW adhesin, but is localized to the region of the adhesin that interacts with the host 
epithelium, that is, the binding domain (5, 18, 21, 30). Amino acid diversity within the HMW 
binding domain likely contributes to NTHi tissue tropism. While five distinct NTHi in vitro 
adherence patterns have been reported (62), most strains analyzed to date display adherence 
patterns similar to that of the prototypic NTHi strain 12, with one adhesin conferring HMW1-




Because the HMW adhesins are exposed to the external environment and directly interact 
with host tissues, amino acid diversity likely plays a significant role in immune evasion. NTHi 
outer membrane proteins, and specifically the HMW adhesins, stimulate an antibody mediated 
immune response in their hosts (4, 42). In fact, HMW adhesins are the immunodominant outer 
membrane proteins (4). The antibodies directed against the HMW adhesin, however, offer 
varying degrees of cross protection against heterologous NTHi strains (4, 62). That antibodies 
targeting the HMW adhesins are not broadly protective highlights the potential of amino acid 
diversity to mediate NTHi immune evasion. 
All current, publicly available, hmwA DNA sequence data come exclusively from disease 
isolates (5, 9, 21, 30, 34, 62), but, disease isolates represent only a subset of the total NTHi 
population, much of which resides as commensal strains in the pharynges of healthy individuals. 
In this study, we utilized a well characterized collection of NTHi strains collected from the 
middle ears of children with otitis media (OM strains) or from the throats of healthy children 
(commensal strains) from Finland, Israel, and the US (36). We determined that the overall hmwA 
prevalence was 72% and that OM strains were significantly more likely to possess hmwA than 
were commensal strains. We then sequenced the binding domain region of hmwA1679 and 
hmwA1598 from 33 strains that, based upon prior multilocus sequence typing (MLST) analyses 
(36), were phylogenetically distributed and included both OM and commensal strains. hmwA 
sequence analysis revealed a wide range of genetic diversity both within and between NTHi 
strains from this collection and phylogenetic analyses suggested that hmwA binding domains 





Materials and Methods 
Strain collection. The NTHi isolates used in this study have been described in detail 
elsewhere (36). In brief, the collection contains 170 NTHi strains isolated between 1994 – 2002 
from children seven years of age or under living in Finland, Israel, or the United States. Ninety-
five of the isolates were collected from the middle ears of children with acute otitis media (“OM” 
strains) and the remaining 75 were collected from the throats or nasopharynges of otherwise 
healthy children (“commensal” strains). 
 hmwA nomenclature. The HMW adhesins were first characterized in NTHi strain 12, 
which is considered the prototypic HMW-producing strain (4-6). The HMW adhesins differed in 
molecular weight; HMW1 (encoded by hmwA1679 ) migrated at approximately 125 kDa and 
HMW2 (encoded by hmwA1598 ) migrated at approximately 120 kDa. This was the basis of the 
original naming system in which the genes encoding the 125 kDa and 120 kDa adhesins were 
named hmw1A and hmw2A (5). In a later study, Buscher, et al., determined the exact 
chromosomal location of the hmw1 and hmw2 loci in NTHi strain 12 (9) and defined them with 
reference to the respective ORFs in the fully sequenced H. influenzae strain Rd (27). The NTHi 
strain 12 hmw1 locus resides adjacent to Rd ORF HI1679, contains hmw1A, and produces the 
HMW1 adhesin, the strain 12 hmw2 locus resides adjacent to Rd ORF HI1598, contains hmw2A, 
and produces the HMW2 adhesin (9). 
In subsequent studies, various different criteria were used to assign names to the hmwA 
genes in newly characterized strains. Buscher, et al., determined the in vitro adherence profiles 
of the HMW adhesins for several strains and categorized them as HMW1-like or HMW2-like 
using the NTHi strain 12 HMW adherence patterns as a reference (9). Most NTHi strains 
analyzed to date contain two hmw loci – one  locus encodes a HMW1-like adhesin, which 
mediates adherence via interaction with α 2,3-sialic acid, and the other an HMW2-like adhesion, 
whose adherence interactions are not α 2,3-sialic acid and remain unknown (9, 30). While hmw 
loci chromosomal locations are conserved, the specific adhesin encoded at each locus can vary 
by strain, for example, hmwA adjacent to HI1679 in NTHi strain 12 confers HMW1-like 
adherence whereas in strain 5 the hmwA adjacent to HI1679 encode an HMW with HMW2-like 
adherence (9).  Other groups refer to hmwA genes with reference to their chromosomal location 




adherence characteristics (30). This later approach is necessary for tracking specific hmwA genes 
when their HMW adherence characteristics are unknown.  
 In this study, we assign each hmwA a locus-specific designation, hmwA1598 or hmwA1679, 
that corresponds its chromosomal location relative to Rd ORF HI1598 or Rd ORF HI1679, 
respectively. Since we did not determine HMW adherence profiles in this study, this allows us to 
track each hmwA locus without reference to the respective proteins’ adherence characteristics. 
With reference to NTHi strain 12, our hmwA1679  and hmwA1598 designations correspond to strain 
12 hmw1A and hmw2A, respectively. 
 hmwA-leader PCR screen. To determine hmwA prevalence, whole cell lysates of all 
170 strains were interrogated with a single pair of PCR primers that annealed to a conserved 
region of the hmwA1679 and hmwA1598 signal sequences (Table 3.1). Whole cell lysate was 
prepared by suspending several bacterial colonies, collected with a sterile cotton swab, from a 
fresh plate into Tris-EDTA (TE, pH 7.5), heating for 10 min at 100 
o
C in a thermocycler, 
centrifuging for 10 min, and removing the supernatant, which was stored at – 20 
o
C until used for 
PCR. For routine hmwA-leader screening, PCR was performed with Taq polymerase (New 
England Biolabs, Ipswich, MA, cat. no. M0267). Each 20 µl PCR reaction consisted of 1X 
ThermoPol Reaction buffer, 0.2 mM of each dNTP, 0.2 µM of each primer, 2.0 units of Taq 
polymerase, and 2 µl crude lysate (template). Reactions were subjected to an initial denaturation 
step of 2 minutes at 95 
o
C followed by 30 amplification cycles of 95 
o
C for 30 seconds, 58 
o
C for 
30 seconds and 72 
o
C for 1 minute. Amplicons were separated on 1.5% agarose gels in 1X Tris-
Acetate-EDTA (TAE) buffer and visualized with ethidium bromide staining. 
hmwA1679 and hmwA1598 PCR amplification. Total genomic DNA was isolated for all 
hmwA-leader PCR-positive NTHi isolates and subjected to further analysis with hmwA1679 and 
hmwA1598 specific PCR primer pairs (Table 3.1). In a majority of strains tested, primers A1FL5.1 
and hmwAcore_1R successfully amplified hmwA1679 and A2FL5.2 and hmwAcore_1R 
successfully amplified hmwA1598. The strains listed in Table 3.S1, however, required alternative 
primer pairs (Table 3.1) for successful hmwA amplification. Genomic DNA was isolated using 
the Wizard genomic DNA purification kit (Promega, Madison, WI., cat. no. A1120) according to 
the manufacturer’s instructions, resuspended in 1x Tris-EDTA buffer (10 mM Tris-HCL and 
1mM EDTA at pH 8), and stored at 4 
o




performed with Phusion High-Fidelity DNA polymerase (New England Biolabs, Ispwich, MA, 
cat. no. M0530). Each 25 µl PCR assay consisted of 1X Phusion HF buffer,  125 ng of genomic 
DNA template, 0.2 mM of each dNTP, and 0.2 µM of each primer, and 0.5 units of Phusion 
polymerase. Reactions were subjected to an initial denaturation step of 2 minutes at 98 
o
C 
followed by 30 amplification cycles of 98 
o
C for 15 seconds, 65 
o
C for 15 seconds and 72 
o
C for 
3 minutes. Amplicons were separated on 1.0% agarose gels in 1X Tris-Acetate-EDTA (TAE) 
buffer and visualized under UV illumination following ethidium bromide staining. 
hmwA core binding domain amplification, cloning, and sequencing. The hmwA1679 
and hmwA1598 binding domain regions were sequenced from a subset of the NTHi isolates used 
in this study (Table 3.2). Binding domain regions were amplified separately for each strain using 
Phusion amplified hmwA1679 and hmwA1598 amplicons as DNA template. Prior to re-
amplification, each primary hmwA amplicon was purified using a QIAquick PCR purification kit 
(QIAGEN, Valencia, CA, cat. no. 28104) following the manufacturer’s protocol. Each hmwA 
binding domain was PCR amplified with primers that bound to a conserved region of both 
hmwA1679 and hmwA1598, hmwAseq1 and hmwAseq4 (Table 3.1), with Phusion High-Fidelity 
DNA polymerase (New England Biolabs, Ispwich, MA, cat. no. M0530). Each 25 µl PCR assay 
consisted of 1X Phusion HF buffer, 10 ng of purified hmwA PCR product, 0.2 mM of each 
dNTP, 0.2 µM of each primer, and 0.5 units of Phusion polymerase. Reactions were subjected to 
an initial denaturation step of 1 minute at 98 
o
C followed by 30 amplification cycles of 98 
o
C for 
15 seconds, 65 
o
C for 15 seconds and 72 
o
C for 1.25 minutes. Amplicons were separated on 1.5% 
agarose gels in 1X Tris-Acetate-EDTA (TAE) buffer and visualized with ethidium bromide 
staining. 
The resultant hwmA binding domain amplicons were cloned into Invitrogen’s pCR4 
sequencing vector using the Zero Blunt TOPO PCR cloning kit (Invitrogen, Carlsbad, CA, cat. 
no. K2875) according to the manufacturer’s protocols. Plasmid was isolated from a bacterial 
culture, grown overnight at 37 
o
C in the presence of 50 µg/ml kanamycin, with a GenCatch Plus 
plasmid DNA miniprep kit (Epoch Life Sciences, Sugar Land, TX; cat. no. 21-60050) following 
manufacturer’s protocols. hmwA insert size was verified by restriction enzyme digestion 
followed by separation on 1.5% agarose gels in 1X Tris-Acetate-EDTA (TAE) buffer and 




Sanger DNA Sequencing was performed at the University of Michigan DNA Sequencing 
Core. Multiple sequencing reactions were required per hmwA core binding domain and 
additional sequencing primers, 400 in total, were designed as needed. PCR primers were 
designed with IDT PrimerQuest (http://www.idtdna.com/Primerquest/Home/Index), sequence 
editing and contig assembly was performed with SeqMan Pro v8 (DNASTAR, Madison, WI). 
Fifteen publicly available NTHi hmwA nucleotide sequences, obtained from GenBank, 
were also included in the analyses (Table 3.2). 
hmwA sequence analysis. hmwA sequence alignments were performed in two stages. 
First, hmwA nucleotide sequences were translated to amino acids using the computer package 
MEGA5 and aligned using the MUSCLE algorithm (23). Aligned amino acids were converted 
back to their original nucleotide sequence and neighbor joining (NJ) tree was estimated in 
MEGA5 (59). This first alignment was performed simply to estimate a NJ tree to serve as an 
initial guide tree for the following alignment steps. Using the NJ tree as a guide tree, hmwA 
nucleotide sequences were converted to amino acids, aligned with the computer program 
PRANKSTER, and then converted back to the original nucleotides (37). The process was then 
repeated, using a NJ tree estimated from the first PRANKSTER alignment, and this second 
alignment was used for all subsequent analyses. This two-stage alignment process is suggested 
when the phylogenetic relationships among sequences are uncertain. 
Evolutionary analyses were conducted with the computer program MEGA5 (59). 
Pairwise amino acid p-distances – the proportion of amino acids that vary between two 
sequences – were calculated for all sequence pairs using the pairwise gap deletion option. 
Maximum composite likelihood distances (65) were estimated from the hmwA nucleotide 
sequences. Rate heterogeneity between was modeled using a discrete gamma distribution with 
five rate categories; the gamma parameter value was estimated for each hmwA alignment under a 
general time reversible substitution model (41). Gaps were deleted from nucleotide alignments 
prior to analyses. Standard errors of the distance measures, both amino acid and nucleotide, were 
estimated using a bootstrap method with 1000 replicates (26). 
Sequence alignments were tested for evidence of recombination with the PHI test (7), 




between hmwA sequences were assessed using the Neighbor-Net (8) method implemented in 
SplitsTree4 (35). hmwA phylogenies were also estimated using a maximum likelihood approach 
using maximum composite likelihood distances with rate heterogeneity among sites modeled 






hmwA prevalence. All 170 strains in the collection (36) were screened for the presence 
of hmwA by PCR using hmwA_leader PCR primers (Table 3.1) that annealed to conserved 
regions of the signal sequence of both hmwA1598 and hmwA1679; these primers did not 
differentiate between the two hmwA loci. Overall, 123 (72%) strains were hmwA-leader PCR 
positive (Fig 3.1). hmwA prevalence varied by geographic region, (Table 3.3) and was 
significantly higher among strains from Finland (85%) than from Israel (66%) (P = 0.0231) or 
the US (66%) (P = 0.0196). 
Overall, OM strains were significantly (P = 0.038) more likely to possess hmwA (69%) 
than were commensal strains (31%) and the prevalence ratio comparing hmwA prevalence among 
ear strains with that of commensal strains was 1.23 (95% CI (1.01, 1.50); i.e., OM strains were 
1.23 times more likely to be hmwA-positive than were commensal strains. Within each 
geographic region, OM strains were more likely than commensal strains to contain hmwA, but, 
these differences were not statistically significant (α = 0.05) for any region (Table 3.3). 
Ninety-one hmwA-positive strains were interrogated by PCR assay to determine if they 
possessed two separate hmw loci adjacent to Rd ORFs HI1679 and HI1598. Eighty-five (93.4%) 
of the hmwA-leader positive strains tested contained both hmwA1679 and hmwA1598. One strain 
was PCR-negative for hmw1679 (G1222,), two strains were PCR-negative for hmwA1598 (G1522 
and I167), and three strains lacked both hmwA loci (G123, G522, and F1158). 
hmwA sequencing. The hmwA1679 and hmwA1598 binding domain regions were sequenced 
from 33 strains selected based upon their phylogenetic relationships estimated by MLST analysis 
(Fig. 3.1) (36). By selecting strains widely distributed across the MLST phylogeny, it was our 
intention to capture a wide range of hmwA diversity. Of the 33 strains, 12 were from Finland, 11 
from Israel, 10 from the US, and, in total, 17 were OM strains (Table 3.2).  
The hmwA binding regions ranged in size from 2652 to 3573 nucleotides (Table 3.2) 
which is consistent with previous studies (9, 18, 29, 55, 62). Sequence data was obtained for both 
hmwA1679 and hmwA1598 from 26/33 of the strains in our study collection and for the remaining 




hmwA sequences were excluded due to poor quality and two additional hmwA sequences were 
excluded because they encoded in-frame stop codons.  
 Pairwise evolutionary distances estimated from the hmwA nucleotide sequence data 
ranged from 0.00 to 1.29 base substitutions per site with an overall average genetic distance of 
0.7531 (SE = 0.04327). Pairwise hmwA amino acid p-distances, i.e., the proportion of amino 
acids that vary between two sequences, ranged from 0.0000 to 0.4898 and the overall average 
pairwise amino acid distance was 0.3838 (SE = 0.0093). This means that, on average, the hmwA 
binding region sequences shared approximately 62% amino acid identity.  
Four pairs of hmwA binding region sequences were 100% identical at the nucleotide level 
(F2865 hmwA1679 and F894 hmwA1598; I280 hmwA1679 and I280 hmwA1598; K15RE hmwA1598 and 
H0421 hmwA1679; I283 hmwA1598 and G423 hmwA1598), but only strain I280 contained identical 
hmwAs at both loci. When considering the translated hmwA nucleotide sequences, the binding 
regions at both loci, hmwA1679 and hmwA1598, within the strain varied by no more than three 
amino acids in four strains (I280, F651, F1015, and F11242); each of these strains encoded 
identical or nearly identical HMW adhesin binding domains at each hmw locus.   
hmwA evolutionary analyses. The PHI test (7) detected evidence of recombination (P < 
0.001) within the hmwA sequences. Since recombination can preclude representing phylogenetic 
relationships among sequences with a single phylogeny, we employed a network approach to 
visualize hmwA relationships (Fig. 3.2). The Neighbor-Net LSfit index was 0.993, meaning that 
the phenetic distances between sequences on the network captured 99.3% of the maximum 
composite likelihood genetic distances. The network topology (Fig. 3.2) was identical to the 
bootstrap consensus tree estimated by the maximum likelihood method (Fig. 3.3) using 
maximum composite likelihood distances; this should not be surprising given the high LSfit 
index which means that, despite the evidence for recombination, the dataset is still relatively 
tree-like. 
The hmwA phylogeny revealed four hmwA sequence clusters, but, the majority of hmwA 
sequences (83%) fell into either Clusters 1 or 2 (Fig. 3.3). Interestingly, of the 31 strains for 
which both hmwA loci were sequenced, 29 (94%) possessed at least one locus that belonged to 




were placed in Cluster 1; in one strain (F1015) both genes were placed in Cluster 4; and in one 
strain (F1124-2) both genes were placed in Cluster 2. 
 Evolutionary distances and amino acid p-distances were estimated for Cluster 1 (Table 
3.S2) and Cluster 2 (Table 3.S3) sequences separately whereas Clusters 3 and 4 sequences were 
combined into a single cluster for analysis (referred to as Cluster 3-4; Table 3.S4). The average 
evolutionary distances ranged from 0.502 to 0.636 nucleotide substitutions per site for Cluster 3-
4 and Cluster 1, respectively. Average amino acid p-distances ranged from 0.3341 for Cluster 3-
4 to 0.3467 for Cluster 1; i.e., on average, any two Cluster 1 sequences differ at approximately 
35% of their amino acid sites. 
 hmwA sequences did not cluster by locus, geographic region, or by disease (OM or 
commensal). There are, however, some examples of OM and commensal strains of the same 
MLST sequence type (ST) also having closely related hmwA sequences at both loci (Fig 3.3), 
e.g., H0421 and K15RE2.6 are both ST-11, F1646 and F1942 are both ST-3, F894 and F2865 are 
both ST-155, and F1296-5 and K19RE2.4 are both ST-57; I202 is also a ST-57, the I202 Cluster 
2 hmwA1679 is similar to the other Cluster 2 ST-57s but the I202 Cluster 1 hmwA1598 is more 
distantly related. With the exception of the ST-57 strains, each ST pair with closely related 
hmwA loci represent one OM and one commensal strain isolated from the same geographic 
region. The two ST-57s with similar hmwA sequences at both loci are both OM strains, but, one 






In this study, we determined the prevalence of hmwA in a collection of 170 well 
characterized NTHi strains (36) isolated from healthy children and children with otitis media 
between 1994 and 2002 from disparate geographic regions.  The overall hmwA prevalence in this 
collection was 72% and OM strains were significantly more likely to be hmwA-positive than 
were commensal strains. When stratified by region, strains collected from Finland were 
significantly more likely to be hmwA-positive than were strains from Israel or the US. We further 
characterized 33 of the hmwA-positive strains by sequencing the binding regions of hmwA1679 
and hmwA1598 and documented examples of both highly conserved and markedly diverse hmwA 
sequences within and between strains. Finally, we conducted phylogenetic analyses that 
demonstrated hmwA binding region sequences form four distinct sequence clusters independent 
of chromosomal location, disease status, or geographic location. 
With the exception of the relatively high hmwA prevalence in Finland (85%), our findings 
are consistent with previous studies that report hmw prevalence estimates ranging from 38 – 80% 
(2, 22, 24, 25, 55, 62). In a diverse collection of NTHi strains, Ecevit et al., reported an hmw1A 
prevalence of 55% and hmw-associated genes were significantly more likely to be present in ear 
strains when compared to throat strains (22). In a collection of 58 NTHi strains, 41% were 
defined as HMW-positive and the prevalence of HMW was significantly greater among disease 
isolates, OM and COPD, than throat isolates (62). Two additional studies suggest that 
approximately 38 - 59% of NTHi strains possess hmwA as detected with a PCR based screen (24, 
25). When screened by Western blotting with antibodies raised against recombinant strain 12 
HMW1 protein, approximately 75% of 125 epidemiologically unlinked NTHi strains were 
HMW-positive (5). Thus, while the overall hmwA prevalence in this collection is within the 
ranges reported from other strain collections, the high hmwA prevalence among strains from 
Finland is an interesting finding and warrants further investigation. 
The phylogenetic relationships among the strains in this collection have been recently 
characterized using MLST analysis (36). hmwA-positive strains were distributed throughout the 
MLST phylogeny and, consistent with the phylogenetic relationships among strains as 
determined with MLST (36), do not cluster by geographic region or disease status (Fig. 3.1). The 




et al., that identified hmw-positive strains in nearly all major NTHi clades as defined by MLST 
(25). Similarly, hmwA was distributed across all major NTHi groupings in a collection of disease 
isolates characterized by multi-locus enzyme electrophoresis (55). Among the 170 NTHi strains 
included in this study, there were 109 different STs and 23 of these STs were represented by two 
or more strains. In 16 of the 23 STs the strains were concordant for the presence, or absence, of 
hmwA. Of particular note, the two most abundant STs, ST57 and ST34, both of which consist 
entirely of OM strains, were variable for hmwA presence; 17/18 (94%) of ST57s and 4/5 (80%) 
of ST34s were hmwA-positive. The fact that strains of the same ST can be discordant with 
respect to hmwA presence suggests that the MLST genes and hmwA loci circulate independently.  
 We interrogated a subset of our strain collection with hmwA1679 and hmwA1598 specific 
PCR assays to determine if hmwA-positive strains contained two hmw loci at the chromosomal 
locations defined in NTHi strain 12 (9). The majority of strains tested (93%) possessed two 
hmwA loci. Multiple PCR primer pairs, however, were required to successfully amplify one or 
both of the hmwAs from a small number of strains (Table 3.S1). The failure to detect one, or 
both, hmwA in some strains is likely due to false-negative PCR results owing to nucleotide 
diversity and not the absence of the target gene; false-positive PCR results have been reported 
previously (30, 62). There have, however, been reports of strains possessing a single hmwA locus 
when using PCR (10) and DNA probes specific to the variable regions of NTHi strain 12 
hmwA1679 and hmwA1598 (22). In contrast, studies that rely on Southern hybridization with a probe 
that anneals to conserved regions of both hmwA1679 and hmwA1598 generally report two hmwA per 
cell (9). Thus, further examination of this strain collection via Southern blotting with a conserved 
hmwA probe is warranted. 
The hmwA DNA sequence data currently available comes exclusively from NTHi disease 
isolates. To extend our understanding of hmwA sequence diversity among commensal and OM 
strains, we sequenced the hmwA binding regions from a subset of strains from our collection. 
Strains were chosen for sequencing with two primary objectives in mind. First, we sought to 
capture a wide range of the hmwA sequence diversity; thus, we selected strains that were widely 
distributed across the MLST phylogeny and from all three geographic regions. Secondly, we 
wished compare hmwA distribution and diversity by disease status; thus, we chose approximately 




Targeted sequencing of the hwmA binding regions of 33 strains revealed a wide range of 
diversity in both amino acid composition and size of the binding region. The overall pairwise 
amino acid identity among the translated hmwAs sequenced from this strain collection, 
independent of hmwA locus, was approximately 62%. Evecit et al., reported pairwise amino acid 
identities slightly higher, 66 – 77%, than those reported here, but, their analysis included the 
conserved signal sequences and thus would be expected to be higher (21). A study comparing the 
entire mature binding protein reported only 52% identity, on average, when comparing across 
both hmwA loci from three NTHi strains (9). Finally, although Giufre et al., reported higher 
diversity within the hmwA core binding domain, their study focused on a smaller portion of the 
most diverse region of hmwA (30). Interestingly, they also reported four core-binding domains 
from invasive isolates that were 100% identical at the nucleotide level to strain 12 hmw1A and 
two core-binding domains that were 100% identical to hmw2A (30); we did not have any 
sequences represented more than twice in our collection.  The hmwA binding domains also 
varied in length (Table 3.2). This size variation is consistent with other studies (5, 9, 18, 21) and 
is also evident by Western blotting (4, 9, 11, 29, 62).  
Two of the hmwA binding domains sequenced in this study contained an in-frame stop 
codon. In a previous study of hmwA sequence diversity, Giufre et al., identified a stop codon 
within the strain 72 HMW2 nucleotide sequence resulting from a single base pair deletion (30). 
Additionally, they failed to detect strain 72 HMW2 protein by Western blotting, but, it is unclear 
if that is a result of phase variation, lack of antibody cross-reactivity, or a consequence of the 
premature stop codon (30). Both examples in our study appear to be the result of single 
nucleotide deletions within homopolymeric tracts. Homopolymeric tracts of more than eight 
nucleotides (e.g. nine or more consecutive A’s) are considered simple sequence repeats (SSRs) 
(44). Variation in SSRs within the hmwA coding region could introduce frameshifts resulting in 
phase variable HMW adhesin expression. A survey of four fully sequenced H. influenzae 
genomes identified between 13 and 17 homopolymeric SSRs per genome, but, none of the SSRs 
were predicted to be phase variable (44). Six hmwA sequences in the current study showed a total 
of ten homopolymeric SSRs (seven adenine (A) and three guanine (G)) ranging in length from 
nine to ten repeats each.  One of the frameshifted hmwA sequences in our study (I168 hmwA1598) 
had a single A-deletion in one of the nine-repeat tracts and the second (G423 hmwA1679) had a 




homopolymeric SSRs within the hmwA coding sequence represents a second phase variable 
mechanism affecting HWM adhesin expression. It is also possible, however, that the insertions 
we observed represent PCR artifacts. Further studies are necessary to determine if these SSRs 
truly mediate phase variable HMW adhesin expression. 
Four strains in this collection possessed nearly identical hmwA sequences at both hmw 
loci and these strains possessed hmwA sequences that fell into three different sequence clusters. 
One possible explanation for the similarity of the sequences within a single strain is that they 
represent recent gene conversion events. The gastric pathogen Helicobacter pylori has a diverse 
array of adhesins, including babA and babB, which are members of a paralogous family of outer 
membrane proteins that interact with the gastric epithelium (48). During the course of infection, 
H. pylori babB-mediated adherence is altered by both gene conversion events, resulting in the 
loss of babA and the duplication of babB and by the loss of babA adherence via changes in 
dinucleotide repeats (48). H. pylori intragenomic gene conversion events have also been 
demonstrated in outer membrane proteins, sabA and sabB, and duplication of sabA increases 
SabA production and SabA-mediated adherence (57). Thus, a single NTHi strain that encodes 
two nearly identical HMW proteins may be restricted to a more limited environmental niche 
while displaying increased adherence within that niche. Furthermore, a strain with limited HMW 
diversity could potentially face decreased fitness in the face of antibody mediated immunity, but, 
such a cost could potentially be mitigated by hmwA phase variation mediated by simple sequence 
repeats. While the hmwA sequences described here display a high degree of amino acid identity 
in the binding region, their binding regions differ at a small number of sites and these minor 
differences could potentially affect adherence properties and/or immunogenicity of the encoded 
adhesin. 
NTHi is naturally competent and sequence analysis has demonstrated evidence of both 
horizontal gene transfer and recombination (12-14, 16, 25, 33, 36, 38-40, 43 , 47). 
Recombination confounds phylogenetic reconstructions because no single phylogeny can 
represent the evolutionary history of a recombinant gene. We therefore employed a network 
based approach, the Neighbor-Net method (35), to visualize relationships among hmwA core 
binding regions. In a Neighbor-Net, conflicting phylogenetic signals are represented by boxes 




processes other than homologous recombination, such as, evolutionary rate heterogeneity 
between sequences, we specifically tested for the presence of hmwA recombination. We found 
strong evidence for recombination leading us to conclude that the inconsistencies reflected in the 
hmwA phylogenetic network (Fig. 3.2) were attributable, at least in part, to homologous 
recombination. Although the network topology for the hmwA-family core binding region 
revealed four sequence clusters, most sequences (84%) fell into either Cluster 1 or Cluster 2 (Fig. 
3.2). There was no evidence for disease-associated sequence clusters; all four clusters contain 
hmwA binding sequences from both OM and commensal strains. 
Interestingly, the majority of strains (94%) for which both loci were sequenced possess 
an hmwA that falls within Cluster 1. The HMW adhesins of NTHi strain 12 are known to differ 
in their in vitro adherence properties (9, 53, 62). NTHi strain 12 HMW1 interacts with α-2,3 N-
linked sialic acid moieties on glycoproteins of the respiratory epithelium (49), whereas the 
receptor for strain 12 HMW2 remains uncharacterized. Previous phylogenetic analyses 
demonstrate that hmwA sequences cluster into groups based upon their in vitro adherence 
properties (9). Thus, the sequences in Cluster 1 might be expected to have binding characteristics 
similar to the NTHi strain 12 HMW2. While investigating adherence characteristics in a diverse 
collection of NTHi isolates, van Schilfgaarde et al., identified a small number of NTHi isolates 
that displayed HMW adherence properties distinct from the strain 12 HMW1- and HMW2-type 
adherence (62). In total, four distinct adherence patterns were described, which is interesting 
given that we identified four hmwA sequence clusters. It is possible, therefore, that the Cluster 3-
4 hmwA sequences encode HMW adhesins with novel adherence profiles. 
 Characterization of a diverse collection of NTHi strains with an electrophoretic typing 
scheme suggests that OM strains are more clonal than COPD isolates (60). A second study noted 
that, when tested against a panel of monoclonal antibodies generated against NTHi Strain 12 
HMW adhesins, OM strains expressed less diverse HMW adhesins than did COPD strains or 
strains isolated from the throats of healthy individuals (62). Using the hmwA binding sequences, 
we asked whether the OM strains and commensal strains within each cluster exhibited similar 
levels of genetic diversity. Commensal strains from Cluster 1 and Cluster 2 display a wider range 
of genetic diversity, with mean genetic distances of 0.652 (± 0.220) and 0.583 (± 2.609), 




0.295). The fact that hmwA core binding sequences from OM strains are less diverse than throat 
strains is consistent with the general view that OM strains represent a limited subset of the much 
larger population of commensal strains. 
It is important to exercise caution when evaluating the role of HMW adhesins during OM 
pathogenesis based solely on prevalence data. Prevalence data alone do not provide any 
information regarding expression of functional HMW adhesins and simply reflect the presence of 
the adhesin genes. The relationship between hmwA presence and HMW expression is 
complicated by the fact that both hmwA loci contain tandem repeats located within their 
promoter regions and these repeats, which are gained and lost via slipped strand mispairing, 
affect the level HMW adhesin production (17). High numbers of repeats are associated with 
reduced HMW production and reduced NTHi adherence. Since the HMW adhesins are 
immunogenic, phase variation provides a population-level mechanism that allows NTHi to avoid 
clearance by HMW-specific adaptive immunity. Indeed, mathematical modeling suggests that 
HMW-specific antibody mediated immune pressure can shape the within-host NTHi population 
structure, selecting for bacterial cells with a high repeat number and low levels of surface 
expressed HMW (Dissertation Chapter 5). Variation in HMW adhesin expression has 
implications for NTHi pathogenesis during both OM and COPD. For example, NTHi isolates 
collected from the ears of children with AOM have higher numbers of hmwA–associated simple 
sequence repeats than matched isolates collected from the throat (17) and serial isolates collected 
over time from COPD patients reveal increases in repeat numbers over time, which is associated 
with decreased HMW production and reduced NTHi in-vitro adherence (11).  As these examples 
illustrate, the simple presence or absence of hmwA only tells part of the story. The fact that 
hmwA is more prevalent among OM isolates, however, suggests that hmwA-containing strains are 
more likely to survive in the middle ear space and cause disease than their hmwA-negative 
counterparts and supports a role for HMW adhesins in NTHi virulence. 
Recently a pneumococcal-NTHi protein D conjugate vaccine, composed pneumococcal 
polysaccharide capsule antigens conjugated to NTHi protein D, has been approved for use in 
children in Canada and several European countries (15, 20, 46). Protein D is a highly conserved 
outer membrane lipoprotein present in both typeable and nontypeable H. influenzae (28). The 




ineffective against NTHi as it does not reduce NTHi nasopharyngeal colonization (45, 61). Thus, 
efforts to develop an NTHi vaccine are ongoing. Ideally, an effective vaccine would specifically 
target strains with increased pathogenic potential, leaving behind a community of “commensal” 
NTHi in the pharynx. If hmwA sequences from OM strains formed a distinct phylogenetic cluster 
then those sequences could be used specifically for a vaccine designed to target only a subset of 
virulent NTHi strains.  
HMW has long been championed as an attractive candidate for inclusion in a multivalent 
vaccine since it is both surface exposed and highly immunogenic (1, 5, 63, 64). As highlighted in 
the current study, the observed amino acid diversity coupled with the lack of any apparent 
disease-specific hmwA sequences likely precludes HMW’s usefulness as a vaccine component. 
Furthermore, mathematical modeling of the interaction between hmwA phase variation and the 
host adaptive immune response suggests that a rapid and strong anti-HMW immune response, as 
might be induced by secondary exposure following successful vaccination, may actually increase 
the duration of time that the colonizing NTHi population remains adherent and, as a 
consequence, may increase NTHi transmissibility (Chapter 5 of dissertation). It should be 
emphasized, however, that while interesting, the modeling results are preliminary and warrant 
further analysis. Taken together, these findings cast a long shadow over HMW’s potential as one 
component of a multi-component NTHi vaccine. 
In summary, the prevalence of hmwA among this strain collection was 72% and 
prevalence varied by geographic region. Overall, OM strains were significantly more likely to 
possess hmwA than were commensal strains. The HMW adhesins are presumably costly to 
produce both from an energetic perspective given their large size, especially when compared to 
the relatively small size of the NTHi chromosome, and from a fitness perspective since they are 
an immunodominant target of the host’s adaptive immune system (3). The fact that a majority of 
strains interrogated for hmwA1697 and hmwA1598 possessed an hmwA at both loci suggests that 
having two copies confers a real fitness advantage over having a single hmwA, even when both 
copies possess identical, or nearly identical, binding domains.  Phylogenetic network analysis 
suggests that hmwA sequences form four distinct sequence clusters, but, nearly all strains possess 
an hmwA that falls within Cluster 1 raising the possibility that Cluster 1 sequences may represent 




adherence properties possibly defining distinct niches within the pharynx. Future studies, aimed 
at defining the adherence profiles of Cluster 3 and 4 sequences, will help determine if these 




Table 3.1. PCR primers used in this study. 
Primer Name Primer Sequence (5' to 3') Reference 
hmwA_leader_F GCCAATTTCCGCTTCACCCTCTTT this study 
hmwA_leader_R AACAACTCCGCCGTATTTAACCGC this study 
A1FL5.2 YGATAGSGTAGATCTCCCCGCCTTTGC this study 
hmwA1F_ORF5-1 TGGAACTTCTTTTGCTGTGGCTGATGC (30) 
A2FL5.2 TTGTGGCAATTCAATACCTATTTGTGG this study 
hmwA2F_ORF5-1 CCTCTTAATTGGGCATTAGTTGG (30) 
hmwA_core_1R CCGGTGATATTCACGCTGCTTGAGG this study 
hmwAR_HMWB3R GATGAAGAAGCCAGGCCAAGCAATAC (30). 
hmwAseqR_NotI ATGATCAGCGGCCGCGGSGTGATRTTYACDYTRCTTGAGG this study 





Table 3.2. NTHi strains selected for hmwA sequencing. 
 
a 
NA = not available, ND = not determined, STOP = in-frame stop codon 
b
 Phylogenetic Cluster to which each hmwA belongs (see Fig. 3.3)  
 

















F164-6 3 Finland Ear 2850 3 2739 1 
F286-5 155 Finland Ear 3060 1 3567  2 
F1124-2 12 Finland Ear 3486 2 3477 2 
F1152-8 40 Finland Ear 2796 1 3345 2 
F1296-5 57 Finland Ear 3030 2 2949 1 
F120 472 Finland Throat 3132 2 2880 1 
F441 253 Finland Throat 2967 2 ND  
F651 852 Finland Throat 3069 1 3069 1 
F894 155 Finland Throat 3516 2 3111 1 
F938 853 Finland Throat 2934 1 ND  
F1015 245 Finland Throat 3414 4 3414 4 
F1942 3 Finland Throat 2853 1 2850 3 
I168 12 Israel Ear 2784 1 STOP  
I198 877 Israel Ear 2697 2 2652 1 
I202 57 Israel Ear 2664 2 2868 1 
I208 893 Israel Ear 2847 1 3045 2 
I213 244 Israel Ear 3408 3 3354 1 
I218 238 Israel Ear 3186 3 2871 1 
I249 859 Israel Throat 3042 3 ND  
I256 764 Israel Throat 3573 2 2868 1 
I280 892 Israel Throat 3000 1 3009 1 
I283 165 Israel Throat 3009 1 3306 2 
I336 866 Israel Throat 2865 1 2949 2 
G423 34 US Ear STOP  3384 2 
G922 203 US Ear 2778 1 3213 4 
G1822 34 US Ear ND  3180 1 
K15RE2.6 11 US Ear 3060 1 3243 2 
K19RE2.4 57 US Ear 2877 1 3030 2 
K32RE2.5 143 US Ear 3387 2 2919 1 
63.4-22 196 US Throat 3117 1 3516 4 
H04.2.1 11 US Throat 3243 2 3060 1 
J06.2.2 880 US Throat 2844 1 3042 2 
N02.2.3 881 US Throat ND  2973 1 
Sequences obtained from GenBank 
strain 12
 
      3114 2 2934 1 
strain 5
 
      3297 2 3306 1 
strain 72
 
      2910 2 STOP  
AAr96
 
      NA  3045 2 
PittEE
 
      3246 3 3267 1 
86-028NP
 
      2979 3 3129 1 
A950006
 
      3174 3 NA  
G822
 
      2949 1 NA  
AAr105
 



















 Prevalence ratio (OM/commensal) and 95% confidence intervals 
b
 Fisher’s exact test two-tailed P-value 
  








OM 75 (61) 20 (43) 1.23 (1.01, 1.51) 0.038 
Commensal 48 (39) 27 (57)     
Total    123 (100)       47 (100) 
       
Finland (n = 55) 
    OM 26 (55) 3 (37) 1.11 (0.89, 1.39) 0.455 
Commensal 21 (45) 5 (63)     
Total              47 (100)   8 (100) 
     
Israel (n = 50) 
    OM 21 (64) 7 (41) 1.38 (0.89, 2.13) 0.147 
Commensal 12 (36) 10 (59)     
Total              33 (100) 17 (100) 
     
US (n = 65) 
    OM 28 (67) 10 (45) 1.33 (0.90, 1.95) 0.184 
Commensal 15 (33) 12 (55)     
Total  43 (100) 22 (100)   

















(n = 59) 
Commensal 
(n = 32) 
Total 
(n = 91) 
both 54 31 85 
hmwA1679 only 1 0 1 
hmwA1598 only 2 0 2 
neither 2 1 3 
 






Figure 3.1. MLST phylogeny for the 170 strains used in this study (phylogeny taken from (36)) . 
The first two columns are color coded according to the geographic region the strain was 
collected from (II) and the disease status of the subject (II). Of the 123 hmwA-leader positive 
strains (III), 91 were selected for interrogation by PCR assay for the presence of hmwA1679 (IV) 
and hmwA1598 (V). Strains chosen for hmwA binding domain DNA sequence analysis are 









Figure 3.2. Neighbor-Net phylogenetic network for all hmwA binding domain sequences. The 
network was constructed from genetic distances estimated using the maximum composite 
likelihood model with rate variation among sites was modeled with a gamma distribution and 
five rate categories (shape parameter = 0.567)(58). Boxes in the network reflect inconsistencies 
in the phylogenetic signal such as those arising from recombination; LSfit = 0.9927. There are 
four distinct hmwA sequence clusters, Cluster 1(blue), Cluster 2 (green), Cluster 3 (purple), and 
Cluster 4(red). The majority of strains (94%) possess an hmwA that belongs to Cluster 1 with the 
second hmwA from any given strain falling within the Clusters 2, 3, or 4. All positions containing 
gaps and missing data were eliminated from the analysis resulting in a total of 1809 positions in 









Figure 3.3.  hmwA core binding region evolutionary relationships were estimated using the 
maximum likelihood approach. hmwA sequences form four distinct sequence clusters and most 
strains (94%) possess an hmwA that falls within Cluster 1. The sequences do not cluster by 
geographic region (I), disease status (II), or by hmwA locus (III). The percentage of replicate 
trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are 
shown next to the branches (26); branches recovered in less than 50% of the bootstrap replicates 
were collapsed. Differences in the evolutionary rates among sites were modeled with a five 
category discrete gamma distribution (shape parameter = 0.6044). All positions containing gaps 
and missing data were eliminated from the analysis resulting in a total of 1809 positions in the 





Supplemental Tables and Figures 
 
Table 3.S1. hmwA amps for G strains (see Table 2 for primer sequences). 
 
  hmwA1679 hmwA1598 
Strain forward primer reverse primer forward primer reverse primer 
G322 hmwA1F_ORF5-1 hmwAR_HMWB3R hmwA2F_ORF5-1 hmwAR_HMWB3R 
G423 hmwA1F_ORF5-1 hmwA_core_1R A2FL5.2 hmwA_core_1R 
G822 hmwA1F_ORF5-1 hmwAR_HMWB3R hmwA2F_ORF5-1 hmwAR_HMWB3R 
G922 hmwA1F_ORF5-1 hmwA_core_1R hmwA2F_ORF5-1 hmwA_core_1R 
G1222 no amplification no amplification A2FL5.2 hmwA_core_1R 
G1322 hmwA1F_ORF5-1 hmwA_core_1R A2FL5.2 hmwA_core_1R 
G1522 hmwA1F_ORF5-1 hmwAR_HMWB3R no amplification no amplification 






Table 3.S2. Cluster 1 pairwise amino acid p-distances (above the diagonal) and pairwise 






    1 2 3 4 5 6 
  Strain_locus 63422_1A F120_2A F651_1A F651_2A F894_2A F938_1A 
1 63422_1A   0.4120 0.4398 0.4398 0.3832 0.3775 
2 F120_2A 0.8467   0.3407 0.3375 0.3438 0.3462 
3 F651_1A 0.9792 0.5506   0.0029 0.3678 0.3194 
4 F651_2A 0.9785 0.5418 0.0020   0.3698 0.3226 
5 F894_2A 0.7802 0.5957 0.7435 0.7517   0.3409 
6 F938_1A 0.7642 0.5678 0.4997 0.5080 0.5720   
7 F1296_2A 0.5008 0.6907 0.6316 0.6416 0.8974 0.5268 
8 F1646_2A 0.5627 0.7288 0.7688 0.7813 0.5948 0.5566 
9 F1942_1A 0.5755 0.7192 0.8144 0.8013 0.6230 0.5549 
10 F2865_1A 0.7906 0.5955 0.7551 0.7549 0.0000 0.5824 
11 F11528_1A 0.8228 0.7295 0.8540 0.8525 0.7054 0.6421 
12 G922_1A 0.5219 0.7249 0.7511 0.7629 0.6581 0.4835 
13 G1822_2A 0.5836 0.6184 0.7918 0.8031 0.4980 0.4959 
14 H0421_2A 0.8602 0.5172 0.6449 0.6548 0.6185 0.4735 
15 I168_1A 0.8069 0.7307 0.8491 0.8382 0.7030 0.6429 
16 I198_2A 0.7683 0.7769 0.7741 0.7613 0.8579 0.7271 
17 I202_2A 0.6161 0.4981 0.5864 0.5935 0.7861 0.6194 
18 I208_1A 0.7161 0.5542 0.6728 0.6632 0.5735 0.5436 
19 I213_2A 0.6834 0.5454 0.8183 0.8271 0.5906 0.4603 
20 I218_2A 0.7034 0.5836 0.6876 0.6981 0.6046 0.4665 
21 I256_2A 0.5761 0.6980 0.7885 0.7759 0.6503 0.5487 
22 I280_1A 0.7344 0.5793 0.5623 0.5621 0.6945 0.6716 
23 I280_2A 0.7343 0.5789 0.5710 0.5618 0.7035 0.6811 
24 I283_1A 0.7415 0.5931 0.5679 0.5746 0.6970 0.6775 
25 I336_1A 0.6643 0.6652 0.5817 0.5877 0.4324 0.6734 
26 J0622_1A 0.7565 0.7656 0.7506 0.7622 0.9160 0.6949 
27 K15RE_1A 0.8694 0.5258 0.6648 0.6658 0.6365 0.4947 
28 K19RE_1A 0.5400 0.6613 0.6120 0.6220 0.7255 0.3479 
29 K32RE_2A 0.6712 0.6567 0.6730 0.6809 0.5944 0.5027 
30 N0233_2A 0.6896 0.5066 0.7030 0.6921 0.6152 0.4830 
31 G822_1A 0.5202 0.7462 0.6477 0.6579 0.8984 0.5352 
32 86-028NP_2A 0.3912 0.6643 0.7980 0.8065 0.6100 0.5135 
33 strain 5_2A 0.3222 0.7059 0.6127 0.6215 0.7277 0.7148 
34 strain 12_2A 0.7973 0.5740 0.5291 0.5356 0.5965 0.0376 





Table 3.S2. Cluster 1 distances (con’t).  
    7 8 9 10 11 12 
  Strain_locus F1296_2A F1646_2A F1942_1A F2865_1A F11528_1A G922_1A 
1 63422_1A 0.3016 0.3379 0.3409 0.3852 0.3901 0.3230 
2 F120_2A 0.3803 0.3801 0.3807 0.3448 0.3949 0.3825 
3 F651_1A 0.3710 0.3851 0.3985 0.3711 0.3956 0.3945 
4 F651_2A 0.3742 0.3884 0.3952 0.3711 0.3956 0.3978 
5 F894_2A 0.3975 0.3455 0.3539 0.0000 0.3589 0.3600 
6 F938_1A 0.3222 0.3189 0.3209 0.3449 0.3558 0.3144 
7 F1296_2A   0.3330 0.3510 0.4025 0.3785 0.3209 
8 F1646_2A 0.5538   0.0143 0.3488 0.3592 0.3464 
9 F1942_1A 0.5912 0.0094   0.3550 0.3682 0.3506 
10 F2865_1A 0.9174 0.6066 0.6274   0.3593 0.3645 
11 F11528_1A 0.8033 0.6585 0.6868 0.7028   0.4074 
12 G922_1A 0.4939 0.5626 0.5613 0.6729 0.8413   
13 G1822_2A 0.6859 0.5121 0.5472 0.5034 0.6821 0.6448 
14 H0421_2A 0.6740 0.5909 0.6468 0.6261 0.6588 0.7397 
15 I168_1A 0.8124 0.6699 0.6919 0.6924 0.0077 0.8376 
16 I198_2A 0.5171 0.5834 0.5883 0.8639 0.8667 0.7365 
17 I202_2A 0.5731 0.7210 0.7500 0.8010 0.6619 0.5656 
18 I208_1A 0.6803 0.6405 0.6408 0.5681 0.5938 0.6308 
19 I213_2A 0.6873 0.4685 0.4862 0.6091 0.6073 0.6660 
20 I218_2A 0.6843 0.5858 0.6145 0.6166 0.5774 0.6004 
21 I256_2A 0.5879 0.0474 0.0364 0.6540 0.6702 0.5660 
22 I280_1A 0.6715 0.6668 0.7346 0.7072 0.7144 0.8487 
23 I280_2A 0.6812 0.6771 0.7334 0.7071 0.7179 0.8605 
24 I283_1A 0.6786 0.6731 0.7422 0.7139 0.7124 0.8555 
25 I336_1A 0.7992 0.7205 0.7735 0.4328 0.7065 0.7771 
26 J0622_1A 0.3629 0.5341 0.5735 0.9439 0.8727 0.7054 
27 K15RE_1A 0.6971 0.6187 0.6662 0.6317 0.6535 0.7617 
28 K19RE_1A 0.0945 0.6000 0.6037 0.7396 0.8056 0.3209 
29 K32RE_2A 0.6392 0.2469 0.2674 0.6030 0.4884 0.5803 
30 N0233_2A 0.6865 0.6720 0.6724 0.6168 0.5394 0.6513 
31 G822_1A 0.0217 0.5517 0.5911 0.9186 0.8368 0.4888 
32 86-028NP_2A 0.7369 0.5579 0.5828 0.6261 0.5093 0.5818 
33 strain 5_2A 0.6015 0.5687 0.6158 0.7385 0.7770 0.6305 
34 strain 12_2A 0.5249 0.5815 0.5827 0.6163 0.5989 0.5060 











    13 14 15 16 17 18 19 
  Strain_locus G1822_2A H0421_2A I168_1A I198_2A I202_2A I208_1A I213_2A 
1 63422_1A 0.3432 0.3909 0.3860 0.3859 0.3340 0.3723 0.3821 
2 F120_2A 0.3582 0.3221 0.3942 0.4089 0.3144 0.3584 0.3291 
3 F651_1A 0.3937 0.3421 0.3960 0.3977 0.3311 0.3684 0.3976 
4 F651_2A 0.3957 0.3453 0.3949 0.3966 0.3322 0.3662 0.3996 
5 F894_2A 0.2951 0.3502 0.3605 0.4027 0.3783 0.3468 0.3553 
6 F938_1A 0.3175 0.3172 0.3563 0.3736 0.3448 0.3405 0.3006 
7 F1296_2A 0.3685 0.3598 0.3802 0.3150 0.3272 0.3671 0.3704 
8 F1646_2A 0.3263 0.3330 0.3603 0.3424 0.3632 0.3642 0.3115 
9 F1942_1A 0.3390 0.3522 0.3684 0.3471 0.3699 0.3682 0.3223 
10 F2865_1A 0.2962 0.3522 0.3595 0.4049 0.3820 0.3456 0.3613 
11 F11528_1A 0.3517 0.3646 0.0109 0.4031 0.3618 0.3400 0.3377 
12 G922_1A 0.3662 0.3836 0.4079 0.3841 0.3405 0.3711 0.3487 
13 G1822_2A   0.3347 0.3511 0.3984 0.3758 0.3404 0.2863 
14 H0421_2A 0.5498   0.3662 0.4055 0.3124 0.3488 0.3512 
15 I168_1A 0.6751 0.6617   0.4048 0.3595 0.3397 0.3424 
16 I198_2A 0.7927 0.7821 0.8581   0.3965 0.3671 0.3596 
17 I202_2A 0.7121 0.5269 0.6518 0.8022   0.3678 0.3865 
18 I208_1A 0.5595 0.5955 0.5840 0.6628 0.6804   0.3461 
19 I213_2A 0.3525 0.5764 0.6156 0.6078 0.7171 0.5258   
20 I218_2A 0.5226 0.5227 0.5698 0.6745 0.6786 0.0679 0.5273 
21 I256_2A 0.5183 0.6260 0.6820 0.6036 0.7402 0.6453 0.4909 
22 I280_1A 0.7098 0.7107 0.6968 0.8582 0.6627 0.7940 0.7300 
23 I280_2A 0.7209 0.7203 0.6985 0.8535 0.6710 0.7965 0.7394 
24 I283_1A 0.7170 0.7165 0.7089 0.8652 0.6673 0.8044 0.7207 
25 I336_1A 0.7397 0.6728 0.7029 0.8992 0.7843 0.7494 0.7504 
26 J0622_1A 0.7978 0.7014 0.8715 0.0530 0.7461 0.7231 0.6563 
27 K15RE_1A 0.5703 0.0090 0.6585 0.7789 0.5424 0.5951 0.5941 
28 K19RE_1A 0.6667 0.6876 0.8030 0.5807 0.5457 0.6131 0.6231 
29 K32RE_2A 0.5622 0.5096 0.4873 0.6913 0.5269 0.4551 0.4048 
30 N0233_2A 0.4982 0.4743 0.5327 0.7560 0.4925 0.5626 0.5173 
31 G822_1A 0.6830 0.7016 0.8359 0.5222 0.6013 0.7081 0.7010 
32 86-028NP_2A 0.4884 0.5609 0.5075 0.7881 0.6166 0.4154 0.4479 
33 strain 5_2A 0.5676 0.7729 0.7768 0.7889 0.6991 0.6118 0.7492 
34 strain 12_2A 0.5276 0.4858 0.5997 0.6980 0.6109 0.5600 0.4693 











    20 21 22 23 24 25 
  Strain_locus I218_2A I256_2A I280_1A I280_2A I283_1A I336_1A 
1 63422_1A 0.3659 0.3344 0.3732 0.3732 0.3753 0.3445 
2 F120_2A 0.3585 0.3754 0.3456 0.3456 0.3508 0.3837 
3 F651_1A 0.3579 0.3974 0.3379 0.3400 0.3400 0.3386 
4 F651_2A 0.3611 0.3942 0.3379 0.3379 0.3421 0.3397 
5 F894_2A 0.3449 0.3573 0.3513 0.3532 0.3522 0.2643 
6 F938_1A 0.3226 0.3139 0.3661 0.3680 0.3680 0.3705 
7 F1296_2A 0.3639 0.3459 0.3695 0.3715 0.3725 0.3874 
8 F1646_2A 0.3462 0.0548 0.3526 0.3548 0.3548 0.3693 
9 F1942_1A 0.3594 0.0432 0.3659 0.3658 0.3679 0.3821 
10 F2865_1A 0.3490 0.3584 0.3543 0.3543 0.3563 0.2637 
11 F11528_1A 0.3326 0.3650 0.3647 0.3654 0.3622 0.3681 
12 G922_1A 0.3559 0.3498 0.3987 0.4007 0.4007 0.3921 
13 G1822_2A 0.3312 0.3256 0.3682 0.3701 0.3711 0.3751 
14 H0421_2A 0.3302 0.3461 0.3701 0.3720 0.3720 0.3602 
15 I168_1A 0.3311 0.3662 0.3584 0.3583 0.3605 0.3681 
16 I198_2A 0.3660 0.3497 0.4064 0.4062 0.4050 0.4204 
17 I202_2A 0.3603 0.3660 0.3519 0.3540 0.3540 0.3877 
18 I208_1A 0.0685 0.3715 0.3932 0.3941 0.3951 0.3983 
19 I213_2A 0.3379 0.3259 0.3809 0.3827 0.3766 0.3851 
20 I218_2A   0.3607 0.3941 0.3960 0.3960 0.3949 
21 I256_2A 0.6225   0.3693 0.3691 0.3734 0.3850 
22 I280_1A 0.8151 0.7373   0.0000 0.0030 0.3699 
23 I280_2A 0.8261 0.7362 0.0000   0.0060 0.3719 
24 I283_1A 0.8215 0.7525 0.0020 0.0044   0.3730 
25 I336_1A 0.7722 0.7525 0.6939 0.7037 0.7004   
26 J0622_1A 0.6870 0.5797 0.8230 0.8345 0.8296 0.8493 
27 K15RE_1A 0.5413 0.6399 0.7195 0.7292 0.7348 0.6887 
28 K19RE_1A 0.5998 0.6139 0.7934 0.8043 0.7998 0.8011 
29 K32RE_2A 0.4591 0.2560 0.7513 0.7603 0.7561 0.6495 
30 N0233_2A 0.5168 0.6428 0.6615 0.6608 0.6767 0.7069 
31 G822_1A 0.6928 0.6012 0.7096 0.7197 0.7157 0.8318 
32 86-028NP_2A 0.3873 0.5426 0.7260 0.7354 0.7309 0.7712 
33 strain 5_2A 0.6295 0.6028 0.6157 0.6246 0.6223 0.6660 
34 strain 12_2A 0.4865 0.5756 0.6972 0.7064 0.7010 0.6923 












    26 27 28 29 30 31 
  Strain_locus J0622_1A K15RE_1A K19RE_1A K32RE_2A N0233_2A G822_1A 
1 63422_1A 0.3687 0.3920 0.3246 0.3605 0.3503 0.3067 
2 F120_2A 0.3972 0.3242 0.3698 0.3684 0.3302 0.3934 
3 F651_1A 0.3940 0.3474 0.3596 0.3541 0.3695 0.3753 
4 F651_2A 0.3972 0.3474 0.3628 0.3552 0.3665 0.3785 
5 F894_2A 0.4104 0.3542 0.3641 0.3402 0.3435 0.3996 
6 F938_1A 0.3573 0.3227 0.2401 0.3101 0.3236 0.3243 
7 F1296_2A 0.2473 0.3651 0.0972 0.3488 0.3723 0.0244 
8 F1646_2A 0.3231 0.3385 0.3492 0.2276 0.3675 0.3352 
9 F1942_1A 0.3417 0.3543 0.3532 0.2370 0.3716 0.3543 
10 F2865_1A 0.4158 0.3532 0.3686 0.3432 0.3444 0.4046 
11 F11528_1A 0.4025 0.3650 0.3785 0.3057 0.3245 0.3831 
12 G922_1A 0.3727 0.3891 0.2503 0.3469 0.3696 0.3220 
13 G1822_2A 0.3889 0.3387 0.3624 0.3544 0.3114 0.3675 
14 H0421_2A 0.3787 0.0049 0.3592 0.3226 0.3203 0.3661 
15 I168_1A 0.4018 0.3666 0.3791 0.3017 0.3262 0.3848 
16 I198_2A 0.0770 0.4055 0.3372 0.3850 0.3927 0.3242 
17 I202_2A 0.3782 0.3166 0.3243 0.3068 0.3096 0.3359 
18 I208_1A 0.3754 0.3467 0.3444 0.3185 0.3461 0.3716 
19 I213_2A 0.3628 0.3532 0.3404 0.2933 0.3191 0.3693 
20 I218_2A 0.3645 0.3354 0.3381 0.3179 0.3379 0.3650 
21 I256_2A 0.3388 0.3482 0.3481 0.2313 0.3565 0.3491 
22 I280_1A 0.4053 0.3725 0.3854 0.3521 0.3683 0.3737 
23 I280_2A 0.4072 0.3744 0.3874 0.3541 0.3681 0.3757 
24 I283_1A 0.4072 0.3764 0.3874 0.3541 0.3734 0.3757 
25 I336_1A 0.4096 0.3637 0.3874 0.3524 0.3686 0.3907 
26 J0622_1A   0.3841 0.3322 0.3671 0.4017 0.2591 
27 K15RE_1A 0.7242   0.3644 0.3268 0.3203 0.3713 
28 K19RE_1A 0.5650 0.7126   0.3413 0.3524 0.0899 
29 K32RE_2A 0.6511 0.5340 0.6232   0.3400 0.3477 
30 N0233_2A 0.8320 0.4811 0.6125 0.5746   0.3798 
31 G822_1A 0.3739 0.7269 0.0810 0.6473 0.7258   
32 86-028NP_2A 0.8051 0.5901 0.6753 0.3994 0.5209 0.7637 
33 strain 5_2A 0.7557 0.7988 0.6671 0.6052 0.7657 0.6245 
34 strain 12_2A 0.6937 0.5016 0.3649 0.5299 0.4757 0.5397 
















    32 33 34 35 
  Strain_locus 
86-
028NP_2A strain 5_2A 
strain 
12_2A AAr105_1A 
1 63422_1A 0.2773 0.2426 0.3828 0.3472 
2 F120_2A 0.3724 0.3849 0.3473 0.3160 
3 F651_1A 0.3976 0.3600 0.3312 0.3509 
4 F651_2A 0.3996 0.3630 0.3333 0.3540 
5 F894_2A 0.3514 0.3673 0.3481 0.3265 
6 F938_1A 0.3200 0.3612 0.0470 0.3456 
7 F1296_2A 0.3687 0.3337 0.3159 0.3691 
8 F1646_2A 0.3289 0.3344 0.3256 0.3679 
9 F1942_1A 0.3379 0.3511 0.3273 0.3796 
10 F2865_1A 0.3563 0.3696 0.3543 0.3292 
11 F11528_1A 0.2934 0.3768 0.3381 0.3615 
12 G922_1A 0.3326 0.3450 0.3199 0.3641 
13 G1822_2A 0.3185 0.3285 0.3237 0.3248 
14 H0421_2A 0.3477 0.3709 0.3193 0.3340 
15 I168_1A 0.2914 0.3762 0.3385 0.3626 
16 I198_2A 0.3861 0.3870 0.3599 0.3867 
17 I202_2A 0.3389 0.3494 0.3394 0.3009 
18 I208_1A 0.2975 0.3606 0.3481 0.3682 
19 I213_2A 0.3100 0.3910 0.3017 0.3432 
20 I218_2A 0.2824 0.3565 0.3333 0.3577 
21 I256_2A 0.3298 0.3481 0.3192 0.3678 
22 I280_1A 0.3660 0.3381 0.3764 0.3482 
23 I280_2A 0.3679 0.3401 0.3784 0.3503 
24 I283_1A 0.3690 0.3411 0.3784 0.3503 
25 I336_1A 0.3839 0.3532 0.3727 0.3483 
26 J0622_1A 0.3885 0.3730 0.3540 0.3908 
27 K15RE_1A 0.3518 0.3759 0.3237 0.3397 
28 K19RE_1A 0.3515 0.3455 0.2463 0.3469 
29 K32RE_2A 0.2856 0.3434 0.3206 0.3610 
30 N0233_2A 0.3225 0.3730 0.3107 0.0862 
31 G822_1A 0.3728 0.3367 0.3232 0.3745 
32 86-028NP_2A   0.2625 0.3231 0.3435 
33 strain 5_2A 0.3453   0.3674 0.3506 
34 strain 12_2A 0.5217 0.7360   0.3359 




Table 3.S3. Cluster 2 pairwise amino acid p-distances (above diagonal) and pairwise maximum 
composite likelihood genetic distances (below diagonal). 
 
    1 2 3 4 5 6 7 
  Strain_locus G423_2A I283_2A F120_1A F11528_2A 
strain 
12_1A F11242_1A F11242_2A 
1 G423_2A   0.0000 0.2975 0.3020 0.2856 0.3241 0.3278 
2 I283_2A 0.0000   0.2975 0.3020 0.2856 0.3241 0.3278 
3 F120_1A 0.3896 0.3896   0.2338 0.2854 0.3311 0.3350 
4 F11528_2A 0.3649 0.3649 0.3364   0.2510 0.2811 0.2818 
5 strain 12_1A 0.4699 0.4699 0.4019 0.2984   0.2660 0.2697 
6 F11242_1A 0.4293 0.4293 0.4771 0.2230 0.3027   0.0026 
7 F11242_2A 0.4307 0.4307 0.4786 0.2239 0.3038 0.0005   
8 K32RE_1A 0.5001 0.5001 0.4282 0.3662 0.3597 0.4308 0.4322 
9 I256_1A 0.7040 0.7040 0.4851 0.4320 0.4161 0.4880 0.4894 
10 strain 72_1A 0.5622 0.5622 0.5622 0.4240 0.4349 0.5106 0.5121 
11 J0622_2A 0.6274 0.6274 0.7009 0.5006 0.5653 0.6551 0.6569 
12 AAr96_2A 0.6563 0.6563 0.7440 0.5443 0.5847 0.6886 0.6904 
13 F894_1A 0.6795 0.6795 0.6299 0.5861 0.6569 0.6725 0.6743 
14 F2865_2A 0.6824 0.6824 0.6326 0.5887 0.6540 0.6696 0.6714 
15 I198_1A 0.7357 0.7357 0.6987 0.6434 0.7021 0.7328 0.7347 
16 I202_1A 0.7884 0.7884 0.8380 0.6504 0.7233 0.7574 0.7593 
17 F441_1A 0.6207 0.6207 0.6920 0.6025 0.6382 0.6276 0.6293 
18 F1296_1A 0.6191 0.6191 0.7951 0.6334 0.6561 0.6366 0.6383 
19 K19RE_2A 0.6199 0.6199 0.8027 0.6258 0.6552 0.6340 0.6357 
20 I208_2A 0.5901 0.5901 0.4839 0.4952 0.5041 0.5072 0.5087 
21 strain 5_1A 0.5717 0.5717 0.5093 0.4930 0.5357 0.5155 0.5170 
22 I336_2A 0.6188 0.6188 0.5776 0.5783 0.6162 0.6617 0.6634 
23 H0421_1A 0.6094 0.6094 0.4883 0.4935 0.5151 0.5243 0.5258 






Table 3.S3. Cluster 2 distances (con’t). 
 
    8 9 10 11 12 13 14 
  Strain_locus K32RE_1A I256_1A 
strain 
72_1A J0622_2A AAr96_2A F894_1A F2865_2A 
1 G423_2A 0.3471 0.3992 0.3682 0.3902 0.3976 0.3680 0.3660 
2 I283_2A 0.3471 0.3992 0.3682 0.3902 0.3976 0.3680 0.3660 
3 F120_1A 0.3047 0.3387 0.3607 0.3829 0.3925 0.3585 0.3564 
4 F11528_2A 0.2886 0.3568 0.3310 0.3571 0.3724 0.3798 0.3808 
5 strain 12_1A 0.2759 0.3011 0.3046 0.3518 0.3591 0.3456 0.3413 
6 F11242_1A 0.3093 0.3485 0.3404 0.3725 0.3836 0.3719 0.3681 
7 F11242_2A 0.3119 0.3522 0.3427 0.3737 0.3849 0.3739 0.3701 
8 K32RE_1A   0.3168 0.3053 0.3569 0.3692 0.3484 0.3494 
9 I256_1A 0.4883   0.3802 0.3517 0.3605 0.3039 0.3020 
10 strain 72_1A 0.4895 0.6754   0.2684 0.2829 0.3760 0.3737 
11 J0622_2A 0.6557 0.5553 0.3702   0.0473 0.3513 0.3480 
12 AAr96_2A 0.6953 0.5775 0.4292 0.0317   0.3531 0.3520 
13 F894_1A 0.7787 0.5290 0.6767 0.4599 0.4814   0.0034 
14 F2865_2A 0.7820 0.5266 0.6797 0.4607 0.4837 0.0005   
15 I198_1A 0.7850 0.5137 0.7160 0.5455 0.5580 0.3453 0.3436 
16 I202_1A 0.5799 0.6713 0.6530 0.5090 0.5409 0.4415 0.4394 
17 F441_1A 0.7734 0.6207 0.5762 0.3600 0.3867 0.3507 0.3525 
18 F1296_1A 0.8105 0.6594 0.6331 0.3839 0.4292 0.3884 0.3902 
19 K19RE_2A 0.8197 0.6567 0.6303 0.3797 0.4245 0.3854 0.3872 
20 I208_2A 0.5669 0.6302 0.5070 0.5627 0.6091 0.5242 0.5265 
21 strain 5_1A 0.5598 0.6226 0.4869 0.5634 0.6157 0.5390 0.5414 
22 I336_2A 0.6112 0.6402 0.6231 0.7564 0.7711 0.5827 0.5853 
23 H0421_1A 0.5505 0.4526 0.4303 0.5638 0.5967 0.5151 0.5175 






Table 3.S3. Cluster 2 pairwise distances (con’t). 
 
    15 16 17 18 19 20 21 
  Strain_locus I198_1A I202_1A F441_1A F1296_1A K19RE_2A I208_2A strain 5_1A 
1 G423_2A 0.3889 0.3872 0.3599 0.3382 0.3393 0.3420 0.3479 
2 I283_2A 0.3889 0.3872 0.3623 0.3382 0.3393 0.3420 0.3479 
3 F120_1A 0.3834 0.3978 0.3681 0.3765 0.3787 0.3203 0.3341 
4 F11528_2A 0.3729 0.3635 0.3638 0.3623 0.3612 0.3302 0.3232 
5 strain 12_1A 0.3818 0.3731 0.3647 0.3662 0.3673 0.3132 0.3199 
6 F11242_1A 0.3818 0.3803 0.3670 0.3584 0.3595 0.3144 0.3158 
7 F11242_2A 0.3819 0.3817 0.3682 0.3607 0.3618 0.3167 0.3169 
8 K32RE_1A 0.3873 0.3383 0.3876 0.3692 0.3715 0.3349 0.3273 
9 I256_1A 0.3445 0.3676 0.3638 0.3630 0.3641 0.3585 0.3693 
10 strain 72_1A 0.3843 0.3516 0.3790 0.3863 0.3853 0.3463 0.3397 
11 J0622_2A 0.3634 0.3294 0.3309 0.3187 0.3167 0.3479 0.3418 
12 AAr96_2A 0.3646 0.3318 0.3403 0.3350 0.3330 0.3709 0.3600 
13 F894_1A 0.2679 0.2804 0.3023 0.3048 0.3037 0.3360 0.3540 
14 F2865_2A 0.2657 0.2781 0.3001 0.3027 0.3016 0.3326 0.3529 
15 I198_1A   0.0623 0.3076 0.2731 0.2720 0.3791 0.3641 
16 I202_1A 0.0768   0.3152 0.2636 0.2624 0.3781 0.3734 
17 F441_1A 0.3937 0.4455   0.2031 0.2031 0.3356 0.3722 
18 F1296_1A 0.3697 0.3931 0.1891   0.0059 0.3536 0.3624 
19 K19RE_2A 0.3693 0.3926 0.1875 0.0023   0.3558 0.3624 
20 I208_2A 0.5629 0.6424 0.4651 0.5881 0.5874   0.3041 
21 strain 5_1A 0.5987 0.7223 0.6051 0.5776 0.5782 0.3922   
22 I336_2A 0.6288 0.8231 0.5873 0.7161 0.7133 0.4700 0.5392 
23 H0421_1A 0.6190 0.7680 0.6138 0.6713 0.6719 0.3816 0.3462 






Table 3.S3. Cluster 2 pairwise distances (con’t). 
 
    22 23 24 
  Strain_locus I336_2A H0421_1A K15RE_2A 
1 G423_2A 0.3580 0.3715 0.3715 
2 I283_2A 0.3580 0.3715 0.3715 
3 F120_1A 0.3454 0.3383 0.3383 
4 F11528_2A 0.3525 0.3680 0.3680 
5 strain 12_1A 0.3525 0.3216 0.3216 
6 F11242_1A 0.3680 0.3597 0.3597 
7 F11242_2A 0.3692 0.3628 0.3628 
8 K32RE_1A 0.3522 0.3337 0.3337 
9 I256_1A 0.3818 0.3239 0.3239 
10 strain 72_1A 0.3592 0.3040 0.3040 
11 J0622_2A 0.4013 0.3477 0.3477 
12 AAr96_2A 0.4013 0.3519 0.3519 
13 F894_1A 0.3429 0.3246 0.3246 
14 F2865_2A 0.3417 0.3226 0.3226 
15 I198_1A 0.3513 0.3621 0.3621 
16 I202_1A 0.3803 0.3804 0.3804 
17 F441_1A 0.3613 0.3623 0.3623 
18 F1296_1A 0.3874 0.3764 0.3764 
19 K19RE_2A 0.3874 0.3764 0.3764 
20 I208_2A 0.3134 0.2869 0.2869 
21 strain 5_1A 0.3467 0.2903 0.2903 
22 I336_2A   0.3118 0.3118 
23 H0421_1A 0.5200   0.0000 







Table 3.S4. Cluster 3-4 pairwise amino acid p-distances (above diagonal) and pairwise maximum 
composite likelihood genetic distances (below diagonal). 
 
    1 2 3 4 5 6 
  Strain_locus F1646_1A F1942_2A I218_1A I249_1A F1015_1A F1015_2A 
1 F1646_1A   0.0105 0.3018 0.2994 0.3956 0.3923 
2 F1942_2A 0.003   0.3083 0.3004 0.3967 0.3989 
3 I218_1A 0.381 0.387   0.1507 0.4208 0.4178 
4 I249_1A 0.354 0.354 0.110   0.4426 0.4426 
5 F1015_1A 0.705 0.696 0.742 0.791   0.0026 
6 F1015_2A 0.695 0.706 0.731 0.789 0.002   
7 63422_2A 0.703 0.694 0.670 0.761 0.180 0.184 
8 G922_2A 0.667 0.659 0.643 0.748 0.214 0.219 
9 I213_1A 0.531 0.524 0.577 0.625 0.564 0.573 
10 PittEE_1A 0.551 0.558 0.668 0.661 0.568 0.562 
11 86-028NP_1A 0.534 0.541 0.653 0.679 0.557 0.551 





Table 3.S4. Cluster 3-4 distances (con’t). 
 
    7 8 9 10 11 12 
 




1 F1646_1A 0.4125 0.4124 0.3749 0.3863 0.3719 0.3709 
2 F1942_2A 0.4147 0.4135 0.3727 0.3897 0.3753 0.3743 
3 I218_1A 0.3949 0.3956 0.3568 0.4180 0.4047 0.4020 
4 I249_1A 0.4270 0.4395 0.3937 0.4217 0.4217 0.4124 
5 F1015_1A 0.1867 0.2390 0.3742 0.3764 0.3623 0.3615 
6 F1015_2A 0.1885 0.2420 0.3761 0.3744 0.3602 0.3595 
7 63422_2A   0.2236 0.3902 0.3992 0.3871 0.3838 
8 G922_2A 0.188   0.3563 0.3913 0.3877 0.3873 
9 I213_1A 0.597 0.511   0.2225 0.2035 0.2134 
10 PittEE_1A 0.626 0.587 0.149   0.0353 0.0322 
11 86-028NP_1A 0.601 0.567 0.146 0.015   0.0010 
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Chapter 4 
 
Nontypeable Haemophilus influenzae High Molecular Weight Adhesin Molecular Evolution 





Background. Nontypeable Haemophilus influenzae (NTHi) is a human-specific commensal that 
resides within the pharynx. NTHi high molecular weight adhesins (HMWs) mediate attachment 
to the respiratory epithelium where they interact with the host immune system eliciting a strong 
humoral response. The hmw locus is present in two copies on the NTHi chromosome. hmwA, 
which encodes HMW, displays marked sequence diversity, undergoes recombination, and is 
phase variable. These mechanisms presumably interact, as the bacterium attempts to evade host 
immune responses. In this study, we specifically tested for evidence of positive selection acting 
on hmwA. 
 
Methods. Two different methods for measuring selective pressure operating on a gene, both of 
which account for recombination, were employed: (1) MEME, a phylogenetic based maximum 
likelihood method and (2) omegaMap, a population genetics approximation of the coalescent 
with recombination. First, we analyzed the HMW-family of adhesins, that is, all hmw1A and 
hmw2A sequences combined, for evidence of positive selection in a single analysis. Next, two 
hmwA sequence clusters, Cluster 1 and Cluster 2-3, were defined based upon phylogenetic 
network analyses and analyzed separately for evidence of positive selection. Positively selected 
amino acids (AAs) were mapped onto predicted 3-dimensional models of the prototypic NTHi 
strain 12 HMW1 and HMW2 adhesins.  
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Results. Phylogenetic network analysis identified three distinct hmwA sequence clusters. Within 
the HMW-family of adhesins, considering all hmwA sequence clusters in a single analysis, 
approximately 50 AAs were identified as being under positive selection. All positively selected 
AAs were located within the mature HMW protein, and, the majority were within the binding 
domain region. When analyzed by hmwA sequence Cluster, approximately 22 and 30 AAs were 
under positive selection within the Cluster 1 and Cluster 2-3 hmwA sequences, respectively. The 
majority of AAs under positive selection were in regions predicted to be hydrophilic and 
consisting of either turns or loops. 
 
Conclusion. The evolution of NTHi hmwA is driven, in part, by positive selection. The 
positively selected amino acids are restricted to the mature by HMW protein and are largely 
localized to the core-binding domain. 
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Introduction 
 
Nontypeable Haemophilus influenzae (NTHi), a human restricted commensal that 
normally resides within the pharynx, is capable of causing localized respiratory infections, such 
as acute otitis media (AOM) and sinusitis, among otherwise healthy individuals as well as 
invasive infections and bronchitis in patients with chronic obstructive pulmonary disease. One of 
the first steps in NTHi colonization, and pathogenesis, is adherence to the host epithelium, which 
is mediated by a number of surface exposed pili and non-pilus adhesins, including the high 
molecular weight (HMW) adhesins (43-46, 49).  
The HMW adhesins are encoded by the hmw locus which consists of hmwA, hmwB, and 
hmwC (2, 3). The functional HMW adhesin is encoded by hmwA whereas hmwB and hmwC 
encode proteins necessary for adhesin maturation, glycosylation, and secretion (2, 3, 20, 22, 47). 
HMWs, as detected by Western blotting, are present in approximately 75% of all NTHi and, in 
nearly all strains tested, the hmw locus is present in two copies at conserved but unlinked 
locations on the NTHi chromosome (4, 8). The hmw loci, first characterized in NTHi strain 12, 
are designated hmw1 and hmw2 and their chromosomal locations are specified with respect to H. 
influenzae strain Rd as being downstream of HI1679 and HI1598, respectively (2, 8) (Fig. 4.1). 
Mature HMW adhesins display marked amino acid diversity both within and between 
strains (2, 8, 11, 18). The pairwise amino acid similarity of mature HMW adhesin varies from 
approximately 63 – 72% and amino acid identity from 52 – 62%, and the adhesins can also 
exhibit length differences of approximately 17% (8, 11). The HMW binding domain, which is 
localized to an approximately 400 amino acid region of the mature protein and directly interacts 
with epithelial cells (11), displays even greater amino acid diversity with pairwise similarities 
and identities as low as 50% and 35%, respectively (8, 11). 
 HMW amino acid diversity potentially serves two roles. First, it defines tissue tropism. 
The two copies of HMW encoded by a single strain confer different in vitro adherence 
characteristics when tested against a panel of human epithelial cell lines (8, 46). The HMW-
family of adhesins have been characterized by their differing in vitro adherence patterns relative 
to the proteins encoded by prototypic NTHi strain 12 hmw1, located at the HI1679 position, and 
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hmw2, located at the HI1598 position (chromosomal locations are with reference to Strain Rd) 
(8, 11). 
The HMW adhesins, when present, are the immunodominant outer membrane protein (1). 
Amino acid diversity, therefore, maintains population level HMW adhesin diversity which may 
play a role in immune evasion, for example, anti-HMW antibodies offer varying degrees of cross 
protection against heterologous NTHi strains (52). The HMW adhesin sequence diversity may 
thus be a consequence of immune driven selective pressure, such as for diversifying selection. 
The purpose of this study was to test for evidence of positive (e.g., diversifying) selection 
acting on the mature HMW adhesins. Using two different methods for measuring selective 
pressure operating on a gene, both of which account for recombination, we first tested for 
evidence of positive selection acting within the HMW-family of adhesins. We then divided the 
HMW-family of adhesins into two mutually exclusive sequence clusters and tested each cluster 
separately to allow for variation in selective pressure between clusters. We found evidence of 
positive selection in the HMW adhesin family as well as in both hmwA sequence clusters. In all 
three analyses, the majority of positively selected codons were localized to the regions in and 
around the binding domain of the mature HMW adhesin. Our results suggest that HMW adhesin 
diversity is due, at least in part, to the action of positive selection.  
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Materials and Methods 
 
hmwA nucleotide sequences. Nontypeable Haemophilus influenzae hmwA nucleotide 
sequences used in this study (Table 4.1) were obtained from GenBank. Sequences were limited 
to those that covered either the full-length hmwA, including the signal sequence region, or the 
entire mature binding protein.  
Sequence alignments. hmwA sequence alignments were done in two stages. First, hmwA 
nucleotide sequences were converted to amino acids using the computer package MEGA v.5 (51) 
and aligned using the MUSCLE algorithm (14), converted back to the original nucleotide 
sequence and then used to estimate a neighbor joining (NJ) tree in MEGA v.5 (51). Next, hmwA 
sequences were aligned with the computer program PRANKSTER (36) using the NJ tree as the 
initial guide tree; again, nucleotides (nts) were converted to amino acids, aligned, and then 
converted back to nts. Finally, a second PRANKSTER (36) alignment was conducted using a 
guide tree estimated from the previous alignment; this second alignment was used for all 
subsequent analyses. Four sequence alignments were generated: (1) thirteen full-length hmwA 
sequences, (2) fifteen hmwA mature peptide sequences, (3) eight hmwA mature peptide 
sequences defined as Cluster 2-3 sequences, and (4) seven hmwA mature peptide sequences 
defined as a Cluster 1 sequences. For all subsequent analyses, gaps were deleted from the 
nucleotide alignments. 
Genetic distances and tests for recombination. Genetic distances were estimated using 
the maximum composite likelihood (MCL) method (50) with rate variation among sites modeled 
with a gamma distribution. Standard error estimates of MCL genetic distance were estimated by 
a bootstrapping method using 1000 replicates. The value of the gamma distribution shape 
parameter, genetic distances, and variances were estimated in MEGA5 (51). Prior to conducting 
phylogenetic analyses, sequence alignments were tested for substitution saturation using the 
computer program DAMBE (57, 58). Sequence alignments were tested for evidence of 
recombination with the PHI test (6), implemented in SplitsTree4 (27). 
Phylogenetic analyses. Evolutionary relationships among hmwA were inferred using the 
maximum likelihood method (38) assuming a general time reversible (GTR) model of sequence 
evolution with evolutionary rate differences between sites modeled with a discrete gamma 
 
 101   
distribution (+G) (59) with allowance for invariant sites (+I) (16, 17). Consensus trees were 
inferred from 1000 bootstrapping replicates (15). All codon positions were included for analysis, 
alignment gaps were completely removed, and maximum likelihood phylogenetic analyses were 
implemented in MEGA v.5 (51). To account for inconsistencies in the phylogenetic signals, such 
as those introduced by recombination events, phylogenetic networks, based upon MCL distances, 
were constructed using the Neighbor-Net method (7) implemented in SplitsTree4 (27). 
 Positive selection. Positive selection is inferred when the ratio of the rates of 
nonsynonymous (dN) to synonymous (dS) substitutions, defined as omega (ω = dN/dS), at a 
codon is significantly greater than one. Two different methods for measuring selective pressure 
operating on a gene, both of which account for recombination, were employed: (1) a 
phylogenetic based maximum likelihood method (37)  and (2) a population genetics 
approximation of the coalescent with recombination (53). 
Within the maximum likelihood framework, a mixed effects model of evolution (MEME) 
was used that allowed for rate variation from site-to-site along the sequence as well as variation 
among lineages at each site (37). Using MEME, it is possible to identify amino acids that are 
subject to episodic positive selection. Prior to implementing MEME, sequence alignments were 
screened for recombination breakpoints using the genetic algorithms for recombination detection 
(GARD) method (30, 31). GARD identifies potential recombination breakpoints in the sequences 
and defines non-recombinant blocks of sequence. To account for recombination, MEME 
analyzes non-recombinant blocks, identified by GARD, individually for evidence of positive 
selection. Both GARD and MEME were accessed via the Datamonkey public server 
(www.datamonkey.org).  
To detect positive selection, we used omegaMap (53), a Bayesian method based on an 
approximation of the coalescent that can detect positive selection in the presence of 
recombination. Analyses were conducted on all four sequence alignments. Equilibrium codon 
frequencies, excluding stop codons, were estimated from NTHi 86-028NP complete genome. 
Ten product of approximate conditionals likelihood orderings were chosen for each analysis 
(53). Analyses were run for 1,000,000 iterations and a burn-in of 200,000 iterations were 
removed from each run; three runs were completed per sequence alignment. Objective priors 
were specified following recommendations provided in the omegaMap documentation; improper 
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inverse distributions were specified on parameters μ, κ, and φ and inverse distributions for ω and 
ρ. Window sizes of rBlock = 30 and oBlock = 5 were used for all analyses except for the HMW2 
analysis that was run with rBlock = oBlock = 5. Output files were assessed for convergence and 
analyzed with the program R (www.r-project.org). Summary files were generated using the 
computer program summarize (53).  
Hydrophathy plots. Kyte & Doolittle hydrophobicity plots (33) and Hopp-Wood 
hydrophilicity plots (26), using a window size of nine amino acids, were generated for NTHi 
strain 12 HMW1 and HMW2 mature proteins using the ProtScale tool available at the ExPASy 
Bioinformatics Resource Portal (www.expasy.org). Amino acids with a Kyte-Doolittle score > 0 
are considered hydrophobic whereas amino acids with a Hopp-Woods score > 0 are considered 
hydrophilic.  
Protein structure predictions. The I-TASSER server (40, 60) was used to predict three-
dimensional structural models of NTHi strain 12 HMW1 and HMW2 mature proteins. Models 
were visualized with the the molecular graphics and modeling programs PyMOL version 1.3 
(http://www.pymol.org/pymol) (41) and YASARA View (www.yasara.org) (32). 
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Results 
 
Full length hmwA analyses. Thirteen full-length hmwA sequences in GenBank (Table 
4.1) that ranged in length from 4407 to 4803 nts with an average length of 4599 were used in this 
analysis. After aligning the sequences and removing gaps, 3609 nts remained in the final full-
length hmwA alignment. The overall mean genetic distance, using an estimated gamma shape 
parameter = 0.3135, was 0.481 (S.E. = 0.022) base substitutions per site and pairwise distances 
ranged from 0.004 to 0.710 base substitutions per site (Table 4.S1). The observed index of 
saturation, Iss, was significantly smaller than the Iss critical value, Iss.c, (P < 0.001) (57, 58) 
indicating that the sequences have not reached substitution saturation and were suitable for 
phylogenetic analyses. The PHI test for recombination found statistically significant (P < 0.01) 
evidence of hmwA recombination. The hmwA alignment was also screened for evidence of 
recombination with the GARD method and 15 statistically significant (P < 0.1) recombination 
break points were identified (Table 4.S2).  
 The presence of recombination means that hmwA relationships cannot be accurately 
represented with a single phylogenetic tree. Instead, phylogenetic networks were constructed 
using the Neighbor-Net method (7). The hmwA Neighbor-Net displays the relationships among 
sequences while allowing for the visualization of conflicting phylogenetic signals, such as that 
arising from recombination, as boxes in the network. The network (Fig. 4.S1) was constructed 
from MCL distances (Table 4.S1) and suggests a conflicting signal in the hmwA sequences, a 
finding consistent with the statistical tests for recombination. The Neighbor-Net LSfit index was 
0.9924; i.e., the phenetic distances represented on the Neighbor-Net capture 99.24% of the 
estimated MCL genetic distances meaning that, despite the evidence for recombination, the 
dataset is still quite tree-like. Three distinct hmwA sequence clusters are evident in the network 
(Fig. 4.S1). Cluster 1 contains the hmw2A from each of the four strains for which sequence data 
are available for both hmwA loci. Estimation of a maximum likelihood consensus tree (based on 
1000 bootstrap replicates) resulted in a phylogeny with the same overall topology; this is not 
surprising given the high Neighbor-Net LSfit index. 
 The 13 full-length hmwA sequence alignment was used specifically to test for evidence of  
positive selection operating within the first 441 amino acids of the HMW preprotein, which 
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encodes the hmwA signal sequence (11, 22). The GARD method detected five statistically 
significant (P < 0.1) recombination breakpoints within the signal sequence (Table 4.S2); the 
breakpoint information was taken into account when implementing the MEME method. There 
was no evidence of positive selection, using both the MEME method and omegaMap, operating 
within the hmwA signal sequence region. To the contrary, there was strong evidence of purifying 
selection (ω < 1) operating within the signal sequence region (Fig. 4.S2). This was not 
unexpected given that the signal sequence is not exposed on the cell surface and, more 
importantly, may be subject to functional constraints since it must interact with both the Sec-
dependent machinery, HMWC, and HMWB during HMW maturation and cell surface 
localization (22).  
HMW-family mature proteins. The entire HMW adhesin mature protein (corresponding 
to amino acids 442 to 1536 of NTHi strain 12 HMW1A (11)) was represented in 15 hmwA 
sequences. hmwA nucleotide sequences were 60.1% A-T, ranged in length from 2976 to 3540 
nts, and averaged 3275 nts in length. The overall mean genetic distance, assuming a gamma 
shape parameter = 0.5736, was 0.647 (S.E. = 8.668) base substitutions per site and pairwise 
genetic distances ranged from 0.001 to 0.985 base substitutions per site (Table 4.S3). The 
observed index of saturation, Iss, was significantly smaller than the Iss critical value, Iss.c, (P < 
0.001) (57, 58) suggesting that the sequences have not experienced substitution saturation and 
thus are suitable for phylogenetic analyses. The PHI test for recombination found significant (P < 
0.01) evidence of hmwA recombination and the GARD analysis identified 13 statistically 
significant (P < 0.1) recombination breakpoints (Table 4.S2). The MEME method was conducted 
on non-recombinant regions of the sequences defined by the GARD analysis. 
 The Neighbor-Net topology of the 15 HMW mature protein sequences (Fig. 4.2) was the 
same as that for the 13 full-length hmwA sequences (Fig. 4.S1). Three hmwA clusters were 
recovered in the Neighbor-Net and the NTHi strain 15 hmw1A and hmw2A sequences were 
placed in Clusters 2 and 3, respectively (Fig. 4.2). Consistent with tests for recombination, there 
was evidence of conflicting phylogenetic signal in the network. The Neighbor-Net LSfit index 
was 0.996 and the topology of the Neighbor-Net (Fig. 4.2) was identical to the bootstrap 
consensus tree (Fig. 4.S3) estimated using the maximum likelihood method and GTR+G+I (G = 
1.3398, I = 30.50%) model of sequence evolution. 
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 The MEME method, taking into account recombination, identified 55 codons as being 
subjected to episodic diversifying selection (P < 0.05) (Table 4.2, Fig. 4.S2). Using the 
glycosylated amino acids of NTHi strain 12 HMW1A as a reference (23), MEME identified 
three glycosylated amino acids that were also subjected to positive selection (asparagines AA3, 
AA471, AA505).  Sixteen of the PSSs were predicted to be in hydrophobic regions (KD > 0) and 
28 were located in regions predicted to be hydrophilic (HW > 0); one PSS (AA681) was 
predicted to be both hydrophobic (KD = 0.256) and hydrophilic (HW = 0.022) (Table 4.2). 
 omegaMap identified 51 of positively selected amino acids (Table 4.2, Fig. 4.S2), ten of 
which were identified by both MEME and omegaMap as being positively selected. Seven of the 
PSSs identified by omegaMap mapped to hydrophobic regions (KD > 0) and 30 sites mapped to 
regions predicted to be hydrophilic (HW > 0). In both analyses, codons predicted to be positively 
selected were localized to the HMW binding domain region. None of the codons encoding 
glycosylated amino acids, relative to NTHi strain 12 HMW1 (23), were predicted to be positively 
selected.  
hmwA sequence clusters. The hmw1 and hmw2 loci apparently arose as the result of a 
gene duplication event and thus the two hmwA sequences from a given strain are paralogs. This 
provided the rationale for dividing hmwA sequences into two mutually exclusive sequence 
clusters designated Cluster 1 and Cluster 2-3. Sequences were allocated into one of the two 
clusters such that each of the five strains for which both hmwA copies were available had one 
hmwA in each cluster (Fig. 4.2). Cluster 1 contained seven hmwA sequences and included the 
NTHi Strain 12 hmw2A and Cluster 2-3 contained eight sequences and included strain 12 
hmw1A. The strain 12, 5 and 15 hmwA nucleotide sequences clustered in the same way as 
previously reported when HMW amino acid sequences were subjected to phylogenetic analyses 
(8). This suggests that the clusters formed by hmwA nucleotide sequences reflect the in vitro 
adherence characteristics of their respective HMW adhesin. This leads to the prediction that 
Cluster 1 and Cluster 2 sequences may confer HMW2-like and HMW1-like adherence 
properties, respectively. 
 Clusters 2-3 sequences were more genetically diverse than Cluster 1 sequences. Cluster 
2-3 hmwA sequences ranged in length from 3087 – 3474 nts with an average length of 3290 nts. 
Cluster 2-3 hmwA pairwise MCL genetic distances (gamma shape parameter = 0.6711) ranged 
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from 0.001 to 0.843 base substitutions per site and the overall mean genetic distance was 0.566 
(S.E. = 10.860) base substitutions per site  (Table 4.S4a). Cluster 1 hmwA sequences ranged in 
length from 2976 – 3483 nts and averaged 3227 nts. Cluster 1 pairwise MCL genetic distances 
(gamma shape parameter = 0.4925), ranged from 0.263 to 0.693 base substitutions per site and 
the overall mean genetic distance was 0.546 (S.E. = 0.022) base substitutions per site (Table 
4.S4b). The PHI test for recombination identified statistically significant (P < 0.01) evidence of 
hmwA recombination in both clusters. GARD analysis identified four and five statistically 
significant (P < 0.1) recombination breakpoints in the Cluster 2-3 and Cluster 1 sequences, 
respectively (Table 4.S2); MEME analyses were conducted on non-recombinant regions of each 
alignment. 
To allow for the possibility of selective pressures acting differently within each sequence 
Cluster, each Cluster was analyzed separately using MEME and omegaMap. Among Cluster 1 
sequences, 25 and 37 amino acids were identified as under positive selection using MEME and 
omegaMap, respectively (Table 4.3, Figs. 4.3b and 4.S4). Cluster 2-3 sequences encoded 23 and 
20 positively selected sites as predicted by MEME and omegaMap, respectively (Table 4.3, Figs. 
4.3a and 4.S4). In both sequence clusters, the majority of the positively selected amino acids 
were localized to the HMW binding region (Fig 4.S4). While the number of positively selected 
codons identified with each method were similar for both hmwA Clusters, the exact codons 
predicted to be under positive selection differed by the method used (Table 4.3, Fig. 4.S4). In 
general, MEME identified singleton amino acids under selection whereas omegaMap was more 
likely to identify multiple contiguous amino acids as positively selected. 
 Predicted HMW adhesin three-dimensional model. To gain insight into the relative 
localization of positively selected amino acids, three dimensional models were predicted based 
on NTHi strain 12 HMW1 and HMW2 mature protein sequences (the 441 amino acid signal 
sequence was removed). I-TASSER provides a confidence score, C-score, that ranges from [-5, 
2] and can be used to assess the quality of a predicted model; models with higher confidence 
have a higher scores. The C-score for the best fit HMW1 model (Fig. 4.4) was equal to -1.35  
and HMW2 model (Fig. 4.S5) was equal to -1.26. The proteins in the protein data base with the 
most similar structure to the predicted HMW1 was a heme binding protein of E. coli (39) and the 
protein most similar to HMW2 was the passenger domain of the E. coli autotransporter EspP 
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(28). HMW1 and HMW2 predicted models were structurally similar, each containing two 
globular domains in the amino-terminal region (Fig.4.4 and Fig. 4.S5). Interestingly, the HMW1 
binding domain (amino acids 114 – 473 (11)) is restricted to the larger of the two globular 
regions in the predicted HMW1 model whereas the HMW2 binding domain (amino acids 112 – 
475 (11)) encompasses both globular regions of the HMW2 model; this could, however, simply 
reflect inaccuracies in the model reconstruction. The HMW binding domain is predicted to sit on 
top of a stalk region composed of parallel β-strands that extend to the HMW carboxy-terminus. 
The amino acids predicted to be subject to episodic positive selection within Cluster 2-3 and 
Cluster 1, as determined by the MEME method (Table 4.3), were mapped onto the strain 12 
HMW1 (Fig. 4.4) and HMW2 (Fig. 4.S5) models, respectively. The majority of positively 
selected amino acids identified by MEME in were located in regions predicted to form either 
loops or turns (Table 4.S5) and to be hydrophilic (Hopp-Woods score > 0) (Tables 4.S6).  
 The HMW adhesins are glycosylated (20, 21, 23). To explore the relationship between 
glycosylated and positively selected amino acids, the glycosylated amino acids within the NTHi 
strain 12 HMW1 (23) were highlighted in the HMW1 predicted model (Fig. 4.4). There are no 
empirical data related to HMW2 glycosylation, therefore glycosylated asparagines were 
predicted, and mapped, based upon the  NX(S/T) consensus sequence (23) (Fig. 4.S5). The 
majority of glycosylated amino acids also mapped to the binding domain, but, in contrast to 
positively selected amino acids, glycosylated amino acids were distributed across both of the 
globular regions of the HMW predicted structure that encompasses the core binding domain. 
With a single exception in HMW2, none of the glycosylated amino acids were predicted to be 
under episodic positive selection. 
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Discussion 
 
 In this study, we tested for evidence of positive selection acting on the NTHi high 
molecular weight (HMW) adhesins using a collection of publicly available hmwA nucleotide 
sequences. Both methods we employed, MEME and omegaMap, estimate the ratio of the rates of 
non-synonymous (dN) to synonymous (dS) substitutions, commonly defined as omega (ω = 
dN/dS), where values of ω > 1 are indicative of positive selection. First, we analyzed the HMW 
signal sequence region (the first 441 amino acids) of 12 hmwA sequences and found no evidence 
of positive selection. Next, we analyzed 15 sequences of the HMW-family that encompassed the 
entire HMW mature protein, excluding the signal sequence. To allow for differences in selection 
pressures among paralogs, we separated the HMW-family sequences into two sequence clusters, 
Cluster 1 and Cluster 2-3, and analyzed each cluster separately. We found evidence of positive 
selection acting within the HMW-family of mature proteins as well as within both of the 
phylogenetically defined hmwA sequence clusters, and in all analyses the majority of positively 
selected amino acids were localized to the HMW adhesin binding domain.  
 Evolutionary analyses of the 13 full-length hmwA sequences and two additional HMW 
mature protein sequences highlight hmwA sequence diversity, which involves both insertions and 
deletions as well as marked nucleotide diversity. NTHi are naturally transformable and known to 
undergo homologous recombination, this is evident at the whole genome level (9, 10, 34) and has 
been suggested to occur specifically within the hmwA genes (8, 19). Consistent with these 
findings, we detected evidence of recombination within the HMW-family as a whole and, also, 
within Cluster 1 and Cluster 2-3 sequences.  
 Recombination confounds phylogenetic reconstructions because no single tree can 
represent the evolutionary history of a recombinant gene. We therefore employed the Neighbor-
Net method (7), which constructs networks that reflect inconsistencies in the phylogenetic signal, 
to visualize hmwA relationships. The network topology for the hmwA mature binding region 
(Fig. 4.2) revealed three hmwA sequence clusters. A previous phylogenetic analysis that focused 
on relationships among a subset of the HMW mature protein sequences included in the current 
study revealed two HMW clusters that reflected in vitro binding characteristics, one composed of 
HMW1-like proteins and the second of HMW2-like proteins (8). In the current study, these 
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sequences are members of HMW Clusters 1 and 2 (Fig 4.2). In this study, we identified a third 
cluster of phylogenetically distinct hmwA sequences, a finding consistent with a previous study 
of HMW core binding domains by Giufre et al., (19) that suggested not all hmwA core binding 
sequences fell into one of two distinct clusters.  
Interestingly, among the five strains with hmwA sequence data from both loci, each strain 
contains a hmwA from Cluster 1 while the second hmwA belongs to either Cluster 2 or 3 (Fig. 
4.2). This result suggests that following the hmwA duplication event, the Cluster 1 hmwA may 
have retained its original binding affinity whereas the Cluster 2-3 hmwA evolved novel binding 
characteristics. In vitro studies have demonstrated that strain 12 HMW1, encoded by hmw1A of 
Cluster 2, mediates strong adherence, via interaction with α 2,3-sialic acid, to Chang, HaCaT, 
NCI-H292, and HEp-2 cell lines, whereas, HMW2, encoded by hmw2A, mediates adherence 
primarily to HaCaT and NCI-H292 cell lines via unidentified moieties (8, 11, 42, 46). The in-
vitro binding characteristics have been determined for NTHi strains 12, 5 and 15 (8, 46). For 
these three strains, HMW1-like and HMW2-like amino acid sequences cluster with respect their 
in vitro adherence profiles and independently of their chromosomal location; i.e.,  in both strain 5 
and strain 15 the hmwA locus adjacent to HI1679 (hmw1A based on the NTHi strain 12 
nomenclature) encodes a HMW that exhibits HMW2-like binding characteristics (8). The limited 
binding capacity of HMW2-like proteins coupled with the observation that all previously 
characterized HMW2-like proteins form a single cluster, suggests that  HMW2-like binding (i.e., 
sequences from Cluster 1) may be essential for NTHi whereas members of the HMW1-like 
group have evolved to take on expanded binding abilities. Thus, positive selection may be acting 
to shape HMW adhesin adherence capacity, allowing NTHi to expand its niche space within the 
respiratory tract. There are, however, two important limitations to this interpretation that must be 
kept in mind. First, the strains in this study are all clinical isolates (Table 4.1) and therefore 
represent only a subset of NTHi genetic diversity, much of which may reside in the population of 
strains colonizing healthy individuals. The second caveat is that the binding characteristics were 
all determined in vitro using a relatively limited number of cell types. Functional analyses are 
necessary to determine if the observed phylogenetic clustering reflects expanded adherence 
properties. More specifically, it will be interesting to determine if the Cluster 3 HMW adhesins 
display unique adherence properties. 
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There are number of possible explanations for the observed differences between the 
results of the omegaMap method and the MEME method (Table 4.2, 4.3, and Figs. 4.S2, 4.S4). 
First, the methods differ in their underlying models, as omegaMap takes a population genetics 
approach by employing an approximation to coalescent with recombination but does not 
explicitly model the genealogy (53). In contrast, the MEME method is a phylogenetic approach 
and is thus dependent on the estimated phylogenetic relationship among sequences (29). 
Secondly, the MEME method allows for variation from codon-to-codon as well as branch-to-
branch and therefore is capable of detecting both pervasive and episodic diversifying selection 
(29). Analyses of empirical datasets demonstrate that episodic selection is common and that 
methods designed to detect only pervasive selection can underestimate the number of positively 
selected codons (37). While the absolute number of amino acids identified with each method was 
similar, omegaMap was more likely to identify a series of adjacent codons as positively selected 
whereas MEME identified singleton codons distributed throughout the binding region (Table 4.3, 
Figs. 4.S4). This may be a attributable to the block method employed by omegaMap in which a 
user-specified number of adjacent codons (defined as the block size) share a common parameter 
estimate, essentially parameters are averaged across the number of sites defined by the block 
size. The block size affects the amount of time required to complete an analysis, that is, analysis 
time increases as the block size is reduced, and, given the computational intensity of the model, 
computation time influences the choice of block size. In contrast, the MEME method considers 
each codon site individually; this is the equivalent to an omegaMap block size equal to one. 
Because the block method averages across blocks, a single site under strong selective pressure 
(large dN/dS) could influence the block value, leading multiple codons within that block 
showing evidence of positive selection. The converse could occur as well, failure to detect a 
single positively selected site could occur because of purifying selection acting on codons within 
the same block, dampening the average signal. It is important to note, however, that both 
methods generated qualitatively similar results: positively selected sites were located in 
hydrophobic regions of the binding domain predicted to form either loops or turns. 
The exact nature of the selective pressure acting on the HMW adhesins cannot be 
elucidated from in silico studies alone. The fact that HMW adhesins stimulate a strong antibody 
mediated immune response (1), however, suggests that immune mediated selective pressure 
likely plays a role. Interestingly, Barenkamp and St. Geme III mapped B-cell epitopes in HMW1 
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and HMW2 targeted by two monoclonal antibodies (MAb) AD6 and 10C5 (5). The AD6 MAb 
was predicted to recognize a peptide in the last 75 amino acids of HMW1 and HMW2. The 
MEME method identified a single amino acid in the last 75 amino acids as being under episodic 
positive selection in the HMW-family (T1085, relative to strain 12 HMW1) as well as in both the 
Cluster 2-3 and Cluster 1 sequences which correspond to T1085 and R1025, relative to strain 12 
HMW1 and HMW2, respectively.  MAb 10C5 is specific to HMW1 and binds to an epitope 
located within the carboxy-terminal 155 amino acids. The MEME method predicted that amino 
acid L994 was under positive selection in the HMW-family and Cluster 2-3 sequence, but this 
site was not predicted to be under positive selection in Cluster 1 sequences. These findings are 
consistent with a recent study in Streptococcus pneumoniae that found regions containing 
antibody epitopes were more likely to contain positively selected codons than were non-epitope 
encoding regions (35). Taken together, these finding lend support to the potential role of immune 
mediated selection pressure in driving HMW diversity, but, the impact of these associations is 
difficult to assess since the MAbs were not produced nor tested against HMW adhesins in their 
native conformation. Further work is necessary to link the positively selected amino acids 
identified in this study with a functional role in-vivo.  
The findings of this study contribute to our understanding of the mechanisms driving 
NTHi HMW evolution. The hmwA phylogenetic analysis reported here suggests that the majority 
of hmwA sequences fall into one of three distinct sequence clusters and that each strain encodes a 
Cluster 1-hmwA sequence. The molecular evolution of hmwA is driven by positive selection 
acting, primarily, on the region in and around the core-binding domain and may be a response to 
selective pressures applied by the host immune system. Gene prevalence studies suggest that 
HMW proteins are more prevalent in NTHi strains associated with AOM than in colonizing 
strains thus suggesting that HMW adhesins contribute to NTHi virulence (13, 48). Furthermore, 
HMWs stimulate a strong and lasting humoral response in colonized individuals (1, 46, 56). 
Given their potential role in virulence, coupled with the ability to stimulate an immune response, 
the HMW proteins have been proposed as candidates for inclusion in a multivalent NTHi vaccine 
(54-56). Therefore, understanding the genetic diversity of hmwA and the mechanisms driving 
that diversity not only advance our understanding of host-pathogen interactions but can also to 
help inform and guide NTHi vaccine development.  
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Table 4.1. Publicly available strains used in this study. 
a
 full-length hmwA sequences (signal sequence plus mature binding protein) 
b
 lacks signal sequence (mature binding protein only) 
c
 AOM = acute otitis media; OME = otitis media with effusion; NP = nasopharynx; COM = 









 Reference (Comments): 
HIU08876 strain 12
a 
hmw1A 4608 AOM (2) 
HIU08875 strain 12
a 
hmw2A 4431 AOM (2) 
CP000671 PittEE
a 
hmw1A  4743 OME (25)(hmw1A region: 745702-750447) 
CP000671 PittEE
a 





hmw1A 4794 AOM (8) 
AY497552 strain 5
a 
hmw2A 4803 AOM (8) 
AY497553 strain 15
b 
hmw2A 2997 AOM (8) 
AY497554 strain 15
b 

















hmw1A 4446 AOM (12)(downstream of HI1679) 
AY601283 AAr105
a 
hmw1A 4470 AOM (12)(downstream of HI1679) 
AY601284 AAr96
a 
hmw2A 4542 AOM (12)(downstream of HI1598) 
AF180944 A950006
a 
hmwA 4671 COPD (8, 52) 
AJ937359 strain 72
a 
hmw1A 4407 invasive (19) 
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 hmwA region encoding the HMW mature binding proteins, relative to NTHi strain 12 HMW1 
amino acids 442 to 1536  (11) 
b 
positively Selected Site (PSS), sites were considered PSS by MEME if P < 0.05 and PSS by 
omegaMap if the posterior probability > 0.95 
c




 Kyte-Doolittle hydrophilicity score (window size = 9) (33); predicted hydrophobic amino acid  
e 
Hopp-Woods hydrophobicity score (window size = 9) (26); predicted hydrophilic amino acid 
f 
amino acid numbering is relative to the mature binding protein(11), excluding the signal 
sequence; the first amino acid of the mature binding protein corresponds to amino acid number 
442 (Proline) of the NTHi strain 12 preprotein 
g








































3, 29, 39, 44, 47, 48, 54, 65, 75, 112, 
124, 153, 167, 178, 214, 225, 226, 
243, 250, 252, 260, 271, 276, 297, 
328, 372, 403, 421, 422, 431, 450, 
461, 471, 485, 489, 496, 505, 521, 
528, 537, 572, 580, 601, 613, 618, 
622, 640, 649, 662, 668, 681, 686, 












16, 17, 19, 20, 21, 29, 48, 54, 55, 73, 
124, 172, 182, 211, 212, 213, 214, 
226, 230, 231, 241, 242, 243, 246, 
250, 251, 252, 253, 254, 255, 261, 
262, 263, 265, 266, 278, 280, 284, 
342, 343, 344, 345, 346, 347, 348, 
414, 455, 461, 462, 513, 514 
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3, 34, 39, 47, 75, 80, 91, 170, 185, 189, 216, 
252, 271, 318, 369, 403, 421, 436, 572, 622, 












10, 29, 124, 209, 212, 213, 214, 215, 216, 226, 




 hmwA region encoding the HMW mature binding proteins, NTHi strain 12 HMW1 amino acids 442 to 
1536 (11) 
b 
positively Selected Site (PSS), sites were considered PSS by MEME if P < 0.05 and PSS by omegaMap 
if the posterior probability > 0.95 
c




 Kyte-Doolittle hydrophobicity score (window size = 9) (33); predicted hydrophobic amino acids 
e 
Hopp-Woods hydrophilicity score (window size = 9) (26); predicted hydrophilic amino acids 
f,i
 positively selected amino acids; amino acid numbering is relative to the mature binding protein(11), 
excluding the signal sequence; the first amino acid of the mature binding protein corresponds to amino 
acid number 442 (Proline) of the NTHi strain 12 HMW1 or HMW2 preprotein 
g
 hmwA region encoding the HMW mature binding proteins, NTHi strain 12 and HMW2 amino acids 442 
to 1477  (11) 
h
 amino acids predicted to be glycosylated based on amino acid sequence NX(S/T) (23) 
j 
amino acids with KD > 0 and HW > 0, site HMW2 AA435 KD = 0.022, HW =0.567; AA574 KD = 
0.078, HW = 0.356 
k
 GARD analysis identified four statistically significant (P < 0.1) recombination breakpoints 
l































24, 26, 30, 110, 140, 156, 243, 262, 298, 308, 
323, 345, 363, 370, 378, 435
j
, 491, 512, 574
j
, 












16, 17, 18, 19, 24, 25, 26, 31, 36, 38, 55, 56, 62, 
63, 75, 137, 240, 241, 242, 243, 245, 246, 247, 
248, 249, 250, 251, 252, 289, 290, 292, 372, 
378, 379, 380, 413, 414 
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(a)                (b) 
Figure 4.1. Chromosomal arrangements of the hmw1 loci of NTHi strain 12. The hmw loci are 
located in conserved yet unlinked regions of the NTHi chromosome, in strain 12, the hmw1 and 
hmw2 loci are downstream of HI1679 and HI1598, respectively; chromosomal locations are 
named with respect to H. influenzae Rd. Each hmw locus consists of three genes, hmwA, hmwB, 
and hmwC. The functional HMW adhesin is encoded by hmwA. The strain 12 HMW1 adhesin 
preprotein contains a 441 amino acid signal sequence (grey boxes) that is cleaved during 
maturation. The core binding domain is localized to the amino terminus of the mature protein 
and is the region of the adhesin that interacts with the host epithelium. (b) Predicted three 
dimensional strain 12 HMW1 mature adhesin. The structure was predicted using the I-TASSER 
server (40, 60) and visualized with PyMOL (41). The color coding transitions from light blue at 
the amino terminus to red at the carboxy terminus.  
 





Figure 4.2. Neighbor-Net for the 15 hmwA mature binding protein regions. The hmwA loci arose 
from a duplication event; therefore, both hmwA genes from a specific strain represent paralogous 
genes. The 15 full length sequences were partitioned into one of three clusters, based on their 
placement in the Neighbor-Net. The network was estimated from maximum composite 
likelihood genetic distances (TableS3). Boxes in the Neighbor-Net reflect inconsistencies in the 
phylogenetic signal due to recombination. Sequence data were available for both copies of hmw, 
for four strains (indicated by an “*”). Each of the four strains encoded an hmwA from Cluster 1 
(based on the sequences) but, the second hmwA from the four strains belonged to either Cluster 2 
or Cluster 3 (based on the sequences). Branch lengths are drawn to scale and represent the 
number of pairwise base substitutions per site; LSfit index = 0.996.  
 












(b) Cluster 1 sequences 
 
Figure 4.3. Neighbor-Net for hmwA adhesin mature protein sequence Clusters. Boxes in the 
Neighbor-Net network reflect inconsistencies in the phylogenetic signal among hmwA. Branch 
lengths are drawn to scale and represent the number of pairwise base substitutions per site. (a) 
HMW1-group adhesins, LSfit index = 0.996. (b) HMW2-group adhesins, LSfit index = 0.998. 
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Figure 4.4. Theoretical structure for NTHi strain 12 HMW1 predicted by I-TASSER. The 23 
amino acids predicted to be subjected to episodic positive selection, highlighted in blue (Table 
4.3), are localized to the distal globular region of HMW1. Glycosylated amino acids are 
highlighted in green. The three structural model of NTHi strain 12 HMW1 was predicted using I-
TASSER and visualized with YASARA. The model is rotated clockwise approximately 90-
degrees between each panel and the last panel is top-down shot.
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Supplemental Tables and Figures.
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Table 4.S1. Full length hmwA maximum composite likelihood pairwise genetic distances (nucleotide substitutions per site). 
 
 Strain locus              
1 strain AAr96 hmw2A 0.000             
2 strain 72 hmw1A 0.267 0.000            
3 strain 12 hmw1A 0.393 0.327 0.000           
4 strain 5 hmw1A 0.400 0.285 0.396 0.000          
5 PittEE hmw1A 0.568 0.652 0.652 0.612 0.000         
6 86-028NP hmw1A 0.620 0.620 0.684 0.553 0.045 0.000        
7 A950006 hmwA 0.624 0.628 0.688 0.547 0.049 0.004 0.000       
8 AAr105 hmw1A 0.480 0.573 0.569 0.631 0.562 0.596 0.605 0.000      
9 PittEE hmw2A 0.452 0.528 0.551 0.611 0.385 0.522 0.536 0.269 0.000     
10 strain 12 hmw2A 0.493 0.636 0.582 0.565 0.562 0.620 0.624 0.308 0.273 0.000    
11 86-028NP hmw2A 0.600 0.602 0.627 0.456 0.524 0.470 0.472 0.427 0.365 0.323 0.000   
12 strain 5 hmw2A 0.565 0.556 0.659 0.339 0.502 0.463 0.457 0.333 0.365 0.411 0.210 0.000  
13 G822 hmw1A 0.589 0.636 0.710 0.594 0.475 0.431 0.433 0.342 0.397 0.363 0.388 0.319 0.000 
  1 2 3 4 5 6 7 8 9 10 11 12 13 
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Table 4.S2. Statistically significant (P < 0.1) recombination break points identified by GARD 
analysis (30, 31). 
13FL hmwAa 15 hmwAa Cluster 1a Cluster 2-3a 
amino acid 
relative strain 




























148 74 515 547 988 91 532 
180 130 571 793 1234 128 569 
234 232 673 869 1310 360 801 
319 362 803 934 1375 498 939 
417 470 911 
  
615 1056 
561 522 963 
    
637 547 988 
    
686 617 1058 
    
795 647 1088 
    
911 722 1163 
    
979 934 1375 
    
1058 963 1404 
    
1163 1071 1512 
    
1406 
      
1456 
      
a
 hmA  sequence alignments; 13 full-length sequences (13FL), 15 mature binding protein regions (15), 
eight sequences defined as Cluster 2 (Figure_15hmwA neighbor net), and seven sequences defined as 
Cluster 2-3 (Figure_15hmwA neighbor net) 
b
 includes the 441amino acid signal sequence region 
c
 numbering relative to strain 12 full-length HMW1A (including signal sequence) 
d 
numbering relative to the strain 12 HMW1A or HMW2A mature binding protein (MBP) (excluding 
signal sequence)
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Table 4.S3. hmwA mature protein coding region maximum composite likelihood pairwise genetic distances (nucleotide substitutions 
per site).
 Strain locus                
1 Aar 96 hmw2A 0.000               
2 strain 72 hmw1A 0.291 0.000              
3 strain 5 hmw1A 0.409 0.338 0.000             
4 strain 15 hmw1A 0.504 0.403 0.455 0.000            
5 strain 12 hmw1A 0.517 0.394 0.466 0.280 0.000           
6 A950006 hmwA 0.678 0.782 0.710 0.812 0.808 0.000          
7 86-028NP hmw1A 0.676 0.780 0.708 0.811 0.807 0.001 0.000         
8 PittEE hmw1A 0.658 0.768 0.717 0.825 0.824 0.024 0.024 0.000        
9 G822 hmw1A 0.741 0.875 0.799 0.985 0.950 0.628 0.626 0.639 0.000       
10 AAr105 hmw1A 0.705 0.766 0.838 0.966 0.864 0.749 0.747 0.758 0.414 0.000      
11 PittEE hmw2A 0.629 0.734 0.833 0.812 0.831 0.700 0.698 0.618 0.454 0.337 0.000     
12 strain 12 hmw2A 0.659 0.830 0.761 0.934 0.963 0.789 0.787 0.763 0.415 0.412 0.357 0.000    
13 strain 15 hmw2A 0.760 0.849 0.813 0.892 0.787 0.720 0.719 0.721 0.518 0.441 0.512 0.420 0.000   
14 86-028NP hmw2A 0.759 0.915 0.750 0.899 0.847 0.637 0.636 0.664 0.483 0.498 0.430 0.413 0.425 0.000  
15 strain 5 hmw2A 0.726 0.826 0.599 0.962 0.893 0.632 0.631 0.639 0.421 0.409 0.442 0.509 0.537 0.238 0.000 
  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
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Table 4.S4. hmwA mature protein coding region maximum composite likelihood pairwise genetic 
distances (nucleotide substitutions per site) by group.  
(a) Cluster 2-3 sequences 
 Strain locus 
       
 
1 AAr96 hmw2A 0.000 
      
 
2 strain72 hmw1A 0.290 0.000 
     
 
3 strain 5 hmw1A 0.430 0.374 0.000 
    
 
4 strain 15 hmw1A 0.489 0.426 0.437 0.000 
   
 
5 strain 12 hmw1A 0.529 0.433 0.477 0.268 0.000 
  
 
6 A950006 hmwA 0.686 0.835 0.739 0.800 0.829 0.000 
 
 
7 86-028NP hmw1A 0.685 0.831 0.736 0.800 0.829 0.001 0.000  
8 PittEE hmw1A 0.670 0.820 0.747 0.811 0.843 0.021 0.021 0.000 
 
 
1 2 3 4 5 6 7 8 
 
(b) Cluster 1 sequences 
 Strain locus 
      
 
1 G822 hmw1A 0.000 
     
 
2 AAr105 hmw1A 0.505 0.000 
    
 
3 PittEE hmw2A 0.587 0.413 0.000 
   
 
4 strain 12 hmw2A 0.504 0.500 0.432 0.000 
  
 
5 strain 15_hmw2A 0.669 0.578 0.677 0.540 0.000 
 
 
6 86-028NP hmw2A 0.614 0.637 0.554 0.505 0.541 0.000  
7 strain 5 hmw2A 0.527 0.518 0.581 0.629 0.693 0.263 0.000 
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Table 4.S5. Location of PSS in Cluster 2-3 and Cluster 1 sequences mapped to the predicted 
secondary structure of NTHi strain 12 HMW1 or HMW2, respectively.  
(a) Cluster 2-3 
Cluster 
2-3 
coil turn helix sheet total 
MEME 15 2 1 5 23 
oM 15 3 2 0 20 




coil turn helix sheet total 
MEME 15 6 1 3 25 
oM 31 2 3 1 37 
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Table 4.S6. HMW1- and HMW2- group predicted Kyte-Doolittle (KD) values and Hopp-Woods 
(HW) for NTHi amino acids with KD ≠ 0. 
(a) HMW1 Kyte-Doolittle hydrophobicity 
 
PSSs (P < 0.05) 
 
 
YES NO Total 
KD 
>0 8 311 319 
<0 15 586 601 
 Total 23 897 920 
 
(b) HMW1 Hopp-Woods hydrophilicity 
  
PSSs (P < 0.05) 
 
     YES NO  Total 
HW > 0 11 435 446 
  < 0 11 459 470 
 
Total 22 894 916 
 
(c) HMW2 Kyte-Doolittle hydrophobicity 
 
PSSs (P < 0.05) 
 
 
YES NO Total 
KD 
>0 5 255 260 
<0 20 579 599 
 Total 25 834 859 
 
(d) HMW2 Hopp-Woods hydrophilicity 
 
PSSs (P < 0.05) 
 
 
YES NO Total 
HW 
>0 15 443 458 
<0 9 393 402 








Figure 4.S1. Neighbor-Net for 13 full-length hmwA sequences estimated using maximum 
composite likelihood distances (Table S1). There is statistically significant evidence of 
recombination within the full-length hmwA, reflected by boxes in the network. hmwA sequences 
formed three distinct clusters. Sequence data was available for both hmw1A and hmw2A from 
four strains (indicated by an “*”) and each of the four strains encodes an hmwA that belonged to 
Cluster 1, however, the second hmwA from each strain belonged to either Cluster 2 or Cluster 3. 
hmw1A and hmw2A from a strain represent paralogous genes, therefore, sequences were 
partitioned into one of two mutually exclusive groups, Cluster 1 or Cluster 2-3. Branch lengths 
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Figure 4.S2. Estimated omega (ω = dN/dS) by codon for the full-length HMW-family of 
adhesins. The mean (black line) and higher and lower 95% credible intervals (grey lines) for ω 
were estimated by omegaMap; all values have been log10 transformed.  Log(ω) values < 0 
indicate regions under purifying (negative) selection, = 0 neutral evolution, and > 0 positive 
selection. Amino acid positions are plotted with reference to NTHi strain 12 HMW1 full length 
preprotein, the signal sequence and binding domains regions (11) are indicated beneath the plot. 
The vertical red line marks the separation between the signal sequence and the mature HMW 
adhesin. Thirteen sequences were included in the analysis of the signal sequence and fifteen 
sequences were included in the mature HMW-adhesin analysis (Table 4.1), the output files of the 
two separate analyses were merged to generate the plot. The signal sequence, amino acids 1 – 
441, is predicted to be under strong purifying selection (log(ω) < 0). The majority of sites 
predicted to be under positive selection (Table 4.2) were localized to the binding domain region 
of the mature HMW protein and are identified above the plot with either blue (omegaMap; n = 
51) or green (MEME; n = 55) diamonds. All regions containing gaps in the multiple sequence 
alignment, e.g., between amino acids 1150 – 1340, were coded as ω = 1.  
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Figure 4.S3. Maximum likelihood phylogenetic analysis of the 15 hmwA mature binding region 
sequences. The bootstrap consensus tree was inferred from 1000 replicates and branches 
corresponding to partitions reproduced in less than 50% bootstrap replicates were collapsed (15). 
The percentage of replicate trees in which the associated taxa clustered together in the bootstrap 
test are shown next to the branches. The tree is drawn to scale, with branch lengths measured in 
the number of substitutions per site. All positions containing gaps and missing data were 
eliminated and there were a total of 2424 positions in the final dataset. Evolutionary analyses 
were conducted in MEGA5 (51). 
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Figure 4.S4. Estimated omega (ω = dN/dS) by codon for (a) Cluster 2-3 and (b) Cluster 1 hmwA 
mature protein coding region. The mean (black line) and higher and lower 95% credible intervals 
(grey lines) for ω were estimated by omegaMap; all values have been log10 transformed.  Log(ω) 
values < 0 indicate regions under purifying (negative) selection, = 0 neutral evolution, and > 0 
positive selection. Amino acid positions are plotted with reference to NTHi strain 12  (a) HMW1 
or (b) HMW2 protein (11) are indicated beneath the plot. The majority of sites predicted to be 
under positive selection (Table 4.3) were localized to the binding domain region of the mature 
HMW protein and are identified above the plot with either blue (omegaMap) or green (MEME) 
diamonds. All regions containing gaps in the multiple sequence alignment, e.g., between amino 
acids 1170 – 1290 of Cluster 1, were coded as ω = 1.  
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Figure 4.S5. HMW2 predicted three dimensional model. Amino acids predicted to be 
glycosylated based on the NX(S/T) consensus sequence (23) are highlighted in green and 
positively selected amino acids, as identified by using the MEME method, are highlighted in 
purple. There was a single glycosylated amino acid that was also predicted to be positively 
selected (highlighted in red). 
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Chapter 5 
Phase Variation and Host Immunity Against High Molecular Weight (HMW) Adhesins 





Nontypeable Haemophilus influenzae (NTHi) is a gram-negative bacterium that commonly 
resides within the human pharynx. Because NTHi is human-restricted, its long term survival is 
dependent upon its ability to successfully colonize new hosts. Adherence to host epithelium, 
mediated by bacterial adhesins, is one of the first steps in NTHi colonization. NTHi express 
several adhesins, including the high molecular weight (HMW) adhesins that mediate attachment 
to the respiratory epithelium where they interact with the host immune system to elicit a strong 
humoral response. hmwA, which encodes HMW, undergoes phase variation mediated by 7-base 
pair tandem repeats located within its promoter region. Repeat number affects both hmwA 
transcription and HMW production such that as the number of tandem repeats increases HMW 
production decreases. Cells expressing large amounts of HMW may be critical for the 
establishment and maintenance of NTHi colonization, but they might also incur greater fitness 
costs when faced with an HMW-specific antibody mediated immune response. We hypothesized 
that the occurrence of large deletion events allows NTHi to maintain adherent cells in the 
presence of antibody-mediated immunity. To study this, we developed a deterministic 
mathematical model, incorporating hmwA phase variation and antibody mediated immunity, to 
explore the trade-off between bacterial adherence and immune evasion. We employed 
uncertainty and sensitivity analyses to calibrate the model and to identify mechanisms driving 
NTHi within-host dynamics. The model predicts that antibody levels and avidity, catastrophic 
loss rates, and population carrying capacity all significantly affected numbers of adherent NTHi 
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cells within a host. Effects of these mechanisms vary in both time and magnitude. These results 
suggest that the occurrence of large, yet rare, deletion events allows for stable maintenance of a 
small population of adherent cells in spite of HMW-specific antibody induced immunity. These 
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Introduction 
 Haemophilus influenzae is a gram-negative coccobacillus that commonly resides within 
the human pharynx as a commensal and as a potential pathogen.  These bacteria are 
differentiated into typeable and nontypeable strains based on the presence or absence, 
respectively, of a polysaccharide capsule. Encapsulated strains are divided into six capsular 
serotypes (a–f), with serotype b (Hib) being commonly associated with invasive diseases such as 
meningitis and septicemia among non-immune children. In contrast, nonencapsulated strains, 
which are commonly referred to as nontypeable H. influenzae (NTHi), are generally associated 
with localized infections of the respiratory tract such as pneumonia, sinusitis, and acute otitis 
media (AOM). AOM is a common childhood disease and in the United States, approximately 
83% of children have had at least one episode of AOM by the age of three and 45% have 
suffered three or more AOM episodes (65). In adults, NTHi strains are commonly associated 
with acute exacerbations in patients suffering from chronic obstructive pulmonary disease 
(COPD) (25, 50, 55).  
 NTHi diseases impose a significant burden on the health care system. According to 2008 
WHO estimates, COPD was responsible for 3.28 million deaths worldwide, making it the fourth 
leading cause of death (49, accessed September 19, 2012). In the US alone, the total economic 
cost of COPD/asthma for 2008 was estimated to be $68 billion (31). AOM also imposes a 
significant burden on the health care system in the US with a total annual estimated cost of 
approximately $4.2 billion during 2009 (48). Furthermore, both acute exacerbations in COPD 
patients and AOM often result in antibiotic prescriptions (39, 52). Thus, reducing incidence of 
NTHi-associated diseases can reduce a significant burden on the healthcare system and has the 
potential to reduce antibiotic usage and associated concerns regarding emerging antibiotic 
resistance. To these ends, current efforts to reduce NTHi disease incidence are primarily focused 
on preventive measures, such as vaccines. 
 NTHi strains are spread from person to person via infected respiratory droplets where 
they then establish pharyngeal colonization. Among healthy children, colonization generally 
occurs early during childhood and colonization prevalence ranges between 25 – 84% (11, 23, 
30). Pathogenic NTHi arise from the community of NTHi strains colonizing healthy individuals. 
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Thus, colonization is one of the first steps of NTHi pathogenesis and interventions that either 
reduce or prevent colonization would therefore likely decrease the burden of NTHi disease. 
 Adherence to the host epithelium is one of the first steps in bacterial colonization (43). 
Pharyngeal colonization requires that a newly transmitted strain successfully overcome the host’s 
mucociliary clearance mechanisms and innate immunity. Adhesins are a class of cell surface 
structures used by bacteria, including NTHi, to attach to substrates such as the host epithelium. 
During initial stages of colonization adhesin-mediated adherence likely plays a critical role in 
establishment of colonization, allowing newly transmitted cells to avoid being removed from the 
pharynx by mucociliary clearance mechanisms. These adhesins, however, can also become a 
liability for the bacteria as they tend to be key antigens that attract the attention of the host 
adaptive immunity and stimulate an antibody mediated immune response. As demonstrated in 
numerous studies, NTHi colonization and disease stimulates an adaptive immune response 
resulting in the presence of serum antibodies such as IgG, IgM, and IgA, many of which 
specifically target NTHi outer membrane proteins (4, 5, 28, 34, 51). Thus, colonization lasting 
for more than a few days requires that the bacterial population overcome the additional selective 
pressures applied by antibody-mediated immunity.  
 NTHi adherence to the host epithelium is mediated by a number of surface exposed pilin 
and non-pilin adhesins, including the high molecular weight (HMW) adhesins (57-60, 63). 
HMW adhesins are present in approximately 40-75% of all NTHi strains (6, 20-22, 61, 67) and 
when present, they are the immunodominant outer membrane proteins (5). Functional HMW 
adhesins are encoded by hmwA, which resides within the hmw locus and is present in two copies 
in conserved but unlinked regions of the NTHi chromosome (6, 12, 16, 27). This diversity serves 
two roles, first it helps define the tissue tropism of a particular strain, for example, the two copies 
of HMW encoded by a single strain generally confer different in vitro binding characteristics 
(12, 60). Furthermore, anti-HMW adhesin antibodies display varying degrees of cross reactivity 
against the HMW adhesins from heterologous NTHi strains (67). Amino acid diversity therefore 
confers antigenic diversity, and, this may be critical for ensuring availability of immunologically 
naive hosts given that HMW adhesins are highly immunogenic (5). 
 The HMW adhesins are phase variable. HMW adhesin phase variation is mediated by 
simple sequence repeats (SSRs) of seven base-pairs (bp) located within the hmwA promoter 
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region (6, 15). Reversible changes in repeat number affect HMW adhesin levels such that as 
repeat number increases hmwA transcript levels, and HMW protein levels, decrease in a graded 
fashion (15). Since HMW adhesins are highly immunogenic (5), phase variable reductions in 
HMW adhesin expression provides a mechanism by which NTHi populations are able to limit, or 
possibly even evade, antibody mediated immunity. Because phase variable changes in repeat 
numbers is a stochastic process, that occurs independently of any selective pressure, an immune 
evasive NTHi population retains the potential for regaining an adherent phenotype. 
 Differential expression of HMW adhesins is associated with NTHi pathogenicity during 
both AOM (15) and COPD (14). In a study of paired isolates, those collected from the middle 
ears of children with AOM had a higher number of SSRs, and lower levels of HMW adhesin, 
than did their isogenic counterparts isolated at the same time from the nasopharynx (15). Serial 
isolates from the sputum of individuals with COPD revealed that over time the SSR number 
increased, which was often associated with decreased HMW adhesin levels and, in some 
instances, significantly decreased adherence to human respiratory epithelial cells in vitro (14). 
Further support for phase variation-mediated immune evasion comes from the results of an 
HMW-targeted NTHi vaccine study in which isogenic NTHi challenge strains with increased 
hmwA repeat number, and thereby decreased HMW levels, were able to evade HMW antibody-
mediated killing in vivo (2, 15). 
The fitness of a NTHi strain is dependent upon its ability to transmit to and colonize, at 
least transiently, new hosts. With respect to the HMW ahesins, a NTHi population can display a 
spectrum of phenotypes ranging from adherent (few repeats and high HMW adhesin levels) to 
immune evasive (increased repeat numbers and relatively low HMW adhesin levels; Fig. 5.1a). 
At one end of this spectrum, high HMW adhesin levels might be important for transmission or 
for maintaining colonization. At the other end, NTHi population displaying low HMW adhesin 
levels and a non-adherent, immune evasive, phenotype may be favored during colonization. The 
distribution of a NTHi population along the spectrum of HMW adhesin levels likely reflects an 
evolutionary tradeoff between the population’s ability to transmit between hosts versus its ability 
to maintain colonization in spite of antibody mediated immunity. Thus, an open question is: how 
does a colonizing NTHi population retain HMW-mediated host adherence, when within-host 
selective pressures favor a non-adherent, immune evasive, NTHi population? One solution to this 
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challenge is for a NTHi lineage to be rapidly transmitted between hosts (i.e., serially 
transmitted), before antibody-mediated immune pressure drives HMW adhesins to levels that 
might preclude efficient adherence. Empirical evidence, however, does not provide strong 
support for serial transmissions. If strains were rapidly transmitted among individuals one might 
expect that at any given time there would be a high degree of sharing among close contacts. 
While there is some evidence for sharing of strains among adults, within families, and among 
children attending the same day care, this seems to be the exception rather than the rule (18, 23, 
29, 44, 47, 54, 56, 62, 66). In fact, NTHi colonizing strains stand out for their degree of genetic 
diversity within and between hosts. An alternative strategy to serial transmission is that 
phenotypically immune evasive NTHi populations, displaying low levels of HMW, have a 
mechanism for regaining, or maintaining, an adherent phenotype during colonization.  
It is the second hypothesis that we explore in this study. We hypothesize that the 
occurrence of large, yet rare, deletions within the repetitive DNA region that controls hmwA 
transcription allows for the maintenance of a population of adherent cells even when the 
population is faced with a robust antibody-mediated host response. We explore this hypothesis 
by developing a simple mathematical model consisting of a system of ordinary differential 
equations that describe a within-host NTHi population and the antibody mediated immune 
response of a naïve host. Our conclusions suggest that this hypothesis can indeed explain the 
spectrum of phenotypes and their role in survival within the human host. 
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The Model 
 Our goal is to represent, using a mathematical model, NTHi within-host population 
dynamics. The NTHi population will be stratified with respect to the number of repeats in their 
hmwA promoter region (Fig. 5.1b), which we assume is a proxy for the amount of surface 
expressed HMW adhesin and is proportional to a bacterial cell’s ability to adhere to host 
epithelium. We assume that each bacterial cell possesses a single hmw locus and we divide the 
total NTHi population into subpopulations based upon the exact number of 7-bp SSRs in the 
hmwA promoter. Our model consists of 17 NTHi subpopulations REPi(t) (i = repeat number) and 
the host antibody immune response IR(t). Interactions between populations and their rates of 
change are described by a system of 18 ordinary differential equations (ODEs).  As the equations 
are similar for each NTHi subpopulations, we describe a representative equation below and refer 
the reader to the Appendix for the full list of equations. Below we describe characteristics of the 
model and biological support for the assumptions. 
 
         
     (Eq 5.1) 
 
 NTHi population. The total NTHi population size within a single host is constrained by 
the carrying capacity, K, of the pharynx. The 17 subpopulations NTHi subpopulations are 
defined by the exact number of 7-bp SSRs, ranging from 12 to 28, within the hmwA promoter. 
The number of NTHi subpopulations was chosen to capture the majority of the range in repeat 
numbers observed in population-level studies (3, 15, 19, 26, 27, 67). During DNA replication, 
the number or repeats in the hmwA promoter region can remain unchanged or a mutational event 
can occur in which one or more repeats are gained or lost via slipped strand mispairing (15). If 
repeats are gained or lost, the resultant daughter cell transitions into a new subpopulation defined 
by the cell’s SSR number. Since HMW adhesin levels are associated with a bacterial cell’s 
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ability to adhere to host epithelial cells (14, 15), NTHi subpopulations can be characterized 
phenotypically as adherent (i.e., encoding few repeats and producing high levels of HMW),  or 
immune evasive, (i.e., encoding several repeats and producing low levels of HMW). Based on 
these data, we define “adherent” bacterial cells as those in subpopulations 1 – 3 (encoding 12 – 
14 repeats, respectively) and “evasive” bacterial cells as those in subpopulation 15 – 17 
(encoding 26 – 28 repeats, respectively).  
 Phase variation rates for hmwA-associated 7-bp repeats have not been determined. There 
is, however, empirical data for phase variation rates for the NTHi mod gene which, in a manner 
similar to hmwA, possesses variable numbers of tetranucleotide SSRs (17). Both hmwA and mod 
SSRs are gained or lost by the same mechanism, namely slipped stranded mispairing (15, 17). 
Analysis of mod  phase variation suggests that: (1) the most common type of event is the gain or 
loss of a single repeat, (2) repeats are more likely lost than gained, and (3) that for any type of 
event, as the number of the SSRs increases, so too does the mutation rate (17). Interestingly, De 
Bolle et al. (17) documented two large deletion events in strains with large SSR numbers. In a 
study of dinucleotide repeats, Morel et al. (45) also documented large yet rare deletion events in 
(AC)51 SSR tracts inserted onto the E. coli chromosome. Since the number of SSRs in the hmwA 
promoter affects HMW adhesin expression levels, the simultaneous deletion of several SSRs 
provides a mechanism by which a parent-cell with a long tract of SSRs (an immune evasive 
phenotype) can produce a daughter cell with a drastically reduced number of SSRs (an adherent 
phenotype). We refer to the simultaneous loss of several repeats as a “catastrophic loss” event.  
 Model parameterization. Based on the study by De Bolle et al., we defined five 
different phase variation events in our ordinary differential equation model (Appendix A Table 
5.A1 and Table 5.A2) (17). First, bacterial cells can gain or lose a single repeat at rates αi and βk, 
respectively, where i designates subpopulations 1 to 16 and k designates subpopulations 1 to 15. 
Bacterial cells can also gain or lose two repeats in a single event with rates δm and χw, 
respectively, where m designates subpopulations 2 to 17 and w designates subpopulations 3 to 
17. As reported by De Bolle with respect to tetranucleotide repeats (17), for each event type, the 
rate at which repeats are lost is assumed to be greater than the rate at which they are gained and 
the mutation rate increases as the number of SSRs increases. The length of the repeat tract 
therefore determines the level of HMW adhesin expression as well as the rate at which 
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expression levels phase vary. Finally, bacterial cells with the largest number of SSRs (i.e., 26, 
27, or 28 repeats), can lose several repeats in a single event at rate φj, where j = subpopulations 
15, 16, or 17. These large deletion events (catastrophic losses) result in daughter cells 
transitioning from a subpopulation with an immune evasive phenotype to one with an adherent 
phenotype in a single step. Catastrophic losses are the rarest event type. Consistent with the 
results of De Bolle et al. (17), for a given number of repeats, we assumed βk  > αi > χi > δm > φj. 
 NTHi effective growth rate, τ, is a function of bacterial cell replication rates, death rates, 
and clearance rates from the pharynx (e.g., by host mucociliary clearance mechanisms). We 
assumed that NTHi replication rates are the same for each NTHi subpopulation meaning that 
repeat number does not affect replication rate. Bacterial cell death rates are divided into 
subpopulation-independent mechanisms and subpopulation-specific mechanisms; for example, 
HMW adhesin-specific antibody-mediated adaptive immunity is subpopulation specific. We 
incorporated mucociliary clearance into our model by specifying subpopulation specific 
clearance rates, crmax, that were greatest for non-adherent cells and negligible for adherent cells. 
Thus, subpopulation specific effective growth rates, τn, are a function of replication rates, 
subpopulation independent cell death rates, and subpopulation specific clearance rates where n = 
subpopulations 1 -17 and τn < τn-1. 
 HMW adhesins stimulate a host mediated bactericidal antibody response (5) and this 
likely imposes a fitness cost on HMW adhesin-producing cells. Cells displaying high levels of 
surface exposed HMW adhesin present more antigens to the host immune system than do cells 
with lower HMW adhesin levels and as a consequence they likely experience higher HMW 
adhesin-specific antibody-mediated death rates. Both HMW adhesin levels, and hmwA 
transcription, decrease as the number of 7-bp repeats increase (14, 15, 26). To capture this 
dynamic, we assumed that the rate of antibody-mediated killing is proportional to hmwA 
transcription. We defined the term μn, where n = subpopulation 1 – 17, that describes the 
relationship between hmwA repeat number and surface exposed HMW adhesin level. The host 
immune response, described below, directly interacts with the NTHi subpopulation via μ. 
 Once the model was developed, baseline rates for the various parameters were estimated. 
Rates were estimated from published literature when available and in the absence of published 
data, we employed uncertainty analysis (42) to define baseline parameter estimates that gave rise 
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to biologically reasonable outputs. All parameter values are summarized in Table 5.A1 and Table 
5.A2 of the Appendix. The details of how each parameter was estimated are given below. 
 Sensitivity analyses. There is an intrinsic variability in many of the parameter values of 
our mathematical model, due to extensive variability in the data, as well as uncertainty regarding 
their in vivo values, which often are incomplete. We address this uncertainty by coupling an 
extensive and efficient sampling of the parameter space with a generalized correlation 
methodology to assess effects of uncertainties in our parameter estimation on model outcomes.  
 Sensitivity analysis (SA) is a method for quantifying uncertainty in any type of complex 
model. The objective of SA is to identify critical inputs (parameters and initial conditions) of a 
model and to quantify how input uncertainty affects model outcome(s). We use Latin Hypercube 
Sampling (LHS) as a sampling scheme and Partial Rank Correlation Coefficient (PRCC) as a 
sensitivity index. Uncertainty and sensitivity analysis methodologies are described in detail in 
(42) and briefly below. 
 LHS is a so-called stratified sampling without replacement technique, where the random 
parameter distributions are divided into N equal probability intervals, which are then 
independently sampled. N represents the sample size, which here is set to 5000. A matrix of 5000 
rows and k number of columns (k is equal to the number of parameters varied in the analysis) is 
generated. Each row of the matrix serves as input for a single model simulation. The outputs of 
N model simulations are then saved and used for calculating sensitivity indexes. Since our model 
is a dynamical system, 20-day time course outputs are generated. PRCC was then calculated for 
each parameter and statistical significance was assessed (42). Our outcome of interest for 
sensitivity analyses was the total number of adherent cells (Table 5.A1), defined as the sum of 
the number NTHi cells in subpopulations one to three. 
 Computer simulations. Once the parameters were estimated, we solved the system of 
ordinary differential equations (ODEs) to track NTHi population dynamics over time. All 
simulations were performed using MATLAB’s (ver 7.10, R2010a, Copyright 1984-2010, The 
MathWorks, Inc.) ode113 solver for non-stiff differential equations. 
 There are no data on the number of NTHi cells required to successfully colonize a host, 
but, both NTHi and host factors likely play a role in determining the infectious dose. We chose 
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to study colonization dynamics under the assumption that 120 adherent NTHi cells, distributed 
across the first three NTHi subpopulations, enter the pharynx; our model is flexible and stable to 
variations in initial conditions. We consider the total number of adherent bacterial cells (i.e., sum 
of cell numbers in subpopulations 1 – 3) as a key readout for the system. 
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Results 
 In the absence of antibody-mediated immunity, the distribution of NTHi cells among 
subpopulations was solely a function of phase variation rates. Under baseline conditions, the 
NTHi total population distribution gradually shifted so that at the end of the 20 day simulation 
subpopulations 1 through 8 contained nonzero levels of bacterial cells (Fig. 5.2a and Fig. 5.A3). 
Throughout the simulation, the majority (99.6%) of the total population remained within the first 
three subpopulations (i.e., the adherent phenotype) (Fig. 5.2a and Fig. 5.A3). At equilibrium, all 
seventeen NTHi subpopulations contained a positive number of bacterial cells and the total 
population distribution was slightly skewed; however, with the first three subpopulations 
comprised 80.2% of the total population (data not shown). The distribution at equilibrium 
reflected the overall mutation rates which favored the loss of repeats over their gain (Fig. 5.A1). 
Because the mutation rate for the subpopulation containing 12 repeats was nonzero, there were 
always NTHi subpopulations with longer repeat tracts, even though deletions were more likely 
than insertions. In the absence of host-mediated immunity, catastrophic loss events did not 
impact the overall NTHi population distribution during the 20-day simulation. 
 Next we explored the effect of an immune response (Fig. 5.3) on the NTHi population 
distribution in the presence and absence of catastrophic loss events (Fig. 5.2b-c, Fig. 5.A4, and 
Fig. 5.A5). Baseline simulations were initiated with an immune response of 0.001, which 
resulted in 0.001% of the total population being killed on day 1. When compared to the effect of 
mutation rates alone, however, the immune response had a negligible effect until day 10 (Fig. 5.2 
and Figs. 5.A3-5.A5). The immune response was approximately 50% of its maximal level on day 
10 (Fig. 5.3) and the number of adherent cells in the population dropped from approximately 1E5 
on day 11 to less than a single cell on day 12. As the immune response continued to develop, 
immune-mediated selective pressure forced the overall NTHi population distribution toward 
subpopulations with increased repeat number and decreased HMW levels (Fig.5. 2 and Figs. 
5.A3-5.A5). In the absence of catastrophic losses, adherent cells were eliminated from the 
population after day 12 and were never regained during the remainder of the 20 day simulation 
(Fig. 5.2b, Fig. 5.A4). Inclusion of catastrophic loss events had little impact on the NTHi 
population distribution through day 16, but by day 17 a small population of adherent cells was 
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established and it increased each day until the end of the 20-day simulation (Fig. 5.2c, Fig. 5.4, 
and Fig. 5.A5).  
 The adherent NTHi population at day 20 under baseline model conditions consisted of 
approximately 92 NTHi cells (Fig. 5.4). This raised concern given that the final population was 
lower than the initial inoculum used for our baseline simulations; that is, if there are only 92 
adherent cells total how could colonization be initiated with an initial inoculum of 120 cells? To 
determine if our model results were sensitive to changes in the initial conditions, we performed 
simulations with varying numbers of input bacterial cells. Even with an inoculum size of one 
cell, the NTHi population approaches the baseline carrying capacity of 1E09 by the end of the 
first day, long before the immune response influenced the population distribution (data not 
shown). We therefore concluded that our results are insensitive to the initial inoculum size. 
 Sensitivity analyses. To identify parameters that significantly impacted our outcome 
variable of interest, sensitivity analyses were conducted on the model with parameter values 
from Table A1 and ranges given therein (see Methods for details). Maximum antibody levels 
(Ab_max), population carrying capacity (K), and antibody avidity (s) were each significantly 
correlated with the numbers of adherent cells (P < 0.01) (Fig. 5.5). The impact of their effects, 
however, varied in both time and magnitude.  
 Pharyngeal carrying capacity, K, was strongly correlated with the number of adherent 
cells (Fig. 5.5). At all time points, there was a statistically significant (P < 0.001) positive 
correlation between carrying capacity and the number of adherent cells. During the early stages 
of colonization, prior to development of the adaptive immune response, the NTHi population 
distribution was simply a function of mutation rates. Therefore, during the early stages of the 
simulation most NTHi cells were located within the first three subpopulations (e.g., on day 10, 
adherent cells make up over 99% of the total NTHi population) and changes in the number of 
adherent cells were directly proportional to carrying capacity, K. The intense selective pressure 
applied by the immune response rapidly eliminated the adherent subpopulations such that from 
days 12 to 15, there was less than one adherent cell in the population (Fig. 5.4). The positive 
correlation between adherent cells and carrying capacity during this period when there was less 
than a single cell in the model resulted from the assumption that the population acts like a 
continuous function. During the later stages of the simulation, the number of adherent cells was a 
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function of both carrying capacity and the catastrophic loss rate (intercept_cl). By day 20 under 
baseline conditions, there were approximately 4.9E7 immune evasive cells in subpopulations 15 
– 17; that is, the subpopulations capable of undergoing catastrophic losses to produce adherent 
daughter cells. For a given catastrophic loss rate, increasing the pharyngeal carrying capacity 
(K), increased the number of adherent cells. 
 The catastrophic loss rate (intercept_cl) also significantly impacted numbers of adherent 
cells. For the sensitivity analysis, the catastrophic loss rates were varied independently of all 
other mutational events by varying the intercept of the line describing the relationship between 
repeat number and phase variation rate (Fig. 5.A1).  The rates at which one or two repeats were 
gained or lost were varied by varying the scaling factor q (Table 5.A1), in this way the 
relationships between mutation rates (i.e., βk  > αi > χi > δm) were maintained during the 
sensitivity analyses. The rate of catastrophic events was significantly positively correlated (P < 
0.001) with the number of adherent cells from days 12 to 20 (Fig. 5.5), confirming our 
hypothesis that catastrophic loss provide a mechanism that allows for maintenance of adherent 
cells in the face of antibody mediated immunity. The PRCCs between the catastrophic loss rates 
and the numbers of adherent cells increased over time as the immune pressure forced the NTHi 
population to a predominantly immune evasive phenotype (Fig. 5.2b and Fig. 5.A5); the PRCC 
reached its maximal value of 0.26 on day 20 (Fig. 5.5). 
 The sensitivity analysis also found that Ab_max (the maximum level of anti-HMW 
antibodies produced in response to NTHi colonization) and the numbers of adherent cells were 
strongly correlated (Fig. 5.3). Ab_max was negatively correlated (P < 0.001) with the number of 
adherent cells from days 7 to 14 (Fig.5.5). This time period corresponds to rapidly increasing 
antibody levels (Fig. 5.3), immune-mediated elimination of adherent cells, and a shift in the total 
population distribution that favored subpopulations with increased repeat number (Fig. 5.2c and 
Fig. 5.A5). Beginning on day 12, subpopulations 15 to 17 became non-zero and on day 16 
catastrophic loss events slowly repopulated the adherent subpopulations (Fig. 5.A5). By day 15, 
the relationship between Ab_max and the number of adherent cells became significantly 
positively correlated (P < 0.001) and continued to increase through the end of the simulation at 
day 20 (Fig. 5.5).  
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 Finally, our analysis predicts that s (which is analogous to antibody avidity) and the 
number of adherent cells were also strongly correlated (Fig. 5.5). Therefore, increasing s 
increases the per unit killing rate of bacterial cells by the immune response. The effect of s was 
evident by day 5 of the simulation at which time the s and the number of adherent cells were 
significantly negatively correlated (P < 0.001) (Fig. 5.5). In general, the PRCCs for s tracked 
closely with those of Ab_max (Fig. 5.5). This was not surprising since both parameters reflect the 
relationship between the immune response and per unit NTHi killing. 
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Discussion 
 In this paper we have presented a mathematical model that explores how phase variation 
and antibody-mediated immunity can shape the population structure of nontypeable 
Haemophilus influenzae within a host. Specifically, we focused on phase variable expression of 
the HMW adhesin, a surface exposed immunogenic protein that mediates attachment of NTHi to 
the respiratory epithelial cells of its host (5, 60). HMW adhesin phase variation is mediated by 
simple sequence repeats of seven base pairs, located within the promoter region of the adhesin 
gene, hmwA. Phase variable down-regulation of HMW adhesin production, resulting from the 
accumulation of SSRs, presumably allows NTHi to avoid antibody-mediated killing. We predict 
that the occurrence of large deletion events, even though rare, could allow for the presence and 
maintenance of small but stable subpopulations of adherent cells, with high HMW adhesin 
production, in the presence of antibody-mediated immunity. We speculate that these adherent 
subpopulations may be important for maintaining colonization and/or sustaining NTHi 
transmission between hosts (Fig. 5.6). 
 NTHi populations are faced with several challenges during colonization, some of these 
include intra- and interspecific competition with members of the pharyngeal microbiome (13, 41, 
68), surviving assaults by the host immune system, and resisting host mucociliary clearance 
mechanisms. Following transmission, adherence of newly transmitted bacterial cells to the host 
epithelium is one of the first steps of the colonization process. Physical attachment to the host 
epithelium, mediated by surface exposed bacterial structures such as the HMW adhesins, helps 
bacterial cells resist mucociliary clearance mechanisms. HMW adhesins are, however, highly 
immunogenic and antibodies directed against these proteins are bactericidal (5). Therefore, in the 
absence of a mechanism to evade antibody mediated immunity, an adherent, HMW adhesin-
expressing NTHi population risks being eliminated from its host by antibody mediated 
immunity.   
 Bacterial phase variation, reversible genetic changes that affect gene expression, offers a 
survival strategy for overcoming host immunity (7, 64) and this mechanism is the basis of the 
hypothesis tested herein. NTHi contains several phase variable loci, many of which are mediated 
by tetranucleotide repeat tracks (53). HMW adhesins, however, undergo phase variation by 
gaining or losing heptanucleotide repeats within the hmwA promoter region; stochastic changes 
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in repeat numbers are mediated by slipped stranded mispairing during DNA replication (15) (Fig. 
5.1a). Changes in repeat number affect HMW adhesin levels in a graded fashion, as repeat 
numbers increase HMW adhesin protein expression decreases (15). Phase variation, therefore, 
generates a bacterial population that is phenotypically diverse with regards to HMW adhesin 
levels and this diversity potentially confers a survival advantage to the NTHi population. For 
example, population level HMW adhesin diversity increases the probability that at least some 
members of the population can survive rapid environmental changes, such as those that might 
occur during a transmission event. Incremental changes in hmwA expression, however, are 
difficult to track in vivo. Mathematical modeling therefore provides an essential tool for 
exploring the implications of hmwA phase variation during colonization.  
NTHi possesses numerous SSRs, but tetranucleotide repeats tracts are the best 
characterized of the SSR systems. Contraction of tetranucleotide SSR tracts is favored over their 
expansion, a trend that may reflect selection for reduced genome size (i.e., increased replication 
rate) (17, 38). Therefore, in the absence of selection, mutation rates alone would favor a 
population dominated by adherent NTHi that have relatively few SSRs and high HMW adhesin 
levels. The maintenance of variable length hmwA SSR tracts (14, 15, 26) suggests that phase 
variable HMW adhesin expression confers a selective advantage that outweighs the potential 
fitness cost associated with increased genome size. Since the length of a SSR tract affects both 
phase variation rate and HMW adhesin levels, SSR tract length can be tuned to maximize the 
fitness of a bacterial population within its specific host. 
 The role of HMW adhesins in mediating adherence to epithelial cells has been 
established in vitro (14, 60, 67). Since adherence is one of the first steps in colonization, we 
assumed that the HMW adhesins play a critical role during NTHi transmission and colonization. 
We therefore initiated model simulations with a small population of NTHi cells expressing high 
levels of HMW adhesin, that is, adherent cells with few SSRs within the hmwA promoter. Under 
this condition, inability to decrease HMW adhesin expression by phase variation resulted in the 
complete elimination of the adherent NTHi population by the end of the 20-day simulation (data 
not shown). In or model, HMW adhesin phase variation allowed the NTHi population to adapt to 
increasing antibody levels. As the concentration HMW adhesin-specific antibodies increased 
during the simulation, cells expressing high HMW adhesin levels (adherent cells) were 
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preferentially killed and the number of cells with low HMW adhesin levels (evasive cells) 
increased (Fig. 5.4). These results suggest that immune driven selective pressure has the potential 
to drive the NTHi population to a non-adherent state. Tauseef and Bayliss (64) recently 
demonstrated that phase variable expression of the outer membrane protein PorA, which also 
results in graded changes in protein expression, mediates Neisseria meningitidis escape from 
bactericidal antibodies in vitro. If HMW adhesin mediated adherence does, in fact, play a critical 
role in NTHi transmission, loss of the adherent phenotype could potentially drive the population 
to an evolutionary dead-end. 
 In a study of NTHi mod phase variation, De Bolle et al. (17) documented two large SSR 
deletion events in strains possessing relatively long tetranucleotide SSR tracts. They posited that 
large deletions may serve to prevent the accumulation of large SSR tracts. Within the context of 
hmwA phase variation, the simultaneous deletion of several repeats would therefore provide a 
mechanism by which a parent NTHi cell with a relatively long SSR tract can produce a daughter 
cell with a drastically reduced SSR tract (Fig. 5.1). Phenotypically, this is a mechanism by which 
a non-adherent cell, producing low HMW adhesin levels, can generate adherent progeny, 
producing high levels of HMW adhesins. Importantly, this could provide a mechanism for 
maintaining both adherent and immune evasive populations present at all times in the host. We 
incorporated rare large deletion events (i.e., catastrophic losses) into our model and demonstrated 
that they provide a mechanism capable of producing and maintaining a small subpopulation of 
adherent NTHi cells in spite of a strong antibody-mediated immune response.  
 How can we use these results to make relevant predictions regarding NTHi colonization 
and, potentially, pathogenesis? Sensitivity analyses identified four parameters, Ab_max (maximal 
antibody level), s (antibody avidity), intercept_cl (the rate of catastrophic loss events), and K 
(carrying capacity), that significantly impacted NTHi population dynamics and were strongly 
correlated with the total number of adherent NTHi cells (Fig. 5.5). The effect of Ab_max and s, 
varied both in time and magnitude (Fig. 5.5). Both of these parameters directly affect the 
immune mediated killing rate, increasing Ab_max increases the amount of antibody present at 
any given time during the simulation whereas increasing s increases the per unit killing rate for a 
given antibody level. An effective vaccine could increase both of these parameters 
simultaneously. In a study of infants immunized with polysaccharide conjugate vaccines, higher 
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affinity antibodies (which is analogous to increasing s in our model) were associated with higher 
levels of IgG (increased Ab_max) and, independently, with increased serum bactericidal activity 
(32) suggesting that these immune parameters may act synergistically. 
 Our model results suggest, however, that the impact of increasing Ab_max (maximal 
antibody level) on the number of adherent cells is complex. On the one hand, increasing Ab_max 
increases the rate at which adherent NTHi cells are eliminated from the host during the early 
days of colonization (Fig. 5.A6).  On the other hand, bacterial populations subjected to increased 
immune pressure regained adherent cells earlier during the course of our simulation than did 
populations subjected to less intense immune selection (i.e., lower Ab_max) (Fig. 5.A6). The 
earlier appearance of adherent cells resulted from increased selection pressure rapidly driving the 
population to the immune evasive phenotype from which adherent progeny were generated by 
catastrophic losses. This finding suggests that individuals with a more robust immune response 
may be more likely to harbor adherent NTHi cells during the first 20 days of colonization. This 
result warrants further exploration, but suggests, counter intuitively, that vaccination could 
potentially increase NTHi transmission. 
 Finally, our model demonstrated that the pharyngeal carrying capacity and the number of 
adherent cells are positively correlated (Fig. 5.5). In general, NTHi population size and hmwA 
phase variation rates determine the number of phase variants in a population. More specifically, 
this is especially important for the immune evasive population that undergoes catastrophic losses 
to generate adherent progeny. Assuming HMW-mediated adherence plays a role during 
transmission, this result could have important implications for the transmission of disease 
causing strains. Acute otitis media is not generally assumed to be associated with increased 
NTHi transmission of the disease causing strain. However, during AOM the pharyngeal NTHi 
community, which in healthy individuals commonly supports multiple different NTHi strains, is 
dominated by the disease-causing isolate present in the middle ear (10, 35, 40). Decreased NTHi 
strain diversity means that a larger portion of the available pharyngeal capacity could be 
occupied by a disease causing strain, allowing it to achieve a larger overall population size and 
therefore harbor increased numbers of adherent cells. This observation suggests, therefore, that 
disease could potentially improve a particular strain’s fitness, that is, its ability to transmit 
between hosts. 
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 The positive correlation between carrying capacity and adherent cells suggests that 
therapeutic agents or preventive measures that reduce pharyngeal carrying capacity could 
eliminate adherent cells and potentially reduce NTHi transmission. We explored this result in 
more detail by conducting simulations with carrying capacities ranging from 1E04 to 1E06. 
Under these conditions, there were no adherent cells remaining at day 20 (data not shown) 
suggesting that decreased pharyngeal carrying capacity can potentially eliminate adherent cells 
which may, in turn, decrease NTHi transmission.  
As with any experimental system, we made several important assumptions that could 
impact our results. Since hmwA phase variation rates are not known, we assumed that the rate of 
heptanucleotide SSR variation was equal to that of tetranucleotide mediated phase variation 
described by De Bolle et al. (17). This, however, may not be the case and, for example, 
differences in the rate of DNA repair for tetranucleotide and heptanucleotide repeats could bias 
our rate estimates. Phase variation rates of both tetranucleotide repeats and hmwA 
heptanucleotide repeats are recA-independent (9, 15). Furthermore, tetranucleotide repeat 
variation is not affected by mutations in genes encoding components of the mismatch repair 
system, but is increased by inactivation of the Klenow domain of polI and of RnaseHI (8, 9); the 
effects of these mutations on hmwA phase variation are not known. Ultimately, differences in 
DNA repair mechanisms would affect phase variation rates and therefore varying the scaling 
factor q (Table 5.A1) can serve as a proxy for any mechanistic differences in DNA repair 
mechanisms. Sensitivity analyses suggests that differences in mutation rates, within the range 
tested in our analysis (Table 5.A1), are not correlated with the number of adherent cells (Fig. 5.4)  
Thus, while it is possible that there are differences between tetranucleotide and heptanucleotide 
repair mechanisms, we believe that any such differences would have little impact our model 
outcome. 
We described phase variation rates on a per-repeat basis, meaning that for a given 
number of repeats, the absolute number of nucleotides is greater for a heptanucleotide repeat 
tract than a tetranucleotide tract. Since phase variation rate increases with repeat tract length, if it 
is the absolute tract length that dictates mutation rates, then we may have underestimated the 
mutation rates and the correlations that we observed would likely be conservative. We also chose 
to model only a subset of the potential SSR mutation events; for example, we did not incorporate 
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mutational events involving three repeats. While inclusion of additional event types would likely 
affect the overall NTHi population distribution during a model simulation, it seems unlikely that 
it would change our primary conclusion that catastrophic losses allow for the maintenance of a 
subpopulation of adherent cells.  The relationship between HMW adhesin levels and antibody-
mediated killing is unknown; however, we assumed that HMW levels and antibody-mediated 
killing rates are proportional to hmwA transcription levels (Fig. 5.A2). It is possible that the 
relationship is linear or, alternatively, that there is a strict threshold effect. As with the inclusion 
of additional mutational events, the exact functional form of the relationship between HMW 
adhesin level and killing rates would likely impact the overall population distribution during the 
course of a simulation but have little influence on our overall conclusion that catastrophic losses 
allow for the maintenance of adherent cells. 
 This is the first study, to the best of our knowledge, to explore the impact of a graded 
phase variation system on a colonizing bacterial population within the context of evolving host 
immunity using mathematical modeling. We parameterized our model using empirically derived 
mutation rates (17), allowing phase variation rates to vary by both event type and repeat tract 
length. The antibody-mediated immune response of a naive host was modeled in a 
phenomenological fashion to capture the dynamics of a primary adaptive immune response. 
Even using this simple model we were able to predict important roles for phase variation and 
adaptive immunity in shaping within-host NTHi population structure during colonization. 
Further studies can now build a more fine-grained model to allow for specific and mechanistic 
predictions about the interactions between NTHi and its human host. 
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Figure 5.1. The HWM phase variation mechanism illustrated with NTHi 86028-NP hmw1A. (a) 
The hmw1A promoter is located within the intergenic region between yrbI and hmw1A. Phase 
variation is mediated by the gain and loss of heptanucleotide repeats (shaded rectangles), located 
within the hmw1A promoters (demarcated by P1 and P2), via slipped strand mispairing during 
DNA replication (15). Differences in repeat number affect hmwA transcription and HMW levels 
in a graded fashion such that fewer repeats are associated with increased transcription and higher 
HMW-levels (15). Phenotypically, cells expressing high levels of HMW can be characterized as 
adherent cells whereas cells expressing low HMW levels can be described as immune evasive 
cells. (b) Schematic representation of the within-host NTHi population model. Each 
compartment represents a subpopulation of NTHi cells with a specific number of repeats, 
ranging from 12 to 28, upstream of hmwA. Arrows represent the rates at which NTHi 
subpopulations change over time, parameter names and their baseline values are listed in Table 
5.A1 of the Appendix. The system is described by 18 ordinary differential equations (Appendix). 
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Figure 5.2. NTHi cell number for each subpopulation on days 5, 10, 15, and 20. Each bar 
represents the number of NTHi cells (log10) in each of the 17 subpopulations. (a) Population 
distribution as a result of phase variation alone. (b) Effects of phase variation and immune 
selection on NTHi population. The immune response imposes a selective pressure that results in 
overall bacterial population distributions towards cells with increased repeat number. (c) Full 
model, including phase variation, immunity, and catastrophic loss events, under baseline 
conditions. Catastrophic loss events allow for the recovery of a small population of adherent 
cells by day 20. 
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Figure 5.3. Baseline immune response over 20 days of simulation. The initial level of the 
immune response is 0.001 ng/ml of anti-HMW IgG antibody and the maximal level, defined as 
Ab_max, is 3200 ng/ml. We specify three phases of the immune response, demarcated by the 
grey vertical lines, as the lag phase, growth phase, and plateau phase. Between day 7 and day 13, 
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Figure 5.4. NTHi total population size the total number of NTHi killed per day under baseline 
conditions. The upper figure plots the total population (solid line; sum of subpopulations 1 to 
17), the total number of adherent cells (dotted line; sum of subpopulations 1 to 3), and the total 
number of NTHi killed per day (dashed line) under baseline conditions. The bottom figure 
represents the baseline immune response. The effect of anti-HMW immunity becomes evident 
around day 9 as the total NTHi population begins to decline. While the total population is only 
slightly affected, the adherent population is completely eliminated from the host by day 12. 
However, as the immune pressure drives total bacterial population towards subpopulations with 
higher repeat numbers (Fig. 5.2) the adherent subpopulations become non-zero and continue to 
increase in number through simulation day 20. The three main phases of the immune response 
(Fig. 5.3) are demarcated with vertical grey lines as overlays to guide interpretation. 
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Figure 5.5. Partial rank correlation coefficients (PRCCs) of the baseline model uncertainty and 
sensitivity analyses plotted over time. Parameter estimates, and the ranges used for sensitivity 
analysis, are presented in Table 5.A1 of the Appendix. Maximum antibody levels (Ab_max), 
antibody avidity (s), rate of catastrophic losses (interceptcl), and pharyngeal carrying capacity (K) 
are significantly correlated with the total number of adherent cells, however, the strength and 
direction or their effect varies over time. PRCC values outside of the central grey box, that is, 
PRCCs greater than approximately 0.5 and less than -0.5, are statistically significant (P-value ≤ 
0.001) (equation 7 (42). The three main phases of the immune response (Fig. 5.3) are demarcated 
with vertical grey lines.  
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Figure 5.6. Conceptual model. NTHi is a human restricted bacterium and its long term survival is 
dependent upon its ability to colonize new hosts. Adherence to the host epithelium, mediated by 
bacterial adhesins such as HMW, is a first step in NTHi colonization. NTHi cells preferentially 
adhere to non-ciliated host epithelial cells and this attachment is one mechanism employed by 
NTHi to overcome cilia-mediated mucociliary clearance mechanisms of the host. As the NTHi 
cell population increases, HMWs stimulate an HMW-specific antibody mediated immune 
response in the host that preferentially targets NTHi cells expressing high HMW levels. Over 
time, the NTHi population shifts from a predominantly “adherent” phenotype to a predominantly 
“evasive” phenotype capable of colonizing a host despite a robust antibody mediated immune 
response. The simultaneous loss of several hmwA repeats, i.e., catastrophic loss events, during 
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Appendix A 
A.1. Parameter estimation. 
A.1.1. NTHi effective growth rate. The baseline NTHi effective growth rate of 19.96 day
-1
 was 
based upon an “effective mean generation time” of 50 minutes (46). Relative to NTHi 
subpopulations with few repeats, NTHi subpopulations with a high number of repeats and low 
HMW adhesin levels, were assumed to incur a fitness cost in the form of an increased 
mucociliary clearance rate. This assumption was based on two lines of reasoning. First, as 
demonstrated in tissue culture, cells with higher levels of HMW adhesin generally display higher 
levels of adherence (12, 14). This effect is a consequence of physical adherence to the 
epithelium. Second, studies of H. influenzae interactions with nasopharyngeal organ culture 
suggest that NTHi exert a toxin-mediate effect on ciliated cells that reduces their beat frequency 
and therefore would result in decreased clearance rates (1, 24). Adherent cells bind preferentially 
to non-ciliated cells (24), but proximity to the epithelial cell surface and ciliated cells may 
increase their toxin-mediated effects on ciliary beat frequency. This advantage is incorporated 
into the effective growth rate term which is a function of NTHi replication, natural death rates 
(i.e., independent of antibody-mediated immunity), and clearance rates. The maximal clearance 
rate, crmax, of 0.85 day
-1
 was based upon estimates from a model of Helicobacter pylori dynamics 
(36). crmax affects the subpopulation-specific growth rate and increases linearly as repeat number 
increases, cells with a higher repeat number have a lower effective growth rate. 
A.1.2. Phase variation rates. Estimated hmwA phase variation rates (Table 5.A1, Fig. 5.A1) 
were based on the on-to-off switching rate for the tetranucleotide phase variation system 
described by De Bolle et al. (17). The relationship between repeat number and phase variation 




 is described by the linear function: mutation rate = (7E-
6)*(repeat number) – (7E-5). To determine the rate of each event type, e.g., gain one repeat, lose 
one repeat, etc., we estimated the proportion of each event (from Table 2 (17)), multiplied that 





 (Fig. A1). 
A.1.3. Relationship between HMW levels, hmwA 7-bp repeat number and antibody 
mediated killing. HMW levels and hmwA transcription decrease as repeat number increases (14, 
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15, 26). The level of surface expressed HMW adhesin is an important parameter in our system 
since it directly interacts with the host immune system, both to initiate the immune response and 
to target NTHi cells for antibody-mediated killing. There is, however, no quantitative data 
relating hmwA transcript levels to the levels of surfaced expressed HMW adhesin, we therefore 
assume that the level of surface exposed HMW adhesin is proportional to hmwA transcript levels 
measured in vitro. The relationship between repeat number and HMW adhesin-level was 
estimated by fitting a curve to quantitative data for hmwA transcription for SSR tracts of 15 to 22 
repeats (15).  There were no data relating repeat number with hmwA transcription for cells 
containing 12 to 14 repeats, but 6 repeats resulted in the same amount of hmwA transcript as did 
a 15 repeats (Dawid, unpublished data). Based on this observation, we assumed that the 
relationship between repeat number and HMW adhesin level was the same for cells encoding 12 
to 15 repeats. HMW adhesin levels for containing between 23 and 28 repeats were estimated 
from the curve fitted to the empirical data (Fig.5.A2). 
A.1.4. Scaling factor s. The scaling factor, s, relates host antibody level to the subpopulation-
specific killing rates. Uncertainty analysis was used to select the baseline parameter estimate for 
s = 0.00906 which was chosen so that approximately 1.0% of the total NTHi population was 
killed at day 5. For sensitivity analyses (Table 5.A1), we varied s by approximately 6.5-fold 
based upon studies of antibody avidity following Hib vaccination (32, 37). Our model is flexible 
to variations in this number. 
A.1.5. Immune response parameters Abmax and r.  The growth rate of the antibody response 
(Fig. 5.3) was chosen to capture the dynamics of a primary antibody response in a naive host 
(33). Uncertainty analysis was implement to select the baseline intrinsic growth rate of r = 1.5. 
Simulations were initiated with an immune response of 0.001. The baseline Ab_max value of 
3200 ng IgG ml
-1
 was based upon a study of serum IgG levels directed against NTHi outer 
membrane proteins during colonization (51). Under baseline conditions, the immune response 
developed gradually during the first seven days, increased rapidly between days 7 and 11, and 
reached its plateau at approximately day 13 (Fig. 5.3). Specifically, at day 5, 10, and 13, the 
immune response was approximately 0.06%, 50.6%, and 98.9% of its maximal level of 3200 
ng/ml, respectively.  
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A.1.6. Scaling factor q. In order to maintain the relative relationships among mutation rates such 
that for a given number of repeats, βk  > αi > χi > δm > φj, where k = i = m = j, we introduce the 
scaling factor q. We multiply the intercept of the linear function describing each type of mutation 
rate by q; under baseline conditions q = 1. For sensitivity analyses, we vary only q rather than 
independently varying the rate of each mutational event type. We chose to conduct analyses 
under two scenarios, one in which q simultaneously varies all five mutation rates and a second in 
which q affects the rates at which one or two repeats are gained/lost while the rate of catastrophic 
loss, φj, varies independently. 
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Table 5.A1. Parameters, baseline parameter values, and parameter ranges for sensitivity analyses. 
a
 the minimum and maximum values were controlled by varying the scaling factor   






rate at which a single repeat is gained 






rate at which a single repeat is lost (mutations 






rate at which two repeats are gained in a 





rate at which two repeats are lost in a single 






“catastrophic” loss rate, several repeats in a 









0.007 – 1.0  (15) 
τ effective growth rate (generations per day) 19.96
 
 (46) 
Ab_max maximum ng/ml of HMW antibody (ng/ml) 3200 (320, 5775) (51) 








rate NTHi is lost due to mucociliary clearance 
(per day) 
0.85 (0.01, 8.5) (36) 
s 
scaling factor for the relationship between 
repeat number and antibody mediated killing 
rate ; similar to antibody avidity 
0.00906 (0.0023,0.0362) this study 
r 
growth rate of immune response (ng per ml 
per day) 
1.5  this study 
q 
scaling factor that maintains the relationship 
between the rate at which repeats are gained 
and lost during replication 
1 (0.01, 100) this study 
 Derived Quantities    
adherent 
cells 






= ( sum of NTHi cells in subpopulations 1 - 
3)/(total number of NTHi cells in 








Figure 5.A1. Repeats are more likely to be lost than gained and for each event type, mutation 
rates increase with increasing repeat number. This figure illustrates the relationship between 
repeat number for each type of mutational event, both within each event type and between types, 
included in the model. Estimates were based on the tetranucleotide phase variation rates of NTHi 
mod reported by De Bolle, et al. (17). The linear relationships are as follows: (1) αi= 4E-
05(REPi) + 4E-05, (2) βi = 8E-05(REPi) + 8E-05, (3) δi = 8E-06(REPi) + 8E-06, (4) χi = 1E-





Figure 5.A2. hmwA transcription decreases with increasing repeat number. Closed circles (●) 
represent empirically determined values (15) and open circles (○) represent values estimated by 
fitting a curve to the empirical data. A recombinant strain encoding six repeats produced the 
same level of hmwA transcript as a strain encoding 15 repeats (Dawid, dissertation; data not 
shown), therefore, we assume strains encoding between 12 and 15 repeats produce the same 
amount of hmwA transcript. The relationship between hmwA transcript level, μ, and repeat 








Figure 5.A3. NTHi subpopulation distributions, by day, as a function of phase variation alone. 
Each bar represents the number of NTHi cells in each of the 17 subpopulations defined by repeat 
number (Fig. 5.1b). The population distribution is solely a function of the rate at which one or 
two repeats are gained or lost and does not include catastrophic losses or an immune response; 





Figure 5.A4. NTHi subpopulation distributions, by day, as a function of phase variation and 
immunity. Each bar represents the number of NTHi cells in each of the 17 subpopulations 
defined by repeat number (Fig. 5.1b). This simulation includes phase variation and baseline 
immune response but does not allow for catastrophic losses. Relative to the simulation without 
the immune response, Fig. 5.2, the effects of the selective pressure applied by the immune 
response are apparent by day 10. By day 14 the adherent NTHi cells, subpopulations 1 to 3, have 





Figure 5.A5. NTHi subpopulation distributions, by day, under baseline conditions (Table 5.1 of 
Appendix A). Each bar represents the number of NTHi cells in each of the 17 subpopulations 
defined by repeat number (Fig. 5.1b). This simulation includes the baseline phase variation rates, 
baseline immune response and catastrophic losses. Similar to the simulation without catastrophic 
losses, Fig. 5.A4, the effects of the selective pressure applied by the immune response are 
apparent by day 10. By day 14 the adherent NTHi cells, subpopulations 1 to 3, have been 
completely eliminated. On day 17, however, catastrophic loss events produce a small population 





Figure 5.A6. Total numbers of adherent cells over time as a function of Ab_max. For all Ab_max 
values, there is a precipitous decline in adherent cells beginning around day 10 under baseline 
conditions; at this time point, antibody levels are approximately 50% of Ab_max. Increasing 
Ab_max increases the rate at which the number of adherent cells decline with increasing 
immunity; however, it also decreases the total amount of time that there are a nonzero number of 
NTHi cells in the pharynx. The three main phases of the immune response (Fig. 5.3) are 
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Summary and Future Directions 
 
Summary 
The work presented in this dissertation sought to: (1) develop a molecular typing method 
to differentiate typeable from true nontypeable H. influenzae, (2) characterize a geographically 
distributed collection of NTHi isolates with respect to hmwA prevalence and sequence diversity, 
(3) test for evidence of selective pressures operating on hmwA, and (4) develop a mathematical 
model that provides a theoretical framework for exploring how hmwA phase variation and host 
mediated immunity interact to shape NTHi within host population structure. 
The major findings of this work are: 
 The presence of bexB, as determined by PCR or DNA microarray, is a reliable marker of 
the capsule locus allowing for rapid and reliable differentiation between typeable and 
nontypeable H. influenzae. 
 
 Among our collection of 170 NTHi commensal (n = 75) and OM (n = 95) strains 
collected between 1994 – 2002 from children seven years of age or under living in 
Finland, Israel, or the United States: 
o 72 % were hmwA positive 
o hmwA-positive strains were distributed throughout the MLST phylogeny 
o 93 % of the hmwA-positive strains tested contained two hmw loci 




 Phylogenetic analysis of hmwA binding domain regions of 33 NTHi strains (16 
commensal and 17 OM strains) from this collection revealed four distinct sequence 
clusters. 
o 94 % of hmwA positive strains possessed a Cluster 1 hmwA 
o 84 % of the hmwA sequences belonged to either Cluster 1 or 2 
o sequences did not cluster by locus, geographic location, or disease 
 
 HMW adhesin molecular evolution is driven by positive (e.g., diversifying) selection. 
o the majority of positively selected amino acids are localized to the hmwA binding 
domain region 
o the majority of positively selected amino acids are located in structural regions 
predicted to contain hydrophilic loops and turns 
 
 Mathematical modeling of HMW adhesin phase variation demonstrated: 
o in the absence of antibody mediated immunity,  
 phase variation generates a nearly uniform within-host population 
distribution 
 including large deletion events has little effect on the population 
distribution 
o in the presence of antibody mediated immunity,  
 the within-host population is highly skewed and consists entirely of cells 
with low HMW-levels (immune evasive cells) 
 inclusion of large deletion events (catastrophic losses) allows for the 
maintenance of a small population of adherent cells that may be important 
for sustaining colonization and/or maintaining transmission 
 
 The HMW adhesin phase variation model results suggest that antibody levels, antibody 
avidity, catastrophic loss rates, and population carrying capacity significantly affected 






The work presented in Chapters 3, 4, and 5 addressed three different aspects of NTHi 
HMW adhesins.  Each chapter marks only the beginning of a journey that, I believe, has 
provided new and interesting insights regarding the evolution of HMW adhesins, the role of 
HMW adhesin phase variation during colonization, and potential implications of phase variation 
for NTHi transmission.  Below I outline several future directions aimed at advancing our 
understanding of HMW adhesins and their role in colonization and disease. I have made an effort 
to offer suggestions that maintain the interdisciplinary spirit of this work and thus include 
projects that range from the bench top, to the population-level, and to the theoretical.  
The hmwA prevalence and sequencing project presented in Chapter 3 can take a number 
of future directions. The first thing that must be done is to verify hmwA prevalence and copy 
number results with a probe based approach to confirm the PCR based approach used in the data 
presented. In a small number of strains, I experienced considerable difficulty amplifying one or 
both hmwA loci; I attribute the difficulty to sequence diversity within the hmwA locus specific 
PCR primer annealing regions. Probe based methods are less sensitive to nucleotide diversity 
than are PCR-based methods since probes generally anneal to a much larger region of the target 
gene than do PCR primers. The hmwA-leader PCR primers used to screen our strain collection 
can be used to generate an hmwA probe that will hybridize to the signal sequence region of both 
hmwA1679 and hmwA1598. I suggest a two-step approach to screening the strain collection. First, 
genomic DNA of each strain will be interrogated in a dot blot assay using the hmwA probe; this 
will identify hmwA-positive strains but yields no information on the number of loci present. 
Next, the hmwA-positive strains identified with the dot blot, will be interrogated with a Southern 
blot analysis which will determine the number of hmwA loci per strain. Unfortunately, 
determining whether the loci are in conserved chromosomal locations, as previous studies 
suggest, would require a PCR-based approach.  
Previous studies suggest that the HMW adhesins are associated with various other NTHi 
characteristics, such as, the absence of the hia adhesin and certain biochemical traits.  
Using the current strain collection, these would be interesting avenues to explore in further 
understanding the relationships among NTHi microbial factors.  The hia adhesin is a homolog of 




HMW adhesins or an Hia adhesin (1, 7, 8, 14).  Similar to hmw, hia displays marked nucleotide 
diversity and thus would likely prove challenging to screen with a PCR-based approach. Thus a 
probe based approach, as described above, would be preferable. There are also several 
biochemical characteristics associated with strains that possess hmw. For example, hmwA- 
containing strains are typically urease-positive but tend to show negative test results for both 
ornithine decarboxylase and lysine decarboxylase activity (7). The urease operon, like the hmw 
loci, are more prevalent among disease (AOM and COPD) isolates than throat isolates (17). 
These biochemical properties can easily be screened with standard biochemical assays. 
Combining biochemical data with hmwA prevalence data will deepen our understanding of 
potential NTHi virulence associated phenotypes, and, more importantly will more precisely 
define the role, or lack thereof, of HMW adhesins in AOM pathogenesis. For example, an 
alternative hypothesis to HMW adhesins being important for pathogenesis is that urease activity 
is important for AOM pathogenesis and hmwA prevalence among disease isolates reflects linkage 
between hmwA and the urease operon, not hmwA’s contribution to pathogenesis. This might 
explain why HMW-positive strains are more prevalent among OM isolates but HMW protein 
production is reduced in OM strains relative to commensal strains. This hypothesis could be 
tested using a population-level epidemiologic approach and/or an experimental approach using 
an animal model of otitis media pathogenesis. The epidemiologic approach would rely upon 
statistical analyses to determine if there are significant associations between phenotype, e.g., 
urease activity, and disease; epidemiologic studies could be conducted with phenotypic data, 
genotypic data, or a combination of both. Experimentally, this hypothesis could also be tested by 
comparing a wild-type urease-HMW-positive strain to isogenic single ure and hmwA mutants 
and a ure-hmwA-double mutant in an animal model (e.g., chinchilla) of otitis media. Ideally, both 
approaches would be employed. 
HMW adhesins are phase variable and previous studies have demonstrated that strains 
isolated from ears of children with acute otitis media encode a higher number of SSRs than do 
isogenic strains collected from the throat (5). Increases in repeat number have also been 
documented in serial isolates collected over time from the sputum of individuals suffering from 
COPD (2). The strain collection used in this study affords an opportunity to determine if, on 
average, OM isolates possess a higher number of hmwA SSRs than commensal isolates. Thus, 




located within hmwA promoter region of each locus. These data, especially those collected from 
commensal isolates, could be used in combination to test the predictions of the mathematical 
model presented in Chapter 5. There are, however, some limitations to using this strain collection 
to compare SSR numbers in the throat versus the ear. First, the strains in this collection are not 
matched isolates; that is, they were not collected at the same time from the same individual. 
Comparisons between OM versus commensal isolates may, therefore, be confounded if the 
relationship between repeat number and HMW production varies from strain-to-strain depending 
on the total genetic content of a specific strain. Secondly, it is possible that sample collection 
methods could influence such a comparison, as OM isolates are cultured from fluid collected 
from the middle ear space whereas commensal isolates are collected from the throat using a 
swab. For example, fluid collected from the middle ear may be enriched for non-adherent NTHi 
(i.e., those with a large number of SSRs and low HMW adhesin production) whereas collecting 
samples with a swab may increase the probability of collecting adherent cells (i.e., those with 
fewer SSRs and higher HMW adhesin production).  
The presence of hmwA only tells part of the story in NTHi pathogenesis. A more 
biologically relevant question is whether hmwA-positive strains actually produce functional 
HMW adhesins. To make the link between the presence of hmwA and production of HMW 
adhesins, Western blotting could be performed on the hmwA-positive strains. There are several 
methods by which antibodies targeting HMW could be acquired. First, pooled adult human 
serum would be a good source of antibodies for such an experiment, but pooled serum would 
contain antibodies directed against multiple different NTHi antigens. It would be necessary 
therefore to reduce the non-HMW antibodies by first absorbing the sera against NTHi strain 11, 
which does not encode HMW adhesins, or possibly against a genetically engineered NTHi strain 
12 lacking both HMW adhesins. An alternative strategy would be to generate monoclonal 
antibodies against a conserved region of the HMW adhesins, for example, antibodies directed 
against epitopes localized to the HMW adhesin stalk region (Fig 4.1b). Quantitative data on 
HMW adhesin production would be especially interesting when considered in conjunction with 
data on hmwA repeat number; previous studies have demonstrated an inverse relationship 
between repeat number and protein production (4, 5, 9). Furthermore, comparing quantitative 
data could improve our understanding of role of HMW adhesins in colonization and disease.  For 




than commensal strains. Finally, quantitative data would overcome some of the limitations 
inherent in simply relying on SSR number as a proxy for HMW protein production when making 
comparisons between strains as it should control for potential differences in strain-specific 
relationships between repeat number and protein production. 
 Phylogenetic analysis of the hmwA core binding domain sequences identified four 
distinct sequence clusters. Previous studies have defined two different HMW adherence profiles, 
HMW1-like and HMW2-like. The number of NTHi strains for which adherence profiles have 
been reported is limited; in fact, adherence profiles are only available for three of the NTHi 
strains (2, 12, 13) included in the analyses of Chapter 3 and 4, combined. van Schilfgarrde et al., 
tested several NTHi strains against two specific tissue culture cell lines (Chang and NCI-H292), 
with or without dextran sulfate, and defined four distinct adherence patterns among 22 hmw-
positive strains (16); 17/22 exhibited either HMW1-like or HMW2-like adherence. Based on the 
phylogenetic analyses presented in Chapters 2 and 3, all three of the strains encode one HMW 
adhesin belonging to Cluster 1 and a second belonging to Cluster 2 (Figure 3.2 and 4.2). Thus, it 
would be interesting to determine the adherence profiles of representative strains from hmwA 
sequence Clusters 3 and 4. Since current approaches to defining in vitro NTHi adherence profiles 
rely on a limited number of tissue cell lines, using a more sensitive technique, such as glycan 
microarrays (3, 10) or a larger sample of relevant human cells could provide more discriminatory 
power for defining HMW-specific adherence characteristics. 
 We observed a small number of strains in this collection with nearly identical hmwA 
sequences at both chromosomal loci, and this pattern was consistent with a recent gene 
conversion event. It would be interesting to actually test for gene conversion events, and estimate 
their frequency using a flux analysis similar to that employed in a recent study of H. pylori gene 
conversion (15). If gene conversion events are documented, then a next step would be to 
determine if the donor DNA came from within the cell or was taken up from the environment.  
This can be determined using bacterial cells deficient in DNA uptake mechanisms. 
 Several areas of HMW phase variation can be explored with the mathematical model 
presented in Chapter 5. HMW adhesins are usually present in two copies per chromosome. In the 
current model, however, only a single adhesin is considered. A logical extension of this model 




function of several factors. The effect of including a second adhesin on the within host 
population structure would likely be most impacted by the degree of amino acid similarity 
between the two adhesins. The hmwA sequencing component of this work highlighted the degree 
of variation between hmwA loci within a cell, ranging from nearly identical to only 54% amino 
acid identity. For nearly identical HMW adhesins, the bacteria may derive little benefit by having 
a second adhesin since the primary driver of within host dynamics is host immunity. There may, 
however, be an advantage in terms of increased adherence for a cell expressing two nearly 
identical adhesins. In contrast, cells that display genetically diverse adhesins may experience 
very different within host dynamics driven by two factors: the extent to which expression of the 
adhesins is coordinated and the degree of cross-reactivity between the two hmwA loci. There is 
no direct evidence of coordinated regulation of HMW expression, although to the best of my 
knowledge this has not been formally tested, nor is there reason to suspect any form of 
coordinated phase variation at the two hmwA loci. The mechanism of SSR variation, slipped 
stranded mispairing, is a stochastic event that occurs during DNA synthesis and the numbers of 
tandem repeats at each locus within an individual NTHi isolate vary. Thus, if little antigenic 
cross-reactivity exists among HMWs and the hmw loci vary independently of one another, then 
incorporation of a second locus would be expected to have little impact on within-host 
population dynamics. On the other hand, if little cross protection exists and only a single adhesin 
is expressed at one time, then having two loci could extend the HMW-mediated adhesive activity 
and colonization potential of the NTHi population. This could impact both the number of 
adherent cells present at any given time and the duration of time that adherent cells are present. 
Both of these could have important implications for NTHi transmission. 
 Another focus of model modification could be the immune response. We observed that 
increasing the strength of the immune response (varying Abmax) had an unexpected effect on 
NTHi within-host dynamics. Specifically, as Abmax increased the amount of time that adherent 
cells were maintained in the population was also increased. This could have important 
implications for assessing vaccine effectiveness. Thus, another logical extension of the model is 
to represent the immune response in the model in a more mechanistic way. This could be 
informed, for example, by the expectations of previous exposure to a specific HMW or to 
effective vaccination against a specific HMW. In the simplest case, this can be achieved by 




be expected to be faster and to reach a higher titer (Abmax) than a primary response as currently 
implemented. 
 In the current model, only the first 20 days of a colonization event are simulated. At the 
end of the simulation, the majority of the NTHi population is “immune evasive” and there is a 
small but stable population of adherent cells. Incorporating more complex immune dynamics, for 
instance, including waning of the primary response to the HMW adhesin may illuminate more 
complex within-host population dynamics. For example, as the antibody concentration begins to 
decrease, the number of adherent NTHi cells maintained within a host may increase; 
maintenance of a larger population of adherent cells would have implications for NTHi 
transmission.   
Sensitivity analyses of the hmwA repeat region mutation rates demonstrated that the 
critical parameter determining within-host population structure is the rate of catastrophic loss 
events, not the overall mutation rates (e.g., the gain/loss of one or two repeats). These results 
suggest that spending a great deal of time, and money, gathering precise estimates of hmwA SSR 
mutation rates with an in vitro experimental system may not be an efficient use of resources. 
This conclusion, however, is predicated on the assumption, which may not be true, that hmwA 
SSR, which are located within the promoter, are under the same constraints as the mod 
tetranucleotide SSRs, which are located within the coding frame. I would argue that 
characterizing the mutation rates is important, not necessarily for the impact it will have on the 
within host population dynamics, but for gaining a basic understanding of the mechanisms that 
regulate the mutability of SSRs located within the hmwA promoter. For example, specifically 
interrogating hmwA SSRs could verify whether or not hmwA SSR mutation rates increase with 
tract length as demonstrated with mod (6) and as assumed for our model parameterization. 
Additionally, an in vitro system could be used to verify the catastrophic loss mechanism that we 
proposed in our model. This would, however, be a daunting task give the potential rarity of such 
events, making our theoretical approach all the more necessary in generating hypotheses about 
this complex system.  
In conclusion, I would like to finish by addressing the question that initially piqued my 
interest in the questions addressed in this work: Are the HMW adhesins good vaccine 




more prevalent among AOM-causing strains than commensal strains, arguing for their suitability 
as vaccine antigens. The sequence diversity and the fact that the adhesins are phase variable, 
while posing challenges for vaccine development, do not necessarily preclude the possibility that 
they could be effective vaccine targets. For example, if AOM-causing strains formed 
phylogenetic clusters distinct from commensal isolates it might be possible to target specific 
HMW alleles, potentially reducing the complexity of the problem. The same can be said for 
HMW adhesin phase variation: if HMW adhesin production were required for virulence and/or 
transmission, an effective vaccine could potentially prevent disease given colonization or reduce 
transmission, respectively. Chapters 3, 4, and 5 address topics that are relevant to assessing the 
utility of HMW adhesins a vaccine targets. The fact that hmwA sequences in this study did not 
cluster by disease suggests that, as suspected, HMW adhesin amino acid diversity would present 
a significant challenge. Given the immunogenicity of HMW adhesins, the amino acids predicted 
to be subjected to positive selection are likely important for immune evasion. This information 
could potentially be used to inform antigen selection; for example, specifically avoiding the 
regions that are subject to positive selection might increase the probability of identifying 
antigens that stimulate a more broadly protective immune response. An alternative strategy 
would be to target the more conserved carboxyl terminus of the HMW adhesins; this is 
somewhat analogous to the approach being implemented in the pursuit of a universal influenza 
vaccine (11). The mathematical modeling results, however, suggest that a strong immune 
response directed against HMW, as might result from exposure to an antigen following 
successful vaccination, actually could lead to adherent cells appearing more rapidly during 
colonization. Assuming the adherence phenotype is important for transmission, this result 
suggests that vaccination may potentially increase NTHi transmission and this effect would be 
independent of the region of the mature HMW adhesin targeted, the core binding region or the 
conserved stalk region. Taken together, these findings argue against HMW adhesins as viable 
vaccine targets. I reach this conclusion, not because of the results presented in any one chapter, 
but instead by synthesizing all three chapters which I believe highlights the value of the 
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